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Abstract 
Introduction:  Behavioral lifestyle interventions to prevent type 2 diabetes have been successful 
in reducing the risk of diabetes in clinical studies, while translational programs have 
demonstrated the ability to reduce diabetes risk factors in various community settings.  However, 
there remain important questions about the impact of translational diabetes prevention programs 
on non-clinical factors like health-related quality of life (HRQoL) and the time and expenses 
faced by participants in these programs.  
Methods:  Data were collected from participants at three sites where the Group Lifestyle 
Balance (GLB) program, a behavior lifestyle intervention program adapted from the Diabetes 
Prevention Program (DPP) was delivered.  Paper 1 reports on HRQoL among participants in a 
GLB intervention presented by diabetes educators at outpatient clinics.  Paper 2 continues the 
investigation of HRQoL in a GLB program delivered through a medical clinic using group and 
DVD delivery modes.  In Paper 3, direct nonmedical expenses for food and physical activity, as 
well as time in intervention-relate activities are reported. 
Results:  Papers 1 and 2 showed that participants in a translational diabetes prevention 
interventions experienced modest improvements in HRQoL, measured by different assessment 
instruments.  The findings in Paper 3 indicate that diabetes prevention participants can reduce 
clinical risk factors for type 2 diabetes without incurring additional expenses for food or physical 
activity, beyond expense of time due to involvement in activities related to the intervention. 
v 
Public Health Significance:  Many individuals at elevated risk of type 2 diabetes consider 
themselves in good health.  However, these individuals may face morbidities associated with 
type 2 diabetes unless they reduce their risk of the disease.  Behavioral lifestyle intervention 
programs have demonstrated the ability to reduce diabetes risk.  This dissertation suggests there 
may also be improvements in quality of life.  This should help individuals at risk view 
prevention programs more positively, especially since participants need not incur significant 
additional out-of-pocket expenses.  The summary message should be that you can reduce your 
risk of diabetes through moderate lifestyle intervention; you might feel a bit better; and it won’t 
cost you much as long as you are willing to commit some time to the intervention. 
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1.0 INTRODUCTION 
1.1 RISK AND IMPACT OF DIABETES 
It is estimated that over 40% of American adults have hyperglycemic conditions, including type 
2 diabetes, impaired fasting glucose (IFG), and/or impaired glucose tolerance (IGT) [1].  
Although the criteria for the metabolic syndrome overlap with other hyperglycemic categories, 
more than 34% of adults aged 20 and over are also estimated to have the metabolic syndrome 
[2].  Additionally, the presence of prediabetes and the metabolic syndrome raise the risk of type 
2 diabetes [3,4].  
The physiologic impacts of diabetes are substantial, and include elevated risk of heart 
disease and stroke, blindness, kidney disease, nervous system damage, and amputations [5].  
There are also under-acknowledged effects of diabetes on health-related quality of life (HRQoL) 
such as reduced mobility and pain or discomfort [6].  For many individuals with diabetes, the 
effects of these complications are some of the most immediate and debilitating consequences of 
the disease, dramatically affecting HRQoL. 
In addition to the impact of diabetes on the individual, the economic impact of diabetes is 
considerable.  In 2007, the total economic cost of all types of diabetes in the US was 
conservatively estimated at $174 billion [7], including excess medical expenditures and the cost 
of reduced national productivity due to diabetes.  Of that $174 billion, the cost of type 1 diabetes 
2 
is estimated at $14.9 billion or about 8.6% of the total [8].  This is in line with estimates that type 
1 diabetes accounts for 5-10% of all diabetes cases [9], suggesting that the economic costs of 
type 1 diabetes and type 2 diabetes are roughly proportional to their prevalence in the population.  
In 2012, the estimated economic cost of diabetes had risen 41% to $245 billion in constant 2007 
dollars [10].  The health and economic impacts of diabetes are thus substantial, and diabetes 
makes a considerable contribution to the national disease burden on both individual and societal 
bases. 
Using data from the National Health Interview Surveys (NHIS) from 1984 to 2000, it is 
estimated that for those born in 2000, the lifetime risk for diabetes is 32.8% for males and 38.5% 
for females [11], with 90-95% of the risk being for type 2 diabetes.  Simulations of future rates 
and impacts forecast that both the numbers of people with type 2 diabetes and the costs 
associated with type 2 diabetes will continue to rise.  The number of people with diabetes is 
predicted to increase from 23.7 million to 44.1 million in the 25 years between 2009 and 2034, 
with a near tripling of annual diabetes related spending ($113 billion to $336 billion) in constant 
2007 dollars [12].     
1.2 DIABETES PREVENTION 
To help mitigate the increasing public health burden of type 2 diabetes, the Diabetes Prevention 
Program (DPP) was tasked with determining whether it was possible to prevent or delay the 
onset of type 2 diabetes, using either a pharmacological or lifestyle approach.  After an average 
follow-up of 2.8 years, the DPP clinical trial concluded that a structured behavioral lifestyle 
intervention, with targeted activity and dietary goals, was more effective than the anti-diabetes 
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drug metformin in reducing the risk for type 2 diabetes and the metabolic syndrome among those 
at elevated risk [13,14].  International studies have reported similar findings on the efficacy of 
moderate lifestyle change in reducing the risk of developing type 2 diabetes [15,16].  
Effectiveness trials using modified versions of the original DPP curriculum have also been 
successful [17-50], establishing a solid scientific basis to assert that type 2 diabetes should to a 
great degree be considered a preventable condition.  Given the DPP lifestyle results, which 
importantly were achieved without impacting hospitalization or mortality rates [13], 
interventions promoting moderate, healthy lifestyle changes should be considered a safe and 
effective public health prescription to prevent type 2 diabetes.   
1.3 DIABETES AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) 
While the Diabetes Prevention Program (DPP) and translational programs derived from it [17-
50] have been successful in reducing risk factors for type 2 diabetes and/or the metabolic 
syndrome (risk factors include excess body weight, low HDL cholesterol, high triglycerides, 
high blood pressure, and elevated blood glucose [51]), there is increasing interest in using 
informative, non-clinical criteria when evaluating the impact of such programs.  For example, in 
the DPP, HRQoL was assessed over the course of the investigation, with HRQoL scores related 
to physical condition and vitality showing improvements at clinical follow-up points, relative to 
baseline values [52].  This suggests a connection between diabetes risk factors and improvements 
in quality of life.  It also points to potential benefits of weight loss, physical activity, and 
improved nutrition that extend beyond the reduction of clinical risk factors.   
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In addition to improvements in HRQoL reported in the DPP clinical trial [52], benefits to 
HRQoL have been reported in other lifestyle efficacy studies.  The Swedish Björknäs study was 
an efficacy trial designed to improve cardiovascular disease risk factors using an intervention 
“broadly based” on the DPP [53].  Over a three year period, participants in the Björknäs study 
reported significant improvements in HRQoL physical components and in the EuroQol Visual 
Analog Scale (EQ-VAS) [54].  As well, in a consensus statement the International Diabetes 
Federation asserted that “early intervention and avoidance or delay of progression to Type 2 
diabetes is of enormous benefit, both to patients in terms of increasing life expectancy and 
quality of life” [55].  The few efficacy studies that have examined HRQoL thus establish a basis 
to anticipate that participants in community translational interventions for preventing type 2 
diabetes would likewise experience improvements in HRQoL.  To this point, however, this has 
not been documented.  
1.4 COSTS OF DIABETES PREVENTION 
While the economic costs to society for treating the morbidities and reduced productivity 
associated with diabetes are enormous [10], it is predicted that a national diabetes prevention 
program would produce nationwide savings [56].  These types of cost analyses take a broad 
perspective, reporting on overall costs or benefits to the economy or health care system.  
However, there are expenses related to diabetes and its prevention that impact the individual that 
have not been well documented.  For example, there is the time commitment and out-of-pocket 
costs to participants related to involvement in a diabetes prevention program.  When 
participating in a behavioral lifestyle intervention designed to prevent or delay type 2 diabetes 
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and the metabolic syndrome, participants are encouraged to modify their dietary and physical 
activity behaviors.  This requires a commitment of time for program attendance and additional 
physical activity, as well as the potential for changes in out-of-pocket expenses related to food 
choices and transportation, as well as services or items to facilitate increased physical activity.  
Since food expenses have been shown to be the second most important factor behind taste in 
determining dietary choices [57], combined with a perception in the general population that 
healthy foods are more expensive than less healthy options (even if this is not necessarily true 
[58]), expenses, both for food and for other aspects of program involvement may thus be 
perceived as an obstacle to successful participation in a community diabetes prevention program, 
as well as for longer term maintenance of healthy lifestyle behaviors. 
 When considering the costs of a diabetes prevention intervention, several categories of 
expenses may be considered.  Of most immediate interest from the participant’s perspective are 
the direct nonmedical costs, those expenses which occur due to involvement in the program, but 
are not related to actual delivery of the program.  These direct nonmedical costs include the 
value of time spent in the intervention; expenses on services, equipment, or clothing to facilitate 
physical activity; changes in food expenses and additional expenses for food preparation 
equipment; and transportation expenses.   In the Diabetes Prevention Program (DPP), direct 
nonmedical costs for participants in the lifestyle intervention group were $1445 higher over three 
years, compared to the placebo (placebo $15,692, lifestyle $17,137) [59].  The largest component 
contributing to the higher cost for the lifestyle group was the time-cost to the participants of the 
intervention visits—the actual value of time spent in the intervention that would have otherwise 
been spent elsewhere.  Additional small contributing categories were exercise and health club 
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services, and transportation expenses.  Food costs for the lifestyle intervention group were $71 
less over three years, compared with the placebo [59]. 
There is only one prior report on participant costs related to involvement in a diabetes 
prevention program based on the DPP.  The Healthy Living Partnerships to Prevent Diabetes 
(HELP PD) found that expenses for lifestyle participants were $955 (or $1.31/day) greater than 
for the usual care participants over two years [60].  If this is confirmed in further translational 
studies, and by more comprehensive analyses, it would help reduce concerns that reducing 
diabetes risk factors through adopting a healthy lifestyle requires a significant financial outlay, 
beyond the time commitment necessary for successful participation in the intervention.  Such a 
finding could be a helpful catalyst to reduce financial fears among many, particular those of 
lower socioeconomic status, which could contribute to a reluctance to participate in healthy 
lifestyle interventions from which they could derive substantial benefit.  
These two topics, quality of life and cost, together constitute much of what a participant 
in a diabetes prevention intervention most directly experiences.  Simply put, the answer to the 
questions “how do I feel and what’s it costing me?” have an enormous impact on a participant’s 
satisfaction with an intervention, and thus their willingness to remain enthusiastically engaged.  
Despite the importance of these issues, to this point there are limited reports addressing either 
quality of life issues or changes in expenses that participants face due to their involvement in 
diabetes prevention programs in the community. 
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1.5 STUDY GOALS 
Research findings have demonstrated that type 2 diabetes can be prevented, or the onset of 
diabetes can be delayed, using a behavioral lifestyle approach that includes moderate dietary, 
weight loss, and physical activity goals.  Translational intervention programs have been effective 
in adapting successful clinical lifestyle approaches for community group delivery.  In terms of 
expenses, the Diabetes Prevention Program (DPP) clinical trial reported that direct, nonmedical 
costs to participants were modest, with the major additional expense being that of the time spent 
participating in intervention activities.  There have, however, been few reports on health-related 
quality of life among participants in translational diabetes prevention interventions.  
Additionally, direct nonmedical expenses accrued by participants in translational diabetes 
prevention intervention have not been thoroughly examined.  
Based on the state of the literature, summarized above, this dissertation will analyze and 
describe the experience of participants in a modified DPP known as the Group Lifestyle Balance 
(GLB) program [18], a translational lifestyle intervention program that has been successfully 
implemented in a variety of community settings, [17,19-25].  The focus will be on the participant 
experience in terms of effects that are tangible and discernible from the participant’s perspective.  
Specifically, it will include an evaluation of changes in health-related quality of life among 
participants over the course of the intervention, as well as an investigation of direct, nonmedical 
out-of-pocket expenses and time expenses related to program participation.   
The following two questions will be examined in three papers that report findings from three 
separate GLB interventions: 
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1. What changes in health-related quality of life (HRQoL) occur among participants 
over the course of involvement in a translational diabetes prevention program 
delivered in the community? 
This question will be addressed in papers 1 and 2.  Paper 1 reports on changes in HRQoL 
among participants in a GLB program delivered by trained diabetes educators in three hospital 
outpatient settings.  This was a single group, non-randomized prospective study, with clinical 
evaluations at baseline, four, six, and 12-months.  At each clinical visit, participants completed 
the CDC HRQoL–14 Healthy Days Measure (CDC HRQoL) [61].  This assessment tool consists 
of four core questions about general health and the number of unhealthy days during the past 30 
days, followed by ten questions about recent levels of pain, depression, anxiety, sleeplessness, 
and vitality; and the cause, duration, and severity of any current limitation of activity.  As well as 
reporting changes in HRQoL over the course of the intervention, additional analyses will be 
presented that compare HRQoL categories with attendance of GLB session, as well as 
achievement of weight loss and physical activity goals.  It is hypothesized that modest 
improvements in HRQoL will occur among participants in the GLB program, compared to 
baseline. 
Paper 2 contains an analysis of HRQoL changes in a second GLB intervention, a pilot 
project evaluating two modes of delivering the intervention program:  a traditional group setting 
in a primary care clinic, and via DVD with telephone support. The goal was not to compare 
delivery modes, but rather to demonstrate the effectiveness of the DVD as an alternative to the 
established and successful group mode.  In this non-randomized study design, participant 
HRQoL was assessed by the EuroQol EQ-5D-3L™.  This instrument consists of two 
components:  the EQ-5D, on which participants indicated their current level of functioning in 
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each of five dimensions (mobility, self-care, usual activities, pain and discomfort, anxiety and 
depression) by choosing one of three levels, equivalent to “none,” “moderate,” and “extreme.” 
These five dimensions can be converted into a single index score that summarizes overall 
HRQoL.  Also part of the EuroQol EQ-5D-3L is the Visual Analogue Scale (VAS) which 
consists of a figure resembling a thermometer marked 0-100.  Participants use this device to 
report their current health state, with zero representing the “worst imaginable health state” and 
100 represents the “best imaginable health state.”  It is hypothesized GLB program participants, 
regardless of delivery mode, will report increases in some HRQoL components, compared to 
baseline values.   
Taken together, these two papers will provide an accounting of HRQoL among 
participants in translational diabetes prevention interventions, using a variety of assessment tools 
and analytical approaches.  These findings will add to the existing literature about type 2 diabetes 
prevention and quality of life in community-delivered diabetes prevention programs based on the 
DPP behavioral lifestyle intervention. 
2. What changes in direct nonmedical out-of-pocket expenses do participants face 
while taking part in a translational diabetes prevention program?  Are there 
associations between attainment of the program goals for weight loss, physical 
activity, or session attendance, and the amount spent or types of expenditures 
made by participants? 
Paper 3 will present results from participants in a GLB intervention delivered through a 
network of community centers with a high proportion of older adults.  At the clinical baseline 
and follow-up visits, participants completed a multi-question expenses survey that captured the 
time and out-of-pocket expenses related to their involvement in the intervention.  The survey was 
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compiled for this investigation from various sources, including the National Health and Nutrition 
Examination Survey (NHANES) Consumer Behavior Questionnaire [62].  In addition to the 
survey, participants were requested to save household food purchase receipts for two-week 
periods, providing a supplementary itemized record of food purchase amounts at grocery and 
other food stores, take-out food, and restaurants. It is hypothesized that participants will 
experience little change in direct nonmedical expenses over the course of the intervention, 
compared with baseline.  Additionally, some associations between clinical or behavioral 
outcomes and money or time expenses will emerge. 
These findings will help strengthen the diabetes intervention and prevention literature 
regarding the direct expense to participants in prevention efforts.  As well, they will provide 
values of typical participant expenses that can be used to inform perspective participants as to the 
time and expense commitments associated with involvement in a translational diabetes 
prevention program. 
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2.0 HYPERGLYCEMIC CONDITIONS:  DIABETES AND THE METABOLIC 
SYNDROME 
Three main types of diabetes are generally recognized, conditions where for various reasons 
blood glucose is elevated above a normal level: type 1 diabetes and gestational diabetes will be 
briefly described; type 2 diabetes will be addressed in greater depth as it is the focus of this 
dissertation. 
2.1 TYPE 1 DIABETES 
Previously referred to as juvenile or childhood diabetes, and alternatively known as insulin 
dependent diabetes mellitus (IDDM), type 1 diabetes is an autoimmune disease where insulin 
producing beta cells in the pancreas become damaged and are unable to produce sufficient 
insulin [63].  This results in elevated blood glucose levels.  Although diabetes statistics at times 
lump type 1 and type 2 diabetes together (in economic analyses, for example [10]), type 1 
diabetes accounts for 5-10% of all diabetes cases [9], with the incidence of type 1 diabetes 
increasing in children and youth by about 3% per year [64].  A summary of the characteristics of 
type 1 and type 2 diabetes is presented in Table 2.1. 
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Table 2.1 Characteristics of Type 1 and Type 2 Diabetes 
Characteristics Type 1 Type 2 
Age 6 months to young adulthood Usually pubertal (or later) 
Clinical presentation Most often acute, rapid 
Variable: from slow, mild 
(often insidious) to severe 
Insulin dependence Permanent, total, severe 
Uncommon, but insulin 
required when oral 
hypoglycemic agents fail 
Insulin sensitivity Normal Decreased 
Frequency (% of all diabetes 
in young people) 
Usually 90%+ 
Most countries <10% (Japan 
∼80%) 
 Association with Obesity No Strong 
Derived from [65,66]  
 
The long-term vascular complications of type 1 diabetes include retinopathy, 
nephropathy, neuropathy, and macrovascular disease. Diabetic retinopathy results in visual 
impairment and blindness; diabetic nephropathy leads to renal failure and hypertension; diabetic 
neuropathy leads to pain, muscle weakness and autonomic dysfunction; diabetic macrovascular 
disease raises the risk of cardiac disease, peripheral vascular disease and stroke [67].  It will be 
noted in the next section that these complications and morbidities are also experienced by those 
with type 2 diabetes.  This is not unexpected, for although the etiologies of type 1 and type 2 
diabetes are different, they both result in persistently elevated blood glucose which negatively 
impacts organs and organ systems. 
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2.2 TYPE 2 DIABETES 
2.2.1 Background and Epidemiology 
Type 2 diabetes was formerly known as adult onset diabetes, or non-insulin dependent diabetes 
mellitus (NIDDM).  This chronic, lifestyle-related disease is characterized by an elevated level 
of plasma glucose.  The state of elevated plasma glucose arises from a relative, not an absolute 
insulin deficiency, as pancreas insulin production does continue.  Rates of type 2 diabetes have 
increased steadily over recent years to the point where it has been labeled an epidemic due to its 
current and anticipated impact on global health [68].  The prevalence of diabetes diagnoses in the 
US rose from 5.1% in 1988-1994 to 7.7% in 2005-2006 [1], and it is estimated that in 2010, 25.6 
million or 11.3% of those aged 20 and older had diabetes [5].  Of these numbers, 90-95% of the 
cases are type 2 diabetes [69].   Globally, the World Health Organization (WHO) estimates that 
approximately 312 million people have type 2 diabetes [70], with this number projected to rise to 
380 million by 2025 [71].  
2.2.2 Diagnostic Criteria 
The 2012 American Diabetes Association criteria for the diagnosis of type 2 diabetes are: [72] 
 A1C ≥6.5%. The test should be performed in a laboratory using a method that is NGSP 
certified and standardized to the DCCT assay.* 
OR 
FPG ≥126 mg/dl (7.0 mmol/l). Fasting is defined as no caloric intake for at least 8h.* 
OR 
2-h plasma glucose≥200mg/dl (11.1mmol/l) during an OGTT. The test should be 
performed as described by the World Health Organization, using a glucose load 
containing the equivalent of 75 g anhydrous glucose dissolved in water.* 
OR 
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In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random 
plasma glucose ≥200 mg/dl (11.1 mmol/l). 
 
* In the absence of unequivocal hyperglycemia, criteria 1–3 should be confirmed by 
repeat testing. 
2.2.3 Risk Factors 
Risk factors for type 2 diabetes include: age > 45 years; first-degree relative with type 2 diabetes; 
African-American, Hispanic, Asian, Pacific Islander, or Native-American ethnicity; history of 
gestational diabetes or delivery of infant weighing ≥9 lbs; polycystic ovary syndrome; 
overweight, especially abdominal obesity; cardiovascular disease; hypertension; dyslipidemia, or 
other metabolic syndrome components [73].  While age, family history, race, and ethnicity are 
clearly non-modifiable, the other factors, particularly obesity, are very much amenable to 
intervention in order to reduce the risk of type 2 diabetes.   
With regard to weight, the Nurses’ Health Study showed that, after adjustment for age 
and body mass index at age 18 years, women who had a weight gain of 5.0 to 7.9 kg between the 
of age 18 and the year 1976 had a relative risk of 1.9 (95% CI, 1.5 to 2.3) of getting diabetes, 
compared with women with stable weight (those who gained or lost less than 5 kg between age 
18 years and 1976).  For women who gained 8.0 to 10.9 kg, the relative risk rose to 2.7 (CI, 2.1 
to 3.3).    A risk reduction for diabetes of 50% or more was noted among women who lost more 
than 5.0 kg after adjustment for age and body mass index at age 18 years [74]. 
Physical activity is also related to the development of diabetes, with Kriska et al [75] 
showing that the incidence rate of diabetes incidence was lower among more active individuals 
compared with less active individuals in all body mass index groups for both men and women, 
excepting the middle body mass index tertile in men.  The relation between physical activity and 
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diabetes incidence remained statistically significant (p < 0.01) when adjusted for age and body in 
women [75]. 
2.2.4 Pathologies in Type 2 Diabetes 
Continuing cellular exposure to high plasma glucose levels in type 2 diabetes leads to serious 
microvascular damage and debilitating morbidities, including retinopathy, neuropathy, and 
nephropathy, as well as damage to larger blood vessels, which raises the risk of heart attack and 
stroke [76,77].  Among adults aged 20-74, the most common cause of new blindness is diabetic 
retinopathy, with >60% of patients with type 2 diabetes acquiring retinopathy within 20 years of 
diagnosis [78].  Nephropathy associated with type 2 diabetes is the leading cause of end stage 
renal disease in the developed world, with 40% of patients starting dialysis in 1998 in the US 
having diabetic nephropathy [79].    
2.3 GESTATIONAL DIABETES 
Gestational diabetes mellitus is a state of elevated blood glucose that emerges during pregnancy 
among women without a prior diagnosis of diabetes [80].  In a review, rates of gestational 
diabetes varied dramatically by geography and racial/ethnic background, with a prevalence of 
less than 2% in Sweden, where there is universal screening; rising to 4.9% to 12.8% in high risk 
Native American, Hispanic, and Asian Americans; and as high as 17% among Indian women in 
Australia [81]. Given the large variability in reported rates, as well as conflicting guidelines and 
screening protocols, it is a controversial diagnosis [82].  In 2008, the US Preventive Services 
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Task Force revisited the issue of screening for gestational diabetes and confirmed the 2003 
finding that there was insufficient evidence to recommend for or against routine screening or 
treatment of gestational diabetes [83]. 
Even though blood glucose often returns to normal following pregnancy, gestational 
diabetes remains a risk factor for the development of type 2 diabetes [80].  Women with a history 
of gestational diabetes have a 35 to 60 percent chance of developing diabetes in the next 10 to 20 
years [5], higher than the 38.5% lifetime risk of acquiring diabetes for all women [11]. 
2.4 PREDIABETES 
2.4.1 Definition, Diagnosis Criteria, and Epidemiology 
Prediabetes is a state of elevated risk for developing type 2 diabetes that is characterized by 
blood glucose indicators that are elevated, but lower than the cut point for a diagnosis of diabetes 
[84].  Prediabetes is defined by The Expert Committee on Diagnosis and Classification of 
Diabetes Mellitus as the presence of impaired fasting glucose (IFG) (fasting plasma glucose 100-
125 mg/dl), impaired glucose tolerance (IGT) (2-hour values in the oral glucose tolerance test 
(OGTT) of 140 mg/dl to 199 mg/dl), or an HbA1C value of 5.7% to 6.4%  [72,85,86 ].  
In 2005, based on fasting plasma glucose and HbA1C levels, 35% of U.S. adults aged 20 
years or older had prediabetes, with a rate of 50% in adults aged 65 years or older.  This yields 
an estimate in the U.S. population in 2010 of 79 million American adults aged 20 years or older 
with prediabetes [5].  Among those with prediabetes, from 5-10% convert to diabetes each year, 
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and, although it may take many years, up to 70% of individuals with IGT and/or IFG develop 
diabetes [87].  
2.4.2 Pathophysiology 
Prediabetes arises due to a failure of body cells to respond to insulin, a condition known as 
insulin resistance.  When pancreatic beta cells can no longer produce enough insulin to overcome 
insulin resistance, blood glucose levels rise, first reaching prediabetes levels, and often 
increasing further to diabetic levels [88].  There is evidence that cellular insulin resistance and 
compensatory pancreatic insulin secretion increase occurs years before the actual development of 
type 2 diabetes [89], and that during the pre-diabetic phase, beta cell function decreases [90]. 
2.4.3 Pathologies in Prediabetes 
While prediabetes does not have a unique ICD-9 code, diagnosable only in the category of “other 
abnormal glucose” [91], there are nevertheless pathologies and complications, usually associated 
with diabetes, that often emerge during the pre-diabetic state.  Prediabetes has been associated 
with early nephropathy and chronic kidney disease [92,93] as well as a variety of neuropathies 
[84].  Although a long-recognized complication of diabetes, retinopathy has also been associated 
with prediabetes and the metabolic syndrome.  In the Diabetes Prevention Program (DPP), 7.9% 
of participants without diabetes showed signs of retinopathy [94].  Using fundus photography, 
lesions consistent with retinopathy were found in 12% of individuals in a study of Pima Indians 
with IGT, none of whom had diabetes at the time of the previous oral glucose tolerance test 
(OGTT) [95].  The Swedish NANSY-Eye Study also reported the presence of retinopathy before 
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the diagnosis of type 2 diabetes [96].  Insulin resistance, characteristic of prediabetes is 
associated with an increased risk of cardiovascular disease [97].  There is, however, evidence 
that any increased risk of cardiovascular disease may be due to the presence of multiple 
cardiometabolic risk factors, and that isolated hyperglycemia may not be a unique risk 
cardiovascular disease factor [98].  The relationship between prediabetes and ischemic stroke, as 
well, is inconsistent, [99].  Taken together, however, these findings support the notion that 
prediabetes may not be merely be a state of elevated risk of diabetes, but that in fact it has 
concomitant morbidities, particularly neuropathy, nephropathy, and retinopathy. 
2.5 THE METABOLIC SYNDROME 
2.5.1 Definition, Diagnosis Criteria, and Epidemiology 
The metabolic syndrome is defined by the National Cholesterol Education Program (NCEP) 
Adult Treatment Panel 3 criteria as a clustering of abdominal obesity, atherogenic dyslipidemia, 
hypertension, and insulin resistance.  Diagnostically, the metabolic syndrome is determined by 
the presence of three or more of the following five conditions: [100] 
1. elevated triglycerides (≥150 mg/dl)
2. low HDL cholesterol (<40 mg/dl for men, <50 mg/dl for women)
3. increased waist circumference (>102cm for men, >88cm for women)
4. blood pressure ≥130/85 mm Hg (or on treatment for hypertension)
5. elevated fasting plasma glucose ( ≥100 mg/dl).
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Analysis of National Health and Nutrition Examination Survey (NHANES) data from 2003-2006 
found that about 34% of US adults met the criteria for the metabolic syndrome [2], and over 40% 
of the population have either type 2 diabetes or prediabetes [1,101].   
 The above criteria, dating from 2001, have been widely used in the US, however, other 
international organizations have proposed alternatives, particularly with regard to the cut-off 
point for waist circumference, and whether or not central adiposity should be an obligatory 
component [102].  As well, there is question as to whether the metabolic system as a single 
factor has any more predictive or descriptive value than its individual components [103].  
Nevertheless, the metabolic syndrome, as defined above, continues to be used by many 
researchers as a diagnostic and predictive criterion. 
2.5.2 The Metabolic Syndrome as a Predictor of Type 2 Diabetes and Cardiovascular 
Disease 
When compared to those with no metabolic syndrome components, those with the three or more 
components of the metabolic syndrome were found to have an adjusted hazard ratio for 
developing type 2 diabetes of 22.50 (95% CI: 11.21-45.19), with abdominal obesity and 
hyperglycemia most strongly linked to an outcome of diabetes [3].  In review, Ford [104] 
concluded that, using the NCEP criteria, those with the metabolic syndrome had a relative risk 
for cardiovascular disease of 1.65 (1.38-1.99) and 2.99 (1.96-4.57) for type 2 diabetes.  
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2.6 THE COSTS OF TYPE 2 DIABETES 
In 2007, the total cost burden of diabetes and its complications in America was estimated at $174 
billion [7].  This amount consists of $116 billion in excess medical costs and $58 billion in lost 
national productivity, including disability, loss of work, and premature mortality [7].  People 
with diabetes have medical expenditures 2.3 times higher than those without diabetes, and about 
$1 of every $10 spent in the US is attributed to the cost of diabetes, along with 1 in every 5 
healthcare dollars being spent caring on an individual with diabetes [7].  By 2012, the estimated 
cost of all diabetes-related expenses had risen by 41% to $245 billion: consisting of $176 billion 
in direct medical costs, and $69 billion in reduced productivity [10].  
 Further analyses, conducted as part of the Novo Nordisk National Changing Diabetes 
Program, estimated that nearly $218 billion was spent on diabetes and prediabetes in the US in 
2007.  This included $14.9 billion for type 1 diabetes and $159.5 billion for diagnosed type 2 
diabetes [105], $18 billion for undiagnosed diabetes [106], $25 billion for prediabetes [107], and 
$636 million for diagnosed gestational diabetes [108].   
Simulations of the future rates and impact of diabetes project that both the numbers of 
people with diabetes and the related costs will continue to rise, with an increase from 23.7 
million to 44.1 million in the number of people with diabetes in the 25 years between 2009 and 
2034, and a near tripling of annual diabetes related spending ($113 billion to $336 billion) in 
constant 2007 dollars [12].  Clearly, then, hyperglycemic conditions constitute an enormous 
economic burden, one that can potentially be attenuated through programs designed to prevent 
type 2 diabetes. 
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2.7 PREVENTION OF TYPE 2 DIABETES AND THE METABOLIC SYNDROME 
Given the prevalence of diabetes and the personal and economic burden it imposes, efforts have 
been made to identify the best ways of preventing type 2 diabetes or delaying its onset.  Initially, 
this consisted of randomized clinical trials, followed by translational interventions in the 
community.  As individuals with prediabetes and the metabolic syndrome are at elevated risk for 
more serious conditions, including diabetes and cardiovascular disease, prevention efforts 
typically focus on the reduction of diabetes risk factors.  One approach is the use of behavioral 
lifestyle programs, including those adapted from the Diabetes Prevention Program (DPP) 
lifestyle intervention [13,14].  The focus of these programs is weight loss, a reduction of fat in 
the diet, and increased physical activity. 
2.7.1 Clinical Trials for the Prevention of Type 2 Diabetes 
The first major study investigating the possibility of diabetes prevention through lifestyle 
intervention was the Swedish Malmö study [109].  Enrolling 181 individuals with impaired 
glucose tolerance (IGT), the study protocol included a six-month period of supervised physical 
training and six months of dietary education.  In 1991, six-year follow-up results were published, 
indicating that it was possible to induce and maintain lifestyle changes in those with IGT, 
resulting in improvement in glucose tolerance as well as reducing blood pressure and lipids.   
Other international studies also demonstrated that lifestyle modification is an effective 
approach to prevent or delay diabetes.  Results from the Da Qing study in China showed that 
participants with IGT randomized to one of three active treatment groups, consisting of diet only, 
exercise only, or diet plus exercise, had diabetes risk reductions of 31%, 46%, and 42%, 
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respectively, when compared with the control group [16].  The Finnish Diabetes Prevention 
Study (DPS) reported in 2001 that among participants with IGT, the risk of type 2 diabetes was 
reduced by 58% in the lifestyle intervention group, compared to the control group [15].  Follow-
up of DPS participants over 13 years shows a continuing reduction in diabetes risk in the 
intervention group, when compared to the control group [110]. 
In 2002, results from the Diabetes Prevention Program (DPP) in the US were published.  
In this trial, 3,234 participants without diabetes were randomized to one of three study arms:  
placebo, metformin (850 mg, 2 times per day), or lifestyle modification, with minimum goals of 
150 minutes per week of moderate physical activity and 7% weight loss.  After almost three 
years of follow-up, the lifestyle and metformin groups were found to have diabetes risk 
reductions of 58% and 31% respectively, relative to the placebo group [13].  As well as reducing 
the incidence of type 2 diabetes, the DPP lifestyle participants had a 41% reduction in the 
incidence of the metabolic syndrome, compared with the placebo [14].  The DPP lifestyle 
intervention was also more effective than the placebo or metformin in reducing cardiovascular 
risk factors and the need for pharmacologic therapy to achieve target blood chemistry values 
[111].  Ongoing follow-up of DPP participants as part of the Diabetes Prevention Program 
Outcomes Study (DPPOS) confirms that participants in the lifestyle arm of the original DPP 
intervention continue to benefit despite partial weight regain, with diabetes incidence rates 
among lifestyle participants 34% lower in the lifestyle group, and 18% lower in the metformin 
group, compared with the placebo after 10 years [112].  These DPP results, in conjunction with 
the earlier international findings, have established the clinical efficacy of type 2 diabetes 
prevention based on moderate lifestyle intervention. 
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Building on the studies described above, the Indian Diabetes Prevention Programme 
[113] randomized individuals of Asian Indian background into one of four groups:  1. Control; 2. 
Lifestyle modification; 3. Metformin; 4. Lifestyle plus metformin.  The participants had IGT at 
baseline and were younger, less overweight, and more insulin resistant than the previously 
mentioned investigations.  Lifestyle modification consisted of advice on a healthy diet, 
specifically, a reduction in total calories, refined carbohydrates, and fats, as well as the avoidance 
of sugar and inclusion of fiber rich foods. After a median follow period of 30 months, the risk of 
diabetes was reduced by 28.5% (p=0.018) in the lifestyle group and 26.4% (p=0.029) in the 
metformin group, compared to the controls.  The combination of metformin and lifestyle 
conferred no additional risk reduction beyond the components taken separately.      
2.7.2 Translational Research Studies  
Since publication of the DPP results, research efforts have focused on translating the clinical 
findings of the DPP in a variety of settings.  Typically, the DPP curriculum is adapted for group 
presentation, rather than the one-on-one delivery used in the DPP, and the content of the original 
16 sessions may be condensed and offered in fewer sessions.   
Several groups have developed DPP-based curriculums and approaches.  Of particular 
interest is the Group Lifestyle Balance (GLB) program, developed by the Diabetes Prevention 
Support Center (DPSC) at the University of Pittsburgh and used in this investigation. The GLB 
program consists of 12 weekly core group sessions, with bi-weekly and then monthly follow-up 
sessions.  This year-long program is designed to be delivered by trained group leaders who have 
medical or educational credentials, and has been successfully implemented in a variety of 
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settings, including a primary care practice, out-patient diabetes education clinics, fitness centers, 
a church, and an underserved urban community [17-25,33].  A DVD adaptation of the GLB 
program has also been shown to be effective [24].  Other translational approaches include the use 
of supervised lay community health workers as group leaders in order to increase the pool of 
potential leaders [44-46,50,114], and various electronic media approaches [48,49,115]. 
2.7.3 The National Diabetes Prevention Program  
Building on the success of clinical and translational programs for preventing type 2 diabetes, in 
2010 the US Congress authorized the establishment of the National Diabetes Prevention Program 
(National DPP) by the Centers for Disease Control (CDC) in order to increase the availability of 
low cost diabetes prevention intervention programs [116].  This program focuses on four core 
elements:  training, recognition programs, intervention sites, and health marketing.  
A variety of training programs are currently available, including through the Diabetes 
Prevention Support Center (DPSC) at the University of Pittsburgh and the Diabetes Training and 
Technical Assistance Center (DTTAC) at Emory University.  The Diabetes Prevention 
Recognition Program (DPRP) is a key component of the National DPP.  The DPRP maintains a 
record of and grants recognition to programs that have demonstrated an ability to effectively 
deliver the lifestyle change intervention and ensure quality and consistency, using an approved 
curriculum.  Additionally, through recognized delivery sites, the National DPP facilitates the 
provision of diabetes prevention programming in sites around the country, and is helping to 
facilitate strategies and approaches to increase referrals and participation in these programs 
[116].  
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3.0 HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LIFESTYLE-
RELATED DISEASES 
The effectiveness of behavioral lifestyle intervention programs in preventing diabetes and the 
metabolic syndrome among those at elevated risk is thus well established in the clinical research 
setting, with such programs having been shown to favorably modify clinical measures and 
reduce the risk of diabetes.  In a translation setting, adaptations of the Diabetes Prevention 
Program (DPP) lifestyle intervention have been shown to be effective in lowering risk factors for 
diabetes and cardiovascular disease.  However, there is also increasing recognition of the value 
of assessing non-clinical outcomes in human-subjects research, known as humanistic outcomes.  
Quality of life is one important non-clinical outcome that has a substantial effect on the 
experience and perceptions of a participant in a biomedical intervention.  The perspective of the 
participant is particularly important in community interventions, where protocol adherence and 
attendance remain challenging issues affecting individual and program success.  
It has been found that the presence of elevated blood glucose is associated with a 
reduction in health-related quality of life (HRQoL) in both individuals with diabetes [6,117-119] 
and those without [120,121] and also in the metabolic syndrome [122].  Thus, there is a basis to 
consider HRQoL among individuals at elevated risk of diabetes, and how participation in a 
diabetes prevention program may impact HRQoL. 
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Previous reports indicate that HRQoL generally improves with physical activity [123] 
and this is specifically true among individuals with prediabetes [124].  The association, however, 
between HRQoL and weight loss is not consistent [125].   
The Centers for Disease Control (CDC) defines health-related quality of life as “an 
individual’s or group’s perceived physical and mental health over time” [126].  There is 
increasing acceptance that traditional, direct measures of population health, including disease 
rates and life expectancy, do not provide a complete picture of the health of a population.  
Recognizing this, the Healthy People 2020 initiative included HRQoL and Well Being as a new 
topic area that will be monitored, with a focus on improving HRQoL, in addition to treating or 
preventing the underlying pathology [127]. 
3.1 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE 
There are multiple instruments that have been developed for assessing health-related quality of 
life (HRQoL).  Typically, these instruments ask a series of questions about recent or current 
mental and physical health, with the participant responding in a quantitative manner by selecting 
from categories that are provided, or by giving their own numerical answers, for example:  
number of days or times in the past month a certain condition has existed.  HRQoL surveys may 
be generic, or designed for use within a specific condition (such as diabetes [128]).   
A description of three widely used generic HRQoL assessment tools follows.  The 36 
item short form (SF-36) was developed in the early 1990s for use in the Medical Outcomes 
Study, a project to identify reasons for variation in hospital patient outcomes [129].  It has been 
extensively used in clinical practice, research, health policy evaluations, and population surveys, 
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and was used in the Diabetes Prevention Program (DPP) to assess HRQoL [52].  The 36 
questions assess eight concepts:  1. Physical functioning; 2. Role limitations due to physical 
problems; 3. Social functioning; 4. Bodily pain; 5. General mental health; 6. Role limitations due 
to emotional problems; 7. Vitality; 8. General health perceptions [130]. 
The EuroQol Group (www.euroqol.org) is an international network of researchers which 
focuses on measuring health status.  In 1990s, the EQ-5D three-level version (EQ-5D-3L) was 
introduced [131].  It consists of two parts: the EQ-5D and the Visual Analogue Scale (VAS).  
The EQ-5D includes five questions about mobility, self-care, usual activities, pain/discomfort, 
and anxiety/depression, for which participants specify their current level of problems in each of 
the five dimensions by choosing one of three options equivalent to “none,” “moderate,” and 
“extreme.”   The VAS is a figure that resembles a thermometer on which participants indicate 
how “good” or “bad” their health is that day, with 0 representing the “worst imaginable health 
state” and 100 representing the “best imaginable health state.”  It has been shown that the EQ-5D 
can suffer from a ceiling effect when administered to the general population or among patients 
with a mild condition, leading to issues in measuring small changes in health, accordingly, the 
EuroQol group has developed and tested a five level version of the EQ-5D, known as the EQ-
5D-5L [132]. 
Developed by CDC, the CDC HRQoL–14 Healthy Days Measure (CDC HRQoL) 
assesses self-reported health [61] .  It consists of four core questions about general health and the 
number of unhealthy days during the past 30 days, followed by ten questions about recent levels 
of pain, depression, anxiety, sleeplessness, or vitality, and the cause, duration, and severity of 
any current activity limitation.   
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3.2 HEALTH-RELATED QUALTIY OF LIFE (HRQOL) IN CARDIOVASCULAR 
DISEASE PREVENTION 
It is instructive to consider quality of life among participants in behavioral or lifestyle programs 
for the prevention or treatment of cardiovascular disease, as many of the clinical and behavioral 
objectives of such programs, including increased physical activity, dietary changes, and weight 
loss, are similar to those utilized in diabetes prevention interventions.   
The ADDITION Netherlands program tested the effect of pharmacological and lifestyle 
treatment to reduce cardiovascular risk factors in patients with type 2 diabetes.  After one year, 
the intensified intervention and routine treatment groups both had similar improvements in 
general heath, vitality, and mental health, as well as unexpected declines in social functioning, 
assessed by the SF-36 [133].  A systematic review of lifestyle interventions to reduce the burden 
of atrial fibrillation concluded that these programs improve HRQoL, with benefits concentrated 
in scores related to physical functioning [134].  Among patients with systolic heart failure, a 
randomized controlled trial of a home-based program of moderate aerobic and resistance 
activities resulted in significant improvement in HRQoL, using the Minnesota Living With Heart 
Failure Questionnaire, compared with the control group [135].  A primary prevention 
telemedicine program promoting lifestyle change (consisting of self-monitoring and physical 
activity) in patients at risk for cardiovascular disease reported significant improvement in 
physical health on the WHO QoL-Short, with no change in other areas of quality of life [136].  
Likewise, participants in a secondary prevention program for heart disease, which included 
modification of behavioral risk factors, including physical activity, nutrition, and weight 
management, also had HRQoL improvements in the mental component summary, social 
functioning, and role-emotional of the SF-36 [137]. 
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The findings from these studies are not entirely consistent.  There is, however, evidence 
that behavioral programs for preventing primary or recurring cardiovascular disease outcomes 
also have a positive effect on HRQoL, measured in a variety of settings and with differing 
HRQoL assessment instruments. 
3.3 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN OBESITY AND 
WEIGHT LOSS 
There has been considerable interest in the relationship between HRQoL and obesity, and what 
impact weight loss has on HRQoL.  It is generally accepted that obesity is associated with 
decreased HRQoL.  Using survey data from the 2000 Medical Expenditure Panel survey, Jia and 
Lubetkin [138] showed that HRQoL decreased with increasing obesity, even in those without 
chronic diseases linked with obesity, using the Physical Components Summary (PCS-12) and 
Mental Components Summary (MCS-12) of the SF-36, as well as the EuroQol EQ-5D, and 
VAS.  Similar findings come from England, where, using the EQ-5D for HRQoL assessment, 
HRQoL was found to peak at a BMI of 26.0 in men and 24.5 in women, declining both as BMI 
increased and decreased [139]. 
As obesity is uniformly associated with decreased HRQoL, it is plausible that weight loss 
would result in increased HRQoL.  The findings on this topic, however, are not consistent, and 
there remains disagreement over the relative contribution of obesity versus poor fitness that is 
responsible for the reductions in HRQoL found in obese individuals.  In 2005, Maciejewski et al 
[125] published a structured review of the relationship between HRQoL and weight loss in 
randomized controlled weight loss trials, concluding that HRQoL outcomes did not consistently 
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improve with weight loss.  However, the overall quality of the trials was judged to be poor, and 
the lack of standardized HRQoL measures limited firm conclusions.  It should be noted that this 
review looked at weight loss using a variety of techniques, including surgical, pharmacological, 
and behavioral.   
Since the 2005 review, behavioral weight loss studies have reported generally positive 
associations between weight loss and HRQoL.  Williamson et al [140] found that among 
overweight or obese adults with type 2 diabetes, those randomized to an intensive lifestyle 
intervention experienced a significantly greater increase in HRQoL than those in a diabetes 
support and education group, using the PCS-12 and Beck Depression Inventory II (BDI-II).   
Importantly, they found that those with the lowest baseline HRQoL experience the greatest 
improvement in HRQoL over the course of the intervention.  In a 12-week workplace weight loss 
program, Bruno et al [141] showed that both in-person and internet-based participants had 
improved HRQoL, assessed with the CDC-14.  There was also a relationship between weight-
related clinical outcomes and HRQoL, consistent with the findings of Ross et al [142] who found 
weight loss contributed individually to improvement in seven of nine domains of the SF-36.   
3.4 HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND PHYSICAL 
ACTIVITY 
The relationship between physical activity and HRQoL remains unclear, with contradictory 
findings in the literature.   Among individuals with prediabetes, Taylor et al [124] concluded that 
those who achieve physical activity guidelines have higher physical and mental HRQoL than 
those who are inactive, using the RAND-12 Health Status Inventory.  In a regression model, Jie 
31 
et al [143] found that physical activity and nutrition were the strongest predictors of improved 
HRQoL, measured by the Spanish language version of the Quality of Life Index-Diabetes 
Version (QLI), among Hispanic adults with diabetes.  As well, Bize et al [123] in a review of the 
topic concluded that cross-sectional data are consistent in showing a positive relationship 
between physical activity and HRQoL.  However, Bize also acknowledges that there is limited 
evidence from controlled trials and cohort studies.  In an attempt to elucidate this issue, Ross et 
al [142] provided a six month lifestyle intervention to 298 obese women.  Using hierarchical 
regression to control for baseline BMI, physical fitness, and HRQoL domain, they determined 
that the only HRQoL domain to which physical fitness contributed beyond the effects of weight 
loss was to the Physical Functioning domain.  Weight loss was significantly associated with 
improvements in most of the other domains.  Thus, while the best-designed study to specifically 
address relationships between physical activity, weight loss, and HRQoL concluded that weight 
loss was the primary contributor to improved HRQoL in lifestyle intervention studies, a 
randomized controlled trial may be required to settle the issue. 
3.5 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PROGRAMS FOR 
PREVENTING TYPE 2 DIABETES AND THE METABOLIC SYNDROME 
 
While associations between individual components of lifestyle-based diabetes prevention 
programs and HRQoL have been investigated, particularly increased physical activity and weight 
loss, there are few reports on HRQoL in community translational diabetes prevention settings.  
As behavioral lifestyle interventions for diabetes prevention are multi-pronged endeavors, 
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consisting of dietary, weight loss, and physical activity goals, as well as a group session 
component,  it is tempting to attempt to identify which of the various intervention components is 
most associated with or responsible for any change in HRQoL that occurs over the course of the 
intervention.   
Ackermann et al [144] looked at changes in HRQoL using the SF-36 among participants 
in the Diabetes Prevention Program (DPP) and found that weight loss was independently 
associated with improvements in HRQoL, in both the lifestyle and metformin arms of the study.  
As the DPP was a large study, statistical power was sufficient to detect significant differences in 
HRQoL between the treatment arms, although these differences were considered “clinically 
small.”  It was also noted that changes in physical function on the PCS-36 scale were greater in 
persons with more severe obesity at baseline, as well as estimating that weight loss in the range 
of 5-10 kg was necessary to result in a “clinically meaningful” increase in overall health status 
[144] (“clinically meaningful” was not defined).   
Reporting on the DPP clinical trial at a mean follow-up of 3.2 years, Florez et al [52] 
found that during the first year of the intervention, the lifestyle group experienced a significant 
increase in physical function, general health, and vitality scores, relative to the metformin and 
placebo groups.  The improvement reached the level of minimally important difference (MID), 
defined as the smallest differences that is perceived as beneficial or deleterious [145], in this 
case, 3%.  There was a decline in these scores in all groups over the subsequent follow-up years, 
but the lifestyle group retained a significant benefit relative to the placebo.  In the lifestyle group, 
weight loss was identified as being the most important factor associated with the improvements 
in HRQoL [52]. 
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In South Korea, Oh et al [146] conducted a six-month lifestyle modification intervention  
in women with the metabolic syndrome.  Fifty-two women with a mean age of 62.7 years were 
randomized to intervention or control groups.  The lifestyle modification program was offered 
over the course of six months, and consisted of a total of 60 sessions.  During the first three 
months, sessions occurred three times per week, followed by twice per week during the final 
three-month maintenance period.  Components of the intervention included health monitoring, 
counseling, health education, supervised exercise, and diet.  The control group was given an 
educational booklet.  At baseline, the mean fasting plasma glucose in the intervention group was 
106.6 mg/dl and 103.6 mg/dl for the control group.  Although data was not provided on the 
prevalence of prediabetes in the participants, the mean values suggest that that many of the 
participants had a fasting plasma level in the prediabetes range (fasting plasma glucose 100-125 
mg/dl [86]).  Participants were assessed at three, six, and 12 months.  In addition to clinical 
assessments, they completed the SF-36 to evaluate HRQoL.  Significant improvements occurred 
in the following variables in the intervention group:  Vitality and General Health at three and six 
months; Physical Function and Mental Health at six months.  These improvements in HRQoL, 
however, did not maintain significance at 12 months.  For the control group, these markers were 
negative or unchanged through six months.  To summarize, Oh and colleagues [146] 
demonstrated improvements in several HRQoL variables through six months of regular contact 
with a study group of middle aged women with the metabolic syndrome, many of whom likely 
had prediabetes. 
In a nine-month intervention for individuals at risk for type 2 diabetes, defined as the 
presence of prediabetes or the metabolic syndrome without diabetes, Cezaretto et al [147] 
randomized 177 participants to either an intensive interdisciplinary intervention or a traditional 
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control group.  The intensive interdisciplinary intervention consisted of three medical visits 
where participants were given written guidelines on dietary change and physical activity (the 
traditional treatment that was also given to the control group) as well as an individual 
appointment with a dietitian and two-hour group sessions: offered four times per month for the 
first month, one to two sessions during the second month, and once per month through the ninth 
month.  Members of the intensive group also were given print materials that included hints for 
living a healthier lifestyle and telephone calls between sessions.  The baseline evaluation 
included clinical and laboratory measures, as well as questionnaires, with a follow-up evaluation 
at nine months.  Participants also completed the SF-36 survey to assess HRQoL.  At the nine 
month visit, participants in the intensive intervention had significant improvements in most of 
the HRQoL domains as well as the summary measures.  There were also improvements in 
HRQoL in the control group.  However, when compared with changes in the control group, the 
intensive intervention group only had greater improvement in the physical function and role-
emotional domains.  Vitality was found to have a significant inverse correlation with BMI.  
In addition to these reports, there are several ongoing community diabetes prevention 
programs that anticipate reporting HRQoL results in future years.  These include: Yates et al in 
the UK [148], Vlaar et al in the Netherlands [149], Colagiuri et al in Sydney, Australia [150], 
and Williams et al in the Fit Body and Soul, a faith-based adaptation of the DPP [32]. 
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4.0  HEALTH-RELATED QUALITY OF LIFE IN TWO TRANSLATIONAL 
DIABETES PREVENTION EFFORTS (PAPERS 1 & 2) 
4.1 OVERVIEW OF THE GROUP LIFESTYLE BALANCE PROGRAM 
The Group Lifestyle Balance Program (GLB) is based on the successful Diabetes Prevention 
Program (DPP) which demonstrated that the risk of type 2 diabetes can be reduced through 
moderate lifestyle intervention [13].  There were, however, significant personnel and financial 
resources that the DPP, as a funded clinical trial, had available that are not typically present in 
public health intervention settings.  Accordingly, the GLB was developed and tested by the 
Diabetes Prevention Support Center (DPSC) at the University of Pittsburgh as a translational 
adaptation of the DPP curriculum for group delivery in the community [18].  Table 4.1 presents a 
comparison of the DPP and GLB interventions. 
 The GLB intervention consists of 12 core sessions, typically delivered over the course of 
12 weeks, presented either in groups or via DVD [24] with trained coach support.    These core 
sessions are followed by 4 bi-weekly core sessions, transitioning to six monthly maintenance 
support sessions, continuing for approximately one year.  Session content alternates between the 
three main content strands of a healthy lifestyle:  eating, physical activity, and behavioral.  
Program materials and support are available through the DPSC 
(www.diabetesprevention.pitt.edu).   
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 GLB group leaders or preventionists generally have a background in a health-related 
field, and participate in a two-day training program offered by the DPSC.  The training includes 
a review of the DPP intervention and findings, as well as thorough coverage of each of the 
intervention sessions.   
 
Table 4.1 Comparison of DPP Lifestyle Intervention to GLB Intervention Program 
Fundamental aspects of DPP and GLB interventions 
■ Goal: 7% weight loss and increase physical activity to 150 minutes/week 
■ Safe and appropriate intervention that incorporates nutrition, physical activity, and 
behavior change 
■ Intervention delivered by appropriately trained group leader 
■ Strong focus on use of self-monitoring tools with feedback 
■ Use of problem-solving techniques to address barriers to healthy eating and physical 
activity 
Specific adaptations to DPP intervention 
 
DPP intervention Modified GLB 
■ 16 core sessions delivered over 24 
weeks with monthly follow-up 
■ 12 weekly core sessions delivered over 12–15 
weeks, with bi-weekly and monthly follow-up 
■ Individual counseling ■ Group classes 
■ Focus on food pyramid ■ Primary focus on healthy food choices 
■ Initial emphasis on fat intake ■ Initial emphasis on fat intake and calories 
■ Pedometer introduced during 
maintenance phase 
■ Pedometer introduced during core sessions 
■ Use of lifestyle toolbox ■ Use of inexpensive food samples and incentives 
■ Lifestyle coach training conducted 
by DPP LRC 
■ Prevention training conducted by DPSC faculty 
via 2-day workshop 
■ Ongoing support for 
implementation provided by LRC 
■ Ongoing support for implementation provided 
by DPSC 
(DPP, Diabetes Prevention Program; DPSC, Diabetes Prevention Support Center; GLB, 
Group Lifestyle Balance; LRC, Lifestyle Resource Core) 
From Kramer et al [18] 
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4.2 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN A COMMUNITY 
DIABETES PREVENTION PROGRAM (PAPER 1, APPENDIX A) 
In order to further address the question of HRQoL changes among participants in a community 
diabetes prevention program, there was an opportunity to analyze the results from a Group 
Lifestyle Balance (GLB) intervention, delivered in Western Pennsylvania and reported in Paper 
1.  (See Appendix A for full paper) 
4.2.1 Overview 
This GLB intervention was conducted at three community hospital and outpatient clinic sites 
operated by the University of Pittsburgh Medical Center.  The three sites included rural, 
suburban, and urban settings.  In keeping with a real-world translational approach, the study 
design was single-group and nonrandomized.  All of the GLB group leaders were diabetes 
educators, and all group leaders attended a 2-day GLB training workshop presented by the 
Diabetes Prevention Support Center (DPSC).    
4.2.2 Eligibility 
Individuals in the community were eligible based on the following: 
 Eligibility Criteria: 
 Nondiabetic individuals age 25 years or older AND 
 BMI ≥ 25 kg/m2 AND 
 Presence of prediabetes (fasting plasma glucose 100-125 mg/dl) AND/OR 
 Presence of the metabolic syndrome [100] 
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Exclusionary Criteria: 
 
 Pregnant or lactating 
 Failure to obtain physician approval to participate 
 Plans to leave area before end of the study 
4.2.3 Recruitment 
Local primary care physicians and endocrinologists were contacted by email and postal mail 
with information about the study.  Additional educational information was presented at visits to 
local healthcare clinics.  The expectation was that the care providers would refer patients 
meeting the eligibility criteria.  Program fliers were posted in the community and advertising was 
placed in local newspapers.  After a 10-month recruitment period, 121 referrals were received, 
with 95 individuals meeting the eligibility criteria and 81 enrolling in the program. 
4.2.4 HRQoL Assessment Tool 
The CDC HRQoL–14 Healthy Days Measure (CDC HRQoL) was used for assessment of self-
reported health [61].  It consists of four core questions about general health and the number of 
unhealthy days during the past 30 days, followed by ten questions about recent pain, depression, 
anxiety, sleeplessness, or vitality; and the cause, duration, and severity of any current activity 
limitation.  The CDC HRQoL was completed at each assessment visit (baseline, six, and 12 
months). 
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4.2.5 Laboratory and Anthropometric Measures 
Local medical laboratories provided fasting (minimum of 8 hours) analysis of total cholesterol, 
HDL cholesterol, LDL cholesterol, triglycerides and fasting plasma glucose.  Blood pressure was 
measured while seated, following a five minute rest period.  Shoeless height and weight 
measurements were recorded along with waist circumference midway between the lower rib 
margin and iliac crest.  All anthropometric measures were conducted twice, with the average 
values used in the analyses.   
4.2.6 Baseline Demographics 
Table 4.2 details baseline demographic characteristics.  The participants were primarily female 
(88%) and white (96%), with an average age of 52.9 years.  Most had completed college or had 
some college or technical school training.  
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Table 4.2 Baseline Demographic Characteristics of Participants (Paper 1) 
 
Kramer et al. [21] 
4.2.7 Paper 1 Abstract (See Appendix A for full paper) 
Health-Related Quality of Life in a Community Diabetes Prevention Program 
 
Purpose:  To evaluate health-related quality of life among participants in a community-based 
diabetes prevention program, delivered by trained diabetes educators. 
Methods:  HRQoL was evaluated for 81 participants in a presentation of the Group Lifestyle 
Balance program at three outpatient clinics in Western Pennsylvania, using the CDC HRQoL–14 
Healthy Days Measure (CDC HRQoL).  Change in HRQoL over the course of the intervention 
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was assessed.  Additionally, associations between HRQoL and GLB attendance, weight loss, and 
physical activity goals were investigated.   
Results:  Post-intervention, participants reported an increase in the number of “healthy days” 
and days when they “felt very healthy and full of energy,” (11.0% to 14.9%, p=0.02) compared 
with baseline, as well as a decrease in the number of days when they reported they didn’t get 
enough rest or sleep (10.7% to 6.3%, p=0.002).  Participants for whom the number of unhealthy 
days in the past month was less than 14 were significantly more likely to have attended 50% or 
more of the sessions than those who reported 14 or more unhealthy days (p=0.001).   
Conclusions:  Individuals with prediabetes and/or the metabolic syndrome who participated in a 
community diabetes prevention intervention experienced positive changes in several HRQoL 
domains over the course of the program.  In addition, HRQoL was associated with participant 
success in achieving some of the program goals.  These results demonstrate that benefits to 
community diabetes prevention programs extend beyond improvement in the physiological 
parameters typically measured.  This finding broadens the scope and value of community 
lifestyle intervention programs for diabetes prevention.  (See Appendix A for full paper) 
The findings presented in Paper 1 demonstrate that participants in a diabetes prevention 
intervention can experience improvements in their health-related quality of life.  In another GLB 
intervention, the program was delivered using DVDs as an alternative to the standard group 
delivery, as well as using a different HRQoL assessment instrument.  These results are reported 
in Paper 2. 
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4.3 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN A DIABETES 
PREVENTION INTERVENTION PRESENTED IN GROUPS AND VIA DVD (PAPER 2, 
SEE APPENDIX B) 
Paper 2 (See Appendix B for full paper) presents an analysis of HRQoL among participants in 
the Group Lifestyle Program (GLB), delivered in a traditional group setting and via DVD with 
long distance telephone support.  Participants completed the EuroQol EQ-5D-3L™ and EuroQol 
VAS HRQoL assessment instruments at baseline, and post intervention (three months), six-
month, and 12-month clinical visits.   Analysis of HRQoL is presented for all participants taken 
together, and separately for those in the group and DVD delivery sections.    
4.3.1 Overview 
This GLB intervention was delivered in a California primary care practice.  Participants chose 
their preferred program delivery mode for the GLB intervention: DVD or group delivery.  Those 
selecting DVD were instructed to view one session per week.  DVD participants received a 
telephone call from the DPSC each week to review program details, collect weight and activity 
levels, and answer questions.   
4.3.2 Eligibility 
Individuals in the community were eligible based on the following: 
Eligibility Criteria: 
 Nondiabetic practice patients age 18 years or older AND 
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 BMI ≥ 25 kg/m2 AND 
 Presence of prediabetes (fasting plasma glucose 100-125 mg/dl) AND/OR 
 Presence of the metabolic syndrome [100] AND 
 Ability to read and understand English 
 
Exclusionary Criteria: 
 Failure to obtain physician approval to participate 
4.3.3 Recruitment 
Patients meeting eligibility criteria were referred by their health care provider.  Baseline 
demographic data collected included age, race/ethnicity, employment status, and highest 
education level attained. 
4.3.4 HRQoL Assessment Tool 
The EQ-5D-3L™, used in this study, is a self-administered questionnaire designed to assess 
HRQoL, consisting of two parts: the EQ-5D and the Visual Analogue Scale (VAS).   For the EQ-
5D, participants indicated their current degree of problem in each of five dimensions by choosing 
one of three levels, equivalent to “none,” “moderate,” and “extreme.”   Results from these five 
dimensions were converted into a single summary index value using an algorithm available from 
EuroQol (www.euroqol.com), based on American rankings of the relative health impact of 
possible EQ-5D responses [151].  Index scores range from 0 to 1, with higher values indicating 
better HRQoL.   
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4.3.5 Laboratory and Anthropometric Measures 
Local medical laboratories provided fasting (minimum of 8 hours) analysis of total cholesterol, 
HDL cholesterol, LDL cholesterol, triglycerides and fasting plasma glucose.  Blood pressure was 
measured while seated, following a five minute rest period.  Shoeless height and weight 
measurements were recorded along with waist circumference midway between the lower rib 
margin and iliac crest.  All anthropometric measurements were taken twice, with the average 
values used in data analyses.   
4.3.6 Baseline Demographics 
Table 4.3 details baseline demographic characteristics.  The participants were primarily female 
(71%) and white (83%), with an average age of 59.7 years.  Over half had completed college or 
had some college or technical school training.  
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Table 4.3 Baseline Demographic Characteristics (Paper 2) 
 Total  
n=48 
n (%) 
Age   mean (range) 59.7 (22-87) 
Female 34 (71) 
White  40 (83) 
Employed full/part time 25 (52) 
Highest Education  
Some High School or 
Lower 
3 (6) 
High School/GED 10 (21) 
Some college/tech school 16 (33) 
College graduate 11 (23) 
Graduate degree 8 (17) 
Smoker 1 (2) 
Family History  
Diabetes 25 (52) 
Heart Disease 24 (50) 
Kramer et al [24] 
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4.3.7 Paper 2 Abstract (See Appendix B for full paper) 
Health-Related Quality of Life (HRQoL) in a Diabetes Prevention Intervention 
Presented in Groups and Via DVD 
 
Purpose:  To evaluate HRQoL among participants in a community-based diabetes prevention 
program, presented in group delivery format and via DVD. 
 
Methods:  HRQoL was evaluated for 48 participants (22 DVD, 26 Group) in a presentation of 
the Group Lifestyle Balance program through a California medical clinic, using the EQ-5D-
3L™.  Change in HRQoL over the course of the intervention was assessed with particular focus 
on participants who had below-average HRQoL levels at baseline.    
 
Results:  No significant changes occurred in the EQ-5D index scores at three, six, and 12 
months, compared to baseline.  This finding remained the same when participants in the two 
delivery methods were combined, and when they were analyzed separately.    However, when 
limiting the analyses to those participants whose baseline EQ-5D index scores were below the 
US average value of 0.87 [152] and who attended the three month assessment visit  (n=27), there 
was an increase in the HRQoL index score at three months of borderline significance (p=0.07).  
Over the course of the intervention, there were significant increases in the median Visual 
Analogue Scale (VAS) scores of study participants from baseline to every clinical follow-up 
point, with the VAS score increasing to 80 at the three- (p<0.010) and six-month (p=0.03) 
assessment visits, and reaching 85 at 12 months (p=0.02).  These increases remained significant 
when analyzing DVD or group delivery modes individually.   
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Conclusions:  Among individuals with prediabetes and/or the metabolic syndrome who 
participated in a community diabetes prevention intervention, there were indications of 
improvement in HRQoL over the course of the intervention, particularly among those with 
below-average HRQoL at baseline.  That the study group as whole did not experience 
improvements in HRQoL as measured by the EQ-5D index score may be because many 
individuals with prediabetes and/or the metabolic syndrome are not yet experiencing a 
substantial impact in their quality of life, at least as measured by the three levels of the  EQ-5D 
(no, some, or extreme).  However, the 0-100 continuum of the VAS scale allowed the capture of 
modest improvements in HRQoL.  (See Appendix B for full paper) 
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5.0  COST ISSUES IN DIABETES PREVENTION 
In order to successfully participate in a behavioral lifestyle intervention for diabetes prevention, 
significant commitments are required by the participant:  time commitments which include the 
actual time spent in intervention sessions; time to travel to the sessions, participation; and time 
spent in physical activity;  financial commitments for the expense of getting to the intervention 
sessions, the potential of lost work hours during session, as well as additional expenses for items 
like activity cloths or services.  Although the benefits of preventing diabetes are enormous, it can 
take years to realize the benefits, while the expenses are more immediate.  It is thus important 
that these expenses be acknowledged and evaluated, as they may pose a real or imagined 
obstacle for some potential participants. 
5.1 COST-EFFECTIVENESS OF DIABETES PREVENTION 
 
The cost-effectiveness of diabetes prevention intervention programs is generally accepted.  In a 
review of 56 studies, Li et al [153] concluded that “a large majority” of interventions 
recommended by the American Diabetes Association (ADA) are cost-effective overall.  In 
particular, intensive lifestyle interventions for prevention of type 2 diabetes among individuals 
with impaired glucose tolerance (IGT) were deemed “very cost-effective” compared with 
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standard lifestyle recommendations.  “Very cost-effective” was defined as ≤$25,000 per life year 
gained (LYG) or quality-adjusted life year (QALY).    
A ten-year intention to treat evaluation of cost-effectiveness in the Diabetes Prevention 
Program (DPP) found that the lifestyle intervention was “cost-effective” and metformin was 
“marginally cost-effective,” compared to the placebo.  The lifestyle intervention resulted in a 
cost of $10,037 per QALY.  With most published cost-effectiveness ratios falling between 
$10,000 and $50,000 per QALY, the DPP lifestyle intervention for diabetes prevention was 
determined to be cost-effective relative to other interventions and treatments [154].  Further 
analyses of adherent DPP participants in the Diabetes Prevention Program Outcomes Study 
(DPPOS), defined as achieving and maintaining a 5% reduction in initial body weight, yielded a 
relative risk reduction for type 2 diabetes of 49.4%.  Over 10 years, lifestyle intervention was 
deemed cost-effective compared with the placebo group [155].  
Taking into account the costs and impact of a community Group Lifestyle Balance (GLB) 
intervention, Smith et al [156] calculated the cost per QALY gained as $3,420.  Anderson [157] 
concluded that among those over 65 years of age, 75% of whom have prediabetes or diabetes, 
lifestyle interventions are highly cost-effective and possibly cost-saving to a health care 
insurance payer.  Using findings from the Finnish Diabetes Prevention Study, simulated in a 
Swedish setting, Lindgren et al estimated that a diabetes prevention program would be cost 
saving for 60 year olds, with a cost of 2,363€ (~$3074) per QALY [158].  Zhuo et al [56] 
estimated that a nationwide community lifestyle intervention program to prevent type 2 diabetes 
would prevent or delay about 885,000 cases of diabetes within 25 years, resulting in savings of 
5.7 billion dollars. In the Indian Diabetes Prevention Programme, Ramachandran et al [159]  
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reported that lifestyle modification was cost-effective, with $1,052 estimated as the cost to 
prevent one case of diabetes. 
Clearly, then, there is strong evidence in support of the overall cost-effectiveness of 
diabetes prevention interventions.  However, some analysis suggests otherwise, with Irvine et al 
[160] estimating the cost-effectiveness of group sessions to prevent type 2 diabetes as being 
beyond generally accepted values (usually ~$20,000/QALY), while admitting a large degree of 
uncertainty. 
Part of cost-effectiveness calculation is the actual expense of the intervention.  Both the 
GLB program and an adaptation of the DPP curriculum for group delivery in YMCA facilities 
have reported on the expenses of delivering these programs in the community.  For the GLB 
intervention, the cost of program delivery, including monthly follow-up visits, materials, and 
supplies, has been estimated to be in the range of $165 to $320, $2731 per center, and $20 per 
pound lost [18,21,161].  Similar cost estimates ($275 to $325) were reported for the YMCA 
DPP-based intervention [162]. 
5.2 PERSPECTIVE IN COST-EFFECTIVENESS ANALYSES 
The economic cost of a preventive intervention, such as diabetes prevention, can be considered 
from a number of perspectives.  A panel convened by the US Public Health Service issued a 
consensus statement in 1996 deeming the societal perspective as the “reference case, where 
benefits, harms, and costs to all parties are accounted for” [163].  This is the most comprehensive 
perspective, as it includes health impacts such as longer life, better function, and unwanted side 
effects, as well as medical and resource costs and the time of patients and caregiver.  Other 
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perspectives will necessarily exclude potential costs or benefits as they are not within the 
purview of the interested party.  For example, it may be that an employer is interested only in the 
costs and benefits that directly affect a business, including employer implementation and 
insurance costs, as well as employee productivity, and have no concern for costs paid by the 
employees [164].  By not considering employee cost, a cost-effectiveness analysis may conclude 
benefit to the employer, when if employee costs were included as part of an analysis from a 
societal perspective, the results would be different.  While it is tempting to assume that the 
societal perspective would be universally used, this is not the case, in part due to the difficulty in 
assessing the whole spectrum of costs and benefits which accrue.   
While cost-effectiveness analyses have generally shown benefit for diabetes prevention 
screening and intervention, there is an important aspect of expenses related to diabetes 
prevention, not reviewed yet, that has received little attention in the published literature, that of 
the personal economic costs faced by a participant due to their involvement in the program.  
These costs are detailed by Songer et al [165] in a comprehensive consideration of the societal 
costs related to type 2 diabetes prevention in children, and include the following direct 
nonmedical expenses faced by participants, and thus of interest here:   
1. Time:  Any time spent on intervention-related activities is time that would otherwise 
be spent on a different activity.  This time expense is known as opportunity cost. 
2. Food Costs:  Diabetes prevention interventions include dietary goals that usually 
require that the participant to make changes in food purchase behavior, including the 
potential for increased expenses. 
3. Physical Activity Costs:  The cost of equipment and clothing used for physical 
activity, as well as any gym membership, and club or personal trainer expenses. 
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4. Travel Costs:  The expense for transportation to and from intervention sessions as 
well as clinical visits.  This may be the expense of using a personal vehicle, public 
transportation, or taxi. 
5.3 PARTICIPANT COSTS IN THE DIABETES PREVENTION PROGRAM (DPP) 
The DPP collected and reported on multiple aspects of cost, looking specifically at 1). direct 
medical costs—the actual expenditure for medical services; 2). direct nonmedical costs—those 
out-of-pocket expenses arising from the intervention, including participant travel and food 
expenses, as well as the opportunity cost of session attendance and time spent in physical 
activity; and 3). indirect costs—the costs for time lost from work as a result of participating in 
the DPP [59].  Of particular interest for the purposes of this investigation are the direct 
nonmedical costs in community diabetes prevention programs, as these expenses may function as 
perceived barriers to greater community participation in such programs. 
5.3.1 Assessment of Nonmedical Costs in the DPP  
Estimates of direct nonmedical participant costs in the DPP were made in a number of ways [59].  
For the opportunity cost of time spent in intervention-related activities, including intervention 
and travel time, estimates were made using estimated time from the frequency and duration of 
contacts as reported by DPP staff.  Travel time was estimated at 30 minutes.  These times were 
multiplied by the value of $8/hour which was 50% of the average hourly wage in 2000.  
Participants reported time spent in physical activity, shopping, and food preparation on a 
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questionnaire.  For physical activity, time was valued at $8 if the participant “disliked,” $4 if 
“neutral,” and $0 if they “liked” leisure-time physical activity.   Shopping and food preparation 
were valued at $4/hour.  Round-trip transportation costs to DPP appointments were estimated at 
$7/visit. 
Questionnaires were used to capture the out-of-pocket costs of activity-related products 
and services, as well as food preparation equipment.  If a given service or product was used by 
>5% of participants, it was included in the analyses.  For specific purchases, it was assumed they 
were purchased once during the three year study period except for activity shoes (2 pair/year for 
lifestyle, 1 pair/year for the metformin and placebo group); health club memberships, exercise 
classes, weight loss programs (1.5 years’ attendance); personal trainer (five visits); and cooking 
classes (three classes).  Durable equipment was defined as items that would last >3 years and 
cost more than $100.  These items were assumed to have 50% of their original purchase price 
after three years.  The unit costs for the various products and services are provided in an 
appendix to the DPP paper [59]. 
A questionnaire also asked participants about any changes in food costs they experienced 
since they started in the DPP.  Response options for food costs at home, fast food restaurants, 
and non-fast food restaurants included:  “increased a lot,” “increased some, “ “stayed the same,” 
“decreased some,” or, “decreased a lot.”  “A lot” was assumed to be 10%, “some” was assumed 
to be 5%, and “stayed the same” was assumed to be 0% change.  These percentages were then 
applied to the US per capita food expenditures from 2000 to estimate participant food costs. 
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5.3.2 DPP Cost Results 
The DPP report compared direct nonmedical expenses for the three study arms during three years 
following the baseline visit.   Only the per capita totals and differences in per capita values 
relative to the placebo are reported.  Table 5.1 summarizes the expense estimates for the 
nonmedical expenses in the three DPP arms:  placebo, metformin, and lifestyle, as presented in 
the original paper. 
 
Table 5.1 Summary of Direct Nonmedical Costs in the DPP, years 1-3 
 Placebo Costs 
 ($) 
Metformin 
Costs 
($) 
Lifestyle Costs 
 ($) 
Metformin vs.  
placebo ($) 
Lifestyle 
vs.  
placebo 
($) 
Participant time 5404 5530 6040 -52 637 
Services 532 514 642 -18 110 
Fitness equipment 165 148 223 -17 58 
Food equipment 71 70 79 -1 9 
Shoes 220 220 439 0 219 
Food costs 9223 9226 9152 3 -71 
Transportation 
Costs 
79 154 562 76 484 
Total 15692 15683 17137 -9 1445 
DPP Group [59] 
As would be expected given their participation in the intervention, those in the lifestyle 
group had greater time costs than the placebo group, a pattern that was present in all cost 
categories except food costs.  There was a net decrease of $71 in food costs in the lifestyle group, 
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compared to the placebo group.  This is due to the lifestyle group spending $79 less than the 
placebo on food eaten away from home and $7 more on food at home (totals do not add up due 
to rounding) [59]. 
5.4 PARTICIPANT COSTS IN INTERVENTION PROGRAMS BASED ON THE DPP 
While numerous diabetes prevention interventions based on the Diabetes Prevention Program 
(DPP) have reported clinical results in the years following publication of the original DPP 
findings, there has been only one report of direct, nonmedical expenses from such programs.  
Lawlor et al [60] reported these results from the Healthy Living Partnerships to Prevent Diabetes 
(HELP PD) trial, a 2-year intervention delivered by community health workers.  The cost 
analyses are presented in a similar format to those of the DPP results [59], which the authors 
assert represent “good practice” and facilitate comparison with the DPP findings.  In the HELP 
PD trial, cost information was collected by questionnaire at 6, 12, 18, and 24 months, with 
results reported from years 1-2.  Not surprisingly, the intervention group had higher expenses 
due to the value of time spent in self-monitoring, physical activity, and travel costs related to the 
intervention, compared to the usual care group.  Both groups had similar expenses for activity 
services and food-related items.  In total, direct nonmedical expenses were $955 higher in the 
intervention group, compared with usual care [60].  
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5.5 FOOD RECEIPTS COLLECTION 
An increase in the cost of household food is a direct, nonmedical expense that participants in a 
healthy lifestyle intervention for type 2 diabetes prevention may face.  In order to evaluate this 
expense component, various strategies have been devised to ascertain food expenses.   
In addition to self-reporting of household food expenses on a questionnaire, participant 
submission of food purchase receipts has been investigated as a way of assessing food expenses, 
as well as a way to validate self-reports.  In a review, French et al [166] concluded that the 
annotated food purchase receipt method, used over two to four weeks, is the best option for 
providing feedback over time about changes in household food purchase patterns.  Ransley et al 
[167] showed in a UK study that the fat and energy food items on supermarket till receipts had a 
strong linear association with actual energy (slope = 0.90, 95% CI 0.80 – 1.00) and fat (slope = 
0.76, 95% CI 0.64 – 0.87) consumed, as measured by food diaries.  French et al [168] reported a 
completion rate of 85% (90 of 106) among households completing a baseline visit submitted 
receipts during a 28-day collection project.  In another study, DeWalt et al [169] found that the 
collection of grocery store receipts was relatively non-intrusive and easily carried out.  As well, 
they reported that this method reduced participant burden relative to other methods and helped 
solve problems of participant non-response.   
5.6 EXPENSE OF HEALTHY FOOD 
The perception that healthy food is more expensive than unhealthy food has been a continuing 
challenge to efforts that promote healthy food as a means of reducing disease risk and 
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maintaining an appropriate body weight.  On this issue, there is apparently conflicting evidence.  
On one hand, diets containing a high proportion of calorie-dense foods appear to cost less per 
unit of energy than nutrient rich foods like fruits and vegetables.  This has led some to conclude 
that, based on economic factors alone, consumer decisions would favor calorie-dense foods of 
low nutrient quality which contribute to obesity, and that obesity is thus largely an economic 
problem [170-172].  This view is supported by the observation that a low socioeconomic status is 
associated with higher rates of obesity among children, with the odds ratio for obesity increasing 
in the presence of low income: 2.91 (1.66-5.08) and medium income: 2.04 (1.21-3. 44) [173].   
However, other analyses have concluded that the costs per calorie of meeting national 
dietary recommendations from a fast food restaurant was 24% higher than with healthy food 
from a grocery store [174].  Additionally, Lipsky [175] has identified potential methodological 
weaknesses in analyses comparing energy density with energy cost, concluding that the relation 
between energy density and food price is confounded by the food category and thus cost per 
calorie may not be an appropriate measure of food price.     
Another way of framing the issues is as a disagreement between observational studies, 
which often conclude that a healthy diet costs more, and intervention studies which indicate that 
dietary quality can improve with minimal if any increase in food expense.  In an intervention 
study among breast cancer survivors, an increase in fruit and vegetable consumption from 6.3 to 
8.9 servings per day was associated with a minimal but significant increase of $1.22/week 
(p=0.027) in grocery costs [176].  The Finnish Diabetes Prevention Study reported no significant 
increase in food costs for the intervention group, compared to the controls, even as diet quality 
improved [177].  Similarly, a pediatric family-based obesity intervention showed a significant 
decrease in dietary cost from baseline to one year ($6.77+/-2.41 to $5.04+/-1.80), by 
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emphasizing decreased consumption of energy dense foods and increased consumption of 
nutrient dense foods [178], although the cost-level of the supermarket (budget, midrange, or high 
street was identified as a factor in cost increase or decrease in a UK study of obese children 
[179]. 
Ultimately, the conclusion depends to a great extent on how cost is measured.  The US 
Department of Agriculture (USDA) Economic Research Service considered this issue in a report 
entitled Are Healthy Foods Really More Expensive? [58]  They concluded that foods lower in 
caloric density appear to have a higher price when price is measured per calorie.  Thus, fruits and 
vegetables are a relatively expensive way to purchase food energy.  Also, less healthy foods, 
especially those with high levels of saturated fat and sugar, tend to have a lower cost per calorie.  
However, based on edible weight or average portion size, grains, vegetables, fruit, and dairy 
foods are less expensive than most protein foods and foods containing high amounts of saturated 
fat, added sugars, and/or sodium. 
It thus appears that while unhealthy food may cheaper per calorie, cost need not be an 
obstacle to dietary improvement.  Indeed there are examples showing that diets high in nutrition 
need not be expensive, including the Thrifty Food Plan from the USDA [180].  These 
conclusions are important for the field of diabetes prevention because behavioral lifestyle 
interventions encourage healthy dietary changes that may be perceived as financial obstacles to 
some participants.  In the next section, the issue of expenses directly faced by participants will 
be further considered in an intervention setting, presenting results from a clinical trial delivered 
in the community.  
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6.0  PARTICIPANT EXPENSES IN A TRANSLATIONAL DIABETES PREVENTION 
INTERVENTION 
As around 15% of Americans, over 47 million, received federal Supplemental Nutrition 
Assistance Program (SNAP) benefits in April 2013 [181], the issue of food expenses is an 
important factor in the lives of many people.  Socioeconomic factors have been shown to be 
associated with rates of type 2 diabetes [182], so there is good reason to recognize that many 
individuals at elevated risk of diabetes may view the prospect of changes to their dietary and 
activity patterns as part of a diabetes prevention program with caution and uncertainty, fearing 
increased expenses.  There have been some reports addressing this topic, however questions 
remain as to the expenses faced by participants in diabetes prevention efforts. 
In 2003, the direct per capita nonmedical expenses of participants in the Diabetes 
Prevention Program (DPP) clinical trial were reported [59], along with recent results from the 
HELP-PD study [60].  However, there are aspects related to participant expenses in translational 
diabetes prevention interventions that have yet to be thoroughly examined.  These include 
statistical evaluation of change between and within intervention and control groups, and 
evaluation of intervention subgroups.   
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Overview of Chapter 6 Organization 
Chapter 6 of this dissertation examines direct nonmedical expenses that are paid out-of-
pocket by participants in a translational type 2 diabetes prevention program.  These are expenses 
related to food, participating in activity, and time in activities prescribed or recommended to 
participants in the intervention program. 
For this dissertation, data was available from two of three settings of a translational 
research investigation focusing on issues and challenges related to delivery of diabetes 
prevention programs in diverse settings.  In Section 6.1, the general background and methods are 
described.  Section 6.2 presents baseline demographic results for both sites, and Section 6.3 
presents six-month clinical findings.  Section 6.4 includes the specific aims for and abstract of 
the third dissertation paper (Appendix C) which is randomized controlled trial (RCT) analyses.  
This section presents changes in expenses that occurred among participants from baseline to six 
months, as well as differences between the intervention and control groups.  In section 6.5, 12-
month pre-post results are presented, showing longer term changes from baseline to 12 months in 
one intervention subgroup.  Section 6.6 presents expenses analyses of those participants who 
reported expenses at a given clinical visit, excluding those who report a value of $0.  Analyses of 
food receipts and food expenses reported in the expenses survey are in Section 6.7, followed by 
subgroup analyses by several demographic variables in Section 6.8 and cross-sectional 
workplace results in Section 6.9.  Section 6.10 concludes with a comparison of self-reported six-
month food expenses in both sites. 
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6.1 GENERAL BACKGROUND AND METHODS 
6.1.1 Setting  
In order to further address the issue of expenses faced by participants in a diabetes prevention 
intervention, an opportunity was available to collect and analyze data as part of an ongoing 
randomized controlled trial (RCT).  Data were collected from two settings (community centers 
and a worksite) in Allegheny County, PA for this Group Lifestyle Balance (GLB) translational 
research study.  Community data came from GLB participants at three community centers, 
consisting of two senior citizens centers that provide lunch and activities at little or no cost, as 
well as a religiously-affiliated community center that offers a wide variety of programming and 
services as well as a fitness center open to the general community.  Workplace data is from the 
employees at a large international corporation in Allegheny County, PA.  Funding for this 
translational investigation was provided by the National Institutes of Health (NIH) through the 
National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK) to Principal 
Investigator Andrea Kriska, PhD, Professor of Epidemiology at the Graduate School of Public 
Health at the University of Pittsburgh. 
6.1.2 Recruitment and Clinical Eligibility 
In the three community settings, recruitment posters were displayed both in the centers and in 
nearby public venues.  Direct mail was used to target residents in zip codes surrounding the 
community centers.  Names and addresses for the mailings were obtained from publicly available 
voter records at the Allegheny County elections office.  At the workplace, corporate employee 
62 
communication channels were used to inform employees of the intervention as well as Lunch 
and Learn events where researchers from the University of Pittsburgh presented an overview of 
the planned investigation as well as answered questions.   
 In order to help identify individuals who were more likely to meet the clinical eligibility 
criteria for this investigation, a two-step screening approach was used at both sites.  The first step 
consisted of an in-person or telephone pre-eligibility screening that quickly and easily identified 
a group of individuals who were more likely to meet clinical eligibility criteria.  This step 
reduced the time and expense of the clinical assessments by reducing the number of ineligible 
individuals who attended the clinical assessment visit.  Interested individuals meeting the 
screening eligibility criteria below were invited to attend an on-site clinical eligibility assessment 
visit: 
 Aged 18 years or older  
 No previous diagnosis of diabetes 
 No plans to leave the area during the next 18 months 
 (Women only) Not currently pregnant or breastfeeding.  Not given birth in the past 6 
weeks.  No plans to become pregnant within the next 18 months 
 BMI ≥ 24 (if Asian, BMI ≥ 22)  
At the clinical assessment visit, one or more of the following three clinical conditions were 
necessary in order to be invited to enroll in the study: 
1. Prediabetes (fasting plasma glucose 100-125 mg/dl or HbA1C 5.7-6.4%) 
2. The metabolic syndrome, as defined by the NCEP ATP III criteria [100].  The presence 
of three or more of the following conditions: 
o 1. elevated triglycerides (≥150 mg/dl) 
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o 2. low HDL cholesterol (<40 mg/dl for men, <50 mg/dl for women) 
o 3. increased waist circumference (>102cm for men, >88cm for women) 
o 4. blood pressure ≥130/85 mm Hg (or on treatment for hypertension) 
o 5. elevated fasting plasma glucose ( ≥100 mg/Dl). 
3. The presence of previously-diagnosed hyperlipidemia plus one other metabolic syndrome 
component 
Additionally, a signed physician referral was required of those electing to enroll in the 
study. 
6.1.3 Study Design, Data Availability, and Variables 
This GLB intervention used a delayed control design (Figure 6.1).  This design was selected 
because it balances research expectations and ethics by providing intervention and control arms 
during the first phase of the randomized controlled trial (RCT), while meeting the ethical 
imperative to provide eligible participants who are at elevated risk of type 2 diabetes and/or have 
the metabolic syndrome, the opportunity to partake of a lifestyle intervention from which they 
should derive benefit, after a delay of six months.  At baseline, two-thirds of the participants 
immediately began the intervention, while one-third were delayed for six-months before entering 
the identical intervention.  This design allows direct comparisons to be made between the 
intervention and control groups at the six month clinical visit, enabling a prospective assessment 
of the effect of the intervention.  
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Immediate 
Intervention Group
Delayed Intervention
Control GroupBaseline assessment
Core intervention
Post-core intervention
General health information
No intervention
6-month assessment
12-month assessment
18-month assessment
24-month assessment (control only)
Core intervention
Post-core intervention
No intervention
Timeline
 
Figure 6.1 Delayed Control Study Design 
6.1.4 Expenses Ascertainment 
Participants expenses related to the intervention were ascertained in two ways:  using an 
expenses survey (Appendix D) that was completed during clinical visits at baseline, and six- and 
12-months, and by food purchase receipts submitted by the participants.  The survey was 
compiled from a variety of sources and included items from the National Health and Nutrition 
Examination Survey (NHANES) Consumer Behavior Questionnaire [62], as well as questions 
about intervention-related travel time and expenses, food preparation patterns and time, 
purchases for physical activity and services, time and expenses of injuries sustained during 
physical activity, time and expenses of post-baseline diabetes diagnoses, hospitalizations and 
visits to the emergency room, physician office visits, and medication changes.  Due to a delay in 
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preparation, the expenses survey was not available for the baseline assessment visit at the 
workplace. Full baseline data was obtained from the three community sites. 
6.1.5 Laboratory and Anthropometric Measures 
Clinical assessment visits were conducted at baseline and six and 12 months after the baseline 
visit.  Participants met with the clinical team from the DPSC at their workplace or community 
enrollment site for the assessment visits.  Clinical variables obtained via blood draw included 
total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, insulin, fasting plasma 
glucose, and HbA1C.  Other measures included height, weight, blood pressure, and waist 
circumference.  A brief medical history was taken that included family and personal history of 
chronic disease, medication use, and cardiovascular events.  Surveys on self-monitoring habits, 
participant willingness to engage in various intervention-related activities, the Modifiable 
Activity Questionnaire (MAQ), as well as evaluation of the program and suggestions for 
improvement, were also given.  
As mentioned previously, this community translational investigation is collecting data 
from participants in multiple sites.  At the Workplace site, data collection is complete, while it 
continues at the three Community sites.  This dissertation includes available data from both 
intervention settings, detailed in Table 6.1.   
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Table 6.1 Data Availability by Intervention Site  
     
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Shading indicates available data 
 
 
 
 
 
 
Community 
 
Baseline Assessment, 134 participants 
 Immediate (baseline), 88 
 Delayed (1st baseline), 46 
132 costs surveys 
87 receipts 
 
 
6-Month Assessment 
Immediate (6 months), 84 
Delayed (2nd baseline), 42 
122 costs surveys 
68 receipts 
 
 
12-Month Assessment 
Immediate (12 months),77  
Delayed (6 months), 37 
114 costs surveys 
43 receipts  
 
 
18-Month Assessment 
Immediate (18 months),  
Delayed (12 months),  
costs surveys 
receipts 
 
 
 
Workplace 
 
Baseline Assessment, 88 participants 
No expenses surveys or receipts 
collected 
 
 
 
 
6-Month Assessment 
Immediate (6 months), 52 
Delayed (baseline), 28 
80 costs surveys 
38 receipts 
 
 
12-Month Assessment 
Immediate (12 months), 46 
Delayed (6 months), 22 
68 costs surveys 
33 receipts 
 
 
18-Month Assessment 
Immediate (18 months), 47 
Delayed (12 months), 21 
21 costs surveys 
10 receipts 
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Variables used in these analyses are derived from questions on the expenses survey 
(Appendix D).  There are three categories of variables.  Those related to participant time in 
various intervention-related activities are given in Table 6.2.  Participants were encouraged to 
self-monitor their food and beverage intake, as well as record the time they spent in physical 
activity.  Time spent related to meal preparation and clean up were also recorded.  Each of these 
behaviors takes time and for the purpose of this investigation may be considered an expense to 
the participant.  
 
Table 6.2 GLB Participation Time Variables 
Variable Name Variable Definition Variable 
Source  
(Appendix D) 
Time Self-Monitoring 
Activity 
Average weekly time spent keeping track of physical 
activity in a log or journal  
Q11, 13 
Time Self-Monitoring 
Eating and Beverage 
Intake 
Average weekly time spent keeping track of food and 
beverage intake in a log or journal  
Q12, 14 
Weekly Time Spent 
in Physical Activity 
Average weekly time spent in physical activity over the 
last 6 months 
Q15 
Physical Activity 
Alternative 
What participant would have been doing if not in 
physical activity 
Q16 
Times Preparing 
Main Meal at Home 
Average number of times in a typical week over the 
last 6 months that participant or family member 
prepared food at home for the main meal 
Q17a 
Time Preparing, 
Cooking, and 
Cleaning Up 
Average weekly time over last six month that is spent 
in preparing, cooking and cleaning up following the 
main daily meal 
Q17b 
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Variables related to the expenses of physical activity encountered by participants are 
shown in Table 6.3.  While being physically active need not necessarily incur expenses, the fact 
is that many individuals will purchase items to help facilitate physical activity, including shoes, 
clothing or other equipment.  As well, particularly during seasons of the year when it is either too 
hot or too cold or icy outside, many people will find a gym or fitness center the best location in 
which to maintain their physical activity program.  
 
Table 6.3 GLB Physical Activity Expense Variables 
Variable Name Variable Definition Variable 
Source (from 
Expenses 
Survey, 
Appendix D) 
Shoe Purchases  Participant purchases of exercise or activity shoes 
during the last 6 months (Y/N). 
Q18 
Number of Pairs 
Purchased 
If exercise shoes were purchased, how many pair Q18a 
Shoes Expense Total cost of exercise shoes Q18b 
Activity Items 
Purchased 
Participant purchases of additional items to help with 
physical activity (Y/N) 
Q19 
Activity Items 
Expense 
Total cost of items purchased by participant for activity 
over the last 6 months plus cost of shoes 
Q18b, Q19 
Activity Services 
Purchased 
Participant purchase of services related to physical 
activity (Y/N) 
Q20 
Cost of Activity 
Services 
Total cost of services purchased by participant for 
activity services over the last 6 months 
Q20 
Total Activity 
Expense 
Total cost of items and services purchased by 
participant related to physical activity over last 6 
months 
Q18b, Q19, 
Q20 
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Probably the expenses of greatest interest to intervention participants are presented in 
Table 6.4, the variables related to the expenses of food from various types of stores.  For most 
families, particularly those at a lower income level, food expenses will be one of the largest 
monthly budget items and any change in food expenses will have a significant effect on the 
overall household budget.   
 
Table 6.4 GLB Food Expenses Variables 
Variable Name Variable Definition Variable 
Source (from 
Expenses 
Survey, 
Appendix D) 
Monthly Grocery 
Food Expense 
Participant expense for average grocery store food over 
last 6 months.  Monthly dollar value, or 4 X weekly 
value.  Subtracting grocery non-food 4Xweekly or 
monthly total, if any.  
Q21 
Monthly Non-
Grocery Store Food 
Expense  
Participant expense for average non-grocery store food 
over last 6 months.  Monthly dollar value, or 4 X 
weekly value.   
Q23 
Monthly Take Out 
Food Expense 
Prepared food purchased outside home, or delivered to 
home.  4Xweekly or monthly average dollar value over 
last 6 months. 
Q24 
Monthly Eating Out 
Food Expense 
Food expenses away from home, regardless of where 
eaten.   4Xweekly or monthly average dollar value over 
last 6 months. 
Q25 
Monthly Store Food 
Expense 
Total food expenses at grocery and non-grocery stores.  
Sum of Monthly Grocery and Monthly Non-Grocery 
Store Food. 
Q21, Q23 
Total Monthly Food 
Expense 
 Q21, Q23, 
Q24, Q25 
 
The NHANES consumer survey includes food purchase from four types of stores:  
grocery, non-grocery or other store that sells food, take-out food, and food eaten away from 
home.  In some settings, for example when looking at inner city food deserts, it may make sense 
to differentiate between food purchased grocery and non-grocery stores.  This distinction would 
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capture food purchased at small convenience or drug stores that may sell food.  However, in a 
suburban setting it does not make sense, particularly due to recent changes in grocery retailing 
where WalMart and Costco are now some of the largest sellers of groceries.  Recognizing this, a 
new category, “store food” was created, consisting of grocery and non-grocery store food. 
6.1.6 Data Analyses 
Descriptive statistics (mean, median, standard deviation, and inter quartile range (IQR)) were 
calculated for baseline, six- and 12-month expense and time variables. These variables were 
tested for change at 6- and 12-months from baseline using paired t-tests when the data was 
normally distributed and the Wilcoxon Signed Rank-Sum test when the data was not normally 
distributed.  In order to test between groups, the independent sample t-test was used for normally 
distributed data and the Wilcoxon-Mann-Whitney test for data that is not normally distributed. 
The Spearman Rank-Order Correlation test was used to test correlations between variables. 
  Given the large number of “0” values that exist for some of the activity expense 
variables, the data were also analyzed when limited to “non-zero” values.  Another way of 
expressing this would be to say “for those participants who have expenses or time in a given 
category, what are the values, and what change occurs over time?”   
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6.2 BASELINE CLINICAL RESULTS 
6.2.1 Intervention in the Community Setting, Baseline Results 
There were no significant differences between the immediate and delayed control groups at 
baseline in the community setting (Table 6.5).  The average age of all participants was in the low 
60s.  Most of the participants (92%) were Caucasian.  The participants were highly educated, 
with almost 56% having a college or graduate degree.  Over 40% were retired, reflecting the use 
of seniors’ centers as recruitment venues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
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Table 6.5 Baseline Characteristics of Community Participants 
 
 
 Intervention 
Mean (sd) 
Median (IQR) 
 (n=88) 
Control 
Mean (sd) 
Median (IQR) (n=46) 
p-between groups 
Gender % female (n)  65.9% (58) 69.6% (32) 0.67 
Age average (sd) 62.8 (12.1) 61.9 (11.9) 0.66 
Weight (lbs) 212.4 (46.3) 
202.3 (181.3-241.5) 
 201.5 (37.1) 
195.1 (176.8-220.4) 
0.17 
Total Cholesterol (mg/dl) 194.4 (37.8) 
188 (174.5-211.5) 
192.7 (43.9) 
188 (157-223) 
0.82 
HDL Cholesterol (mg/dl) 50.8 (14.4) 
50.5 (41-58) 
49.2 (12.4) 
49.0 (41-56) 
0.52 
LDL Cholesterol (mg/dl) 115.2 (33.3) 
117 (90-133) 
113.6 (41.5) 
108.8 (78.5-142) 
0.82 
Triglycerides (mg/dl)  
(median, IQR) 
122.5 (100-163) 137 (99-183) 0.30 
Glucose (mg/dl) 96.0 (10.3) 
94.0 (89-101) 
95.9 (13.1) 
93.0 (87-102) 
0.94 
HbA1C (%) 5.80 (0.32) 
5.7 (5.6-5.9) 
5.76 (0.33) 
5.7 (5.6-5.9) 
0.53 
Insulin 6.84 (6.0) 
5.00 (2-10) 
7.89 (6.7) 
6.00 (3-10.5) 
0.37 
Systolic Blood Pressure 
(mmHg) 
118.2 (11.7) 
118 (109.5-125) 
119.1 (12.2) 
118.5 (112-129) 
0.67 
Diastolic Blood Pressure 
(mmHg) 
72.3 (8.8) 
118 (109.5-125) 
119.1 (12.2) 
118.5 (112-129) 
0.67 
Waist (inches) 42.6 (5.8) 
41.6 (38.6-45) 
41.6 (4.7) 
42 (38-44) 
0.30 
BMI (kg/m2) 34.9 (6.7) 
33.6 (29.9 -38.7) 
33.4 (4.9) 
32.8 (30.3-37.0 ) 
0.16 
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6.2.2 Intervention at the Workplace Setting, Baseline Results 
In the workplace setting the delayed control group was significantly younger than the immediate 
intervention group (53.4 vs 49.9 p=0.03) (Table 6.6).  All other baseline variables were not 
significantly different between the two groups. 
Table 6.6 Baseline Characteristics of Workplace Participants 
 Intervention 
Mean (sd) 
Median (IQR) 
 (n=60) 
Control 
Mean (sd) 
Median (IQR)  
(n=29) 
p-between groups 
Gender % female ( n) 56.7% (34) 51.7% (15) 0.66 
Age average (IQR) 53.4 (49.3-59.3) 49.9 (44.9-53.7) 0.03 
Weight (lbs) 204.6 (40.1) 
197.7 (177-229) 
218.5 (36.6) 
210.8 (194-241) 
0.11 
Total Cholesterol (mg/dl) 195.0 (37.9) 
198.5 (165.5-218) 
195.5 (37.7) 
190.5 (166.6-214.5) 
0.95 
HDL Cholesterol (mg/dl) 53.2 (13.8) 
50.5 (43.5-61.5) 
47.8 (15.1) 
46.5 (39-54) 
0.10 
LDL Cholesterol (mg/dl) 113.2 (33.3) 
110.5 (85.5-137.5) 
116.9 (26.7) 
113 (99-131) 
0.61 
Triglycerides (mg/dl)  
(median, IQR) 
134 (101-161.5) 139 (98.5-191.5) 0.60 
Glucose (mg/dl) 92.1 (9.8) 
91 (86-98) 
91.8 (12.1) 
88.5 (82-98.5) 
0.90 
HbA1C (%) 5.69 (0.31) 
5.7 (5.5-5.9) 
5.60 (0.23) 
5.6 (5.5-5.7) 
0.19 
Insulin 5.66 (6.44) 
3 (1-8) 
9.11 (10.41) 
7.5 (2.5-10) 
0.12 
Systolic Blood Pressure 
(mmHg) 
121.1 (12.3) 
120 (114.5-126.5) 
120.0 (11.6) 
118 (114-125) 
0.70 
Diastolic Blood Pressure 
(mmHg) 
80.2 (8.4) 
80 (76.5-85) 
82.3 (8.1) 
82 (78-87) 
0.26 
Waist (inches) 40.7 (5.2) 
40.75 (37.7-43.1) 
41.7 (4.5) 
41 (39.25-44.25) 
0.39 
BMI (kg/m2) 32.8 (6.0) 
31.2 (28.7-36.1) 
33.6 (5.4) 
32.7 (29.7-35.6) 
0.55 
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6.3 SETTING THE STAGE:  SIX-MONTH CLINICAL RESULTS AND 
INTRODUCTION TO PAPER 3 
6.3.1 Introduction to Six-Month Clinical Results 
In order to draw any valid conclusions as to whether or not the participants in this intervention 
experienced changes in food, activity, or time expenses, it must first be established that there was 
a significant reduction in risk factors for the metabolic syndrome and type 2 diabetes.  In the 
absence of a statistically significant reduction in risk factors for type 2 diabetes or the metabolic 
syndrome, any finding of “no change” for expenses would be moot and contribute nothing to the 
translational literature related to diabetes prevention. 
6.3.2 Six-Month Clinical Results 
In the immediate intervention group, there were significant decreases in weight, glucose, HbA1c, 
systolic blood pressure, waist circumference, and BMI (Table 6.7) at the six-month clinical visit 
when compared with the baseline visit.  Of these, weight, HbA1c, waist, and BMI were all 
significantly decreased when compared with the delayed control group.  These significant 
decreases in established risk factors for type 2 diabetes and components of the metabolic 
syndrome make it clear that participants in the behavioral lifestyle intervention did make changes 
in their dietary and/or physical activity behavior.  The establishment of these clinical 
improvements allows legitimate considerations of whether these improvements were attained in 
the absence of increased spending for food and for physical activity.   
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Table 6.7 Six Month Clinical Results—Community Setting
Variable Delayed 
Group 
baseline I  
Mean (sd) 
Median (IQR) 
n=46 
Delayed Group 
baseline II  
Mean (sd) 
Median (IQR) 
n=46 
Mean 
Change (sd), 
Median 
(IQR) 
n=46 
p Immediate 
Group 
baseline  
Mean  (sd) 
Median (IQR) 
n=88 
Immediate 
Group  
6 MO  
Mean  (sd) 
Median (IQR) 
n=88 
Mean  
Change (sd) 
Median 
(IQR) 
n=88 
 
p p 
diff 
btween 
groups 
Weight (lbs) 201.5 (37.1) 
195.1  
(176.8-220.4) 
199.9 (38.3) 
194.0 
(176.8-219) 
-1.6 (7.0) 
-0.9  
(-6.4-2.2) 
0.13 212.4 (46.3) 
202.3 
(181.3-241.5) 
201.5 (45.6) 
194.7 
(167-233.2) 
-10.9 (10.9) 
-10.5 
(-18.3- -2.9) 
<.0001 <.0001 
Total Cholesterol 
(mg/dl) 
193.4 (45.0) 
185.5  
(156-226) 
192.9 (40.0) 
194.5  
(161-218) 
-0.5 (22.7) 
0.5 
(-12.5-14) 
0.81 196.7 (37.3) 
188 (177-212) 
194.4 (35.7) 
190 (171-210) 
-2.3 (21.9) 
0 (-15-9) 
0.22 0.84 
HDL Cholesterol 
(mg/dl) 
48.7 (12.7) 
48.5 (41-55) 
47.2 (10.8) 
46.0 (39.5-55.5) 
-1.5 (6.8) 
-2.0 (-4-1.5) 
0.11 51.3 (14.6) 
49.5 (41-58) 
50.3 (14.7) 
47.0 (41-57) 
-1.0 (6.7) 
-1.0 (-4-2) 
0.06 0.19 
LDL Cholesterol 
(mg/dl) 
114.5 (42.1) 
110.0 (78-142) 
114.4 (35.1) 
118 (84-136) 
-0.1 (20.5) 
0 (-8-16) 
0.88 115.9 (33.4) 
117.5  
(94.5-132.5) 
115.7 (30.8) 
113.5 (95-130) 
-0.2 (18.6) 
0 (-11-10.5) 
0.85 0.68 
Triglycerides 
(mg/dl) (med IQR) 
142.5  
(95-198) 
147.5  
(105-212.5) 
6.5 
(-16.5-21.5) 
0.64 122.5  
(100-172) 
126.5 
(100-169) 
0  
(-20-20) 
0.61 0.38 
Glucose (mg/dl) 95.9 (13.1) 
93.0 (87-102) 
94.4 (12.2) 
93.0 (86-100) 
-1.7 (6.1) 
0 (-4.0-2.5) 
0.20 96.0 (10.3) 
94.0 (89-101) 
92.9 (10.8) 
90.5 (86-97) 
-3.1 (7.5) 
-2.5 (-5.5-0) 
<.0001 0.25 
HbA1c (%) 5.76 (0.33) 
5.70 (5.6-5.9) 
5.74 (0.41) 
5.70 (5.5-5.9) 
-0.02 (0.16) 
0 (-0.1-0) 
0.38 5.80 (0.32) 
5.70 (5.6-5.9) 
5.66 (0.29) 
5.60 (5.5-5.9) 
-0.14 (0.17) 
-0.10 (-0.2-0) 
<.0001 0.0002 
SBP (mm/Hg) 118.6 (12.3) 
117.5  
(111.5-127.5) 
118.4 (14.3) 
117.0 
(109.5-128) 
-0.25 (9.9) 
-2.0 
(-7.5-6.5) 
0.46 118.4 (11.7) 
118.0 (110-125) 
115.3 (12.6) 
113.0 (108-122) 
-3.12 (10.7) 
-2.0 (-10-3) 
0.01 0.14 
DBP (mm/Hg) 72.8 (11.6) 
74.0 (68-80) 
71.7 (10.0) 
72.0 (65-79) 
-1.1 (9.60 
-0.5 (-7.5-5) 
0.41 72.7 (8.6) 
71.0 (68-78) 
71.9 (9.6) 
71.0 (65-78) 
-0.9 (8.7) 
0 (-8-5) 
0.55 0.87 
Waist (in) 41.5 (4.7) 
42 (38-44) 
41.5 (4.5) 
41.0 (39.3-43.5) 
-0.01 (1.9) 
0.06 
(-1.5-1.4) 
0.96 42.6 (5.8) 
41.6 (38.6-45) 
41.0 (5.9) 
40.0 (37.5-43.8) 
-1.6 (2.0) 
-1.8  
(-2.6- -0.1) 
<.0001 <.0001 
BMI (kg/m2) 33.4 (4.9) 
32.8 (30.3-
37.0) 
33.2 (5.2) 
32.4 (29.9-36.4) 
-0.3 (1.2) 
-0.2 (-0.9-0.4) 
0.16 34.9 (6.7) 
33.6 (29.9-38.7) 
33.1 (6.9) 
32.2 (27.3-37.7) 
-1.8 (1.7) 
-1.8 (-2.9- -
0.5) 
<.0001 <.0001 
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6.3.3 Background and Introduction to Paper 3 (See Appendix C) 
The presentation of participant expenses for this dissertation begins in Section 6.4.  Paper 3 
reports on expenses from the randomized controlled trial phase of the intervention during the 
first six months when there was both an intervention and control group.  In this setting, it is thus 
possible to report baseline to six month expenses results, as well as compare changes in expenses 
and time between the two groups.    
6.4 PAPER 3 (APPENDIX C).  ACTIVITY AND FOOD EXPENSES AMONG 
PARTICIPANTS IN A COMMUNITY TRANSLATIONAL DIABETES PREVENTION 
INTERVENTION:  BASELINE TO SIX MONTHS 
6.4.1 Specific Aims of Paper 3 
Paper 3 reports on the following specific aims: 
 1. To describe changes in direct nonmedical expenses of participants partaking in a 
community diabetes prevention program.   
Results from the six-month assessment visit will be compared with baseline to evaluate 
change in direct nonmedical expenses for participants.  As well, change between groups will be 
assessed to help quantify the impact of the intervention on participant time and expenses.  These 
expenses are broadly defined, and include out-of-pocket expenses related to physical activity and 
food, and the time spent in intervention-related activities. In addition, these changes will be 
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reported with consideration of potential confounding variables, including age, gender, and 
education (a marker for socioeconomic status).   
2.  To determine whether participants with higher attainment of program goals also accrue 
higher expenses associated with that attainment. 
 Participants in the GLB program are given behavioral and weight-loss goals, based on the 
DPP lifestyle intervention.  These include: weight-loss of 7% or greater and increased 
participation in physical activity.  It is not clear whether those who reach established behavioral 
milestone also have greater direct, nonmedical expenses than those who do not attain program 
goals. 
6.4.2 Paper 3 Abstract (See Appendix C for Paper) 
Activity and Food Expenses Among Participants in a Community Translational Diabetes 
Prevention Intervention  
  
 Purpose:  To evaluate direct nonmedical out-of-pocket expenses related to activity, food, and 
time among participants in a community translational diabetes prevention intervention. 
 
Methods:  Participant expenses related to the intervention were collected as part of a randomized 
controlled trial of a Group Lifestyle Balance (GLB) intervention in the community among 
individuals who had pre-diabetes and/or the metabolic syndrome.  This included completion of 
expenses surveys and collection of household food receipts for two-week periods at baseline and 
six months.  The intervention consisted of 12 weekly sessions followed by two bimonthly and 
then monthly sessions where participants received training and suggestions about how to make 
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and maintain healthy lifestyle choices.  134 participants (88 in the immediate intervention group 
and 46 in the delayed control group) enrolled in the study, allowing comparisons within and 
between the intervention and control groups.   
Results:  Among those with complete clinical attendance and survey results (n=91), total food 
expenses were unchanged from baseline to six months in the intervention group, while total food 
expenses significantly increased in the control group at six months when compared to baseline 
(+$79.94 p=0.04).  There was also a significant difference in the amount of money spent eating 
out between the control and intervention groups over the first six months of the program.  
Although not at the level of significance, reported take-out food expenses appeared to decline in 
both the control and intervention groups.  At six months, changes in total expenses for physical 
activity from baseline were not significantly different between the control and intervention 
groups.  Expenses for physical activity services decreased significantly from baseline in the 
intervention group and approached significance in the control group.  There was an increase of 
borderline significance for activity items in the control group from baseline at six months.  
Adjusting food expenses data for food price inflation weakened the significance of the finding 
regarding eating out expenses between the control and intervention groups.  Other food expenses 
results were unchanged after inflation adjustment.  Stratification of change in expenses by 
achievement of weight loss, education, age and gender in the intervention group did not result in 
significant differences between groups, other than a significantly greater decrease in expenses for 
physical activity in men (196 to $103, p<0.05) than in women. There were no significant 
correlations between physical activity expenses or change in physical activity expenses and the 
monthly frequency or change of frequency of activities reported on the modifiable activity 
questionnaire (MAQ). 
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Conclusions:  These findings suggest that statistically significant and clinically meaningful 
reductions in type 2 diabetes risk factors can be achieved without increasing household food and 
activity expenses.  This is consistent with previously reported clinical and community results.  
However, unlike earlier reports, this study included baseline measures and was thus able to 
evaluate change over time. These expenses data are household level, and thus do not allow 
conclusions about individual consumption or use.  However, the findings support the assertion 
that participants in a diabetes prevention program can adjust their individual dietary and activity 
patterns within their economic situation as part of a program to reduce their diabetes risk factors, 
without increasing expenses.  Such a message may help dispel the myth that it costs more to 
make healthy lifestyle changes, and increase the attractiveness of diabetes prevention programs 
to those at elevated risk. 
Paper 3 Findings in the Context of this Dissertation:   The findings presented in Paper 3 are 
analyses of the first six months of data from the community setting.  This is the randomized 
controlled trial (RCT) portion of the project.  These results suggest that at-risk individuals can 
improve their clinical risk factors for type 2 diabetes and/or metabolic syndrome components 
without a significant increase in expenses beyond the time spent on intervention-related 
activities.   
 However, there are additional data available from this ongoing clinical trial from the 12 
month assessment of the immediate intervention group (Table 6.1).  It is instructive to report 
analyses of these data, comparing baseline to 12 months (or pre-post), as the GLB program is 
complete by 12 months and thus the participants have received all of the intervention doses.  As 
well, seasonal effects will be eliminated as the baseline and 12 month assessment visits took 
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place approximately one year after the baseline visit.  These pre-post 12 month results are 
reported in Section 6.5. 
6.5 PARTICIPANT EXPENSES IN IMMEDIATE INTERVENTION GROUP--
BASELINE TO 12 MONTHS IN THE COMMUNITY SETTING 
As the Group Lifestyle Balance (GLB) investigation that provided participant expenses data for 
this dissertation is ongoing (see Table 6.1), complete prospective analyses cannot yet be 
completed.  This section presents analyses of complete data participants in the community setting 
who attended both the baseline and 12 month assessment visits.  When looking at both the 
purchase locations (store, take-out, eating out, and total food spending) there were no significant 
changes in total estimated food expenses from baseline to 12 months (Table 6.8).  In all cases, 
the differences in the dollar amounts from baseline to 12 months were less than $10, strongly 
supporting the evolving thesis of little or any change in food expenses over the course of the 
intervention. 
 
 
 
 
 
 
 
 
81 
Table 6.8 Food Expenses by Purchase Site in the Immediate Intervention Group  
 
Estimates of average 
monthly food purchase 
amounts per month over 
last 6 months 
Baseline  
Mean (sd) 
Median (IQR) 
n=51 
12 Mo  
Mean (sd) 
Median (IQR) 
n=51 
 
Change  
Mean (sd) 
Median (IQR) 
 
p 
Store food  (grocery and 
non-grocery, ($/household) 
 
463.73 (301.55) 
410 (260-600) 
471.53 (291.95) 
400 (250-600) 
7.80 (338.91) 
15 (-140-95) 
0.89 
Purchased take-out food % 
(n) 
70.5% (36) 56.9% (29) -13.6% (-7) 0.23 
Take-out food per month 
($/household) 
 
43.43 (48.60) 
25 (0-80) 
38.63 (53.79) 
20 (0-50) 
-4.81 (54.05) 
0 (-25-0) 
 
0.41 
Purchased eat-out % (n) 94.1% (48) 92.2% (47) -1.9% (-1) 1.0 
Eating out food per month 
($/household) 
 
130.73 (123.71) 
100 (25-200) 
135.63 (122.78) 
100 (40-200) 
4.90 (79.97) 
5 (-25-32) 
 
0.53 
Total of estimated food 
spending per month ($) 
 
637.88 (386.02) 
580 (380-840) 
645.78 (350.69) 
530.00 (400-965) 
7.90 (385.74) 
20 (-165-125) 
 
0.93 
 
For the immediate intervention group in the community setting, expenses related to 
physical activity from baseline to 12 months, both items and services, as well as the total, are 
reported in Table 6.9.  Looking at the individual subcategories as well as the total, there were no 
significant changes reported from baseline to the 12-month assessment visit.  As mentioned 
previously, these pre-post 12 month data control for seasonal factors that may have impacted 
purchase patterns reported in Paper 3, Table 3, where there were significant and borderline 
significant changes in purchases related to physical activity. 
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Table 6.9 Expenses Related to Physical Activity in the Immediate Intervention Group  
 
 
 
 
 
 
 
 
 
 
 
Time spent in intervention-related activities and food preparation from baseline to 12 
months in the immediate intervention group in the community (Table 6.10) not surprisingly 
shows a significant increase in the time spent in intervention-related self-monitoring of physical 
activity (3.18 to 16.88 minutes, p<.0001) and food and beverages (8.92 to 24.31 minutes, 
p<.0001).  As well for both categories of self-monitoring at 12 months, the median values are 
greater than zero, unlike at baseline, indicating that more than half of the participants continue to 
self-monitor one year after baseline.  This finding is important because it has been shown that 
adherence to self-monitoring is associated with maintaining weight loss and high physical 
activity levels [183,184].   
 
 
Household 
Activity 
Expense 
Categories 
($/6 months) 
Baseline 
Mean 
(sd) 
Median 
(IQR)  
n=74 
12 Months 
Mean 
(sd) 
Median 
(IQR) 
n=74 
Change  
Mean (sd) 
Median (IQR) 
  
p 
Items (ex. 
shoes, clothing, 
bike) 
60.95 
(132.03) 
19.5 
(0-80) 
64.65 
(104.44) 
17.5 
(0-90) 
3.70 
(160.72) 
0 
(-50-55) 
0.68 
Services (ex. 
classes, gym 
membership) 
147.59 
(354.04) 
0 
(0-60) 
125.92 
(355.38) 
0 
(0-80) 
-21.68 
(169.46) 
0 
(0-0) 
0.29 
Total  208.54 
(375.32) 
77.50 
(0-240) 
190.57 
(378.13) 
83 
(0-190) 
-17.97 
(218.51) 
0 
(-60-50) 
0.78 
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Table 6.10 Time in Intervention-Related Activities in the Immediate Intervention Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Baseline 
Mean 
(sd) 
Median 
(IQR)  
 
12 Months 
Mean 
(sd) 
Median 
(IQR) 
 
Change  
Mean 
(sd) 
Median 
(IQR) 
  
p 
PA self-
monitoring 
(minutes/wk) 
n=58 
3.81 
(12.71) 
0 
(0-0) 
16.88 
(19.76) 
10 
(0-30) 
13.07 
(22.13) 
6 
(0-30) 
<0.0001 
Food self-
monitoring 
(minutes/wk) 
n=51 
8.92 
(29.84) 
0 
0-0 
24.31 
(26.06) 
20 
0-45 
15.39 
(32.51) 
5 
(0-30) 
<0.0001 
Food 
Preparation 
and Clean Up 
(minutes/wk) 
n=63 
456.03 
(235.25) 
420 
(300-600) 
412.95 
(288.61) 
360 
(150-540) 
-43.08 
(305.94) 
-50 
(-210-120) 
0.14 
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6.6 ANALYSIS OF THOSE PARTICIPANTS REPORTING EXPENSES FOR 
PHYSICAL ACTIVITY 
In the randomized controlled trial results for physical activity expenses (Table 3 of Paper 3) and 
12 month pre-post physical activity expenses (Table 6.9), inter quartile ranges (IQR) for physical 
activity items and for physical activity services have a low value of zero.  This value of zero 
results from at least 25% of participants not reporting any expenses in those categories.  
Additionally, median values of zero are also present in both tables which further results from at 
least 50% of participants not reporting any physical activity expenses in these categories.  This 
suggests that a substantial proportion of all participants did not report any physical activity 
expenses at all at the assessment visits.  Accordingly, mean and median values for the 
participants as a whole may not accurately convey actual participant purchasing behavior.   
Table 6.11 includes only those participants reporting physical activity expenses at each 
clinical assessment visit.  In this analysis, the participants are not the same at each assessment 
time, and there is no consideration given to whether they did or did not have previous physical 
activity purchase.  The “n” in each case is the number of participants attending the given 
assessment visit.  In both the control and intervention groups, no clear patterns emerge, other 
than a continuing decline in the mean values.  There is, however, no evidence that expenses 
increase over time in either the delayed control or immediate intervention groups.  
85 
Table 6.11 Total Activity Expenses For Community Participants Reporting Expenses Greater Than Zero 
 
 
 
Household 
Activity 
Expense  
($/6 months) 
Control 
Baseline I 
% (n) reporting 
Mean 
(sd) 
Median 
(IQR)  
n=46 
Control 
Baseline II 
% (n) reporting 
Mean 
(sd) 
Median 
(IQR)  
n=42 
Control 
6 Months  
% (n) reporting 
Mean 
(sd) 
Median 
(IQR) 
n=37 
Intervention 
Baseline 
% (n) reporting 
Mean 
(sd) 
Median 
(IQR)  
n=88 
Intervention 
6 Months 
% (n) reporting 
Mean 
(sd) 
Median 
(IQR)  
n=81 
Intervention 
12 Months 
% (n) reporting 
Mean 
(sd) 
Median 
(IQR) 
n=77 
Total  63.0% (29) 
291.69 
(322.23) 
204 
(92-425) 
73.8% (31) 
244.72 
(226.44) 
170 
(80-355) 
59.5% (22) 
458.75 
(813.33) 
140 
(100-379) 
 
70.5% (62) 
358.76 
(587.11) 
201 
(75-410) 
64.2% (52) 
280.69 
(454.50) 
151.50 
(70-235.50) 
64.9% (50) 
282.04 
(432.08) 
142.50 
(76-310) 
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6.7 RECEIPTS ANALYSES 
6.7.1 Introduction and Background  
In addition to the self-reported food expenses captured by the expenses survey, household food 
receipts collected and submitted by intervention participants in the community setting over a two 
week period near the assessment visits provided an additional source of information about food 
purchases.  Receipt collection formed an ancillary study to the investigation, and all participants 
were invited to take part.   Upon receipt of the receipts, research staff made photocopies of the 
receipts for archival purposes.  Each receipt was then categorized into one of four general 
purchase types:  grocery store, other food store, take-out, and eating-out.  Store receipts were 
also scrutinized to identify and subtract non-food items from the total amount.   As with the 
expenses survey, food amounts from grocery and other food stores were combined into a single 
store food category. 
6.7.2 Results 
A substantial number of participants did not submit receipts despite encouragement to do so by 
research team personnel at the assessment visit as well as reminder telephone calls.  Reasons 
given included the following: variants of “it’s too much bother,” “I’m a nanny and my employer 
family provides my food,” and “my wife/husband does most of the shopping and she/he won’t do 
it.”   
87 
Complete baseline and six-month receipts collection and survey data were available from 
37% (49/134) of participants in the community setting.  These participants attended both the 
baseline and six-month clinical visits, submitted household food receipts at both visits, 
completely filled out the expenses surveys (no “I don’t know” or missing data).  This subset of 
the population provided the most complete expenses data and thus allowed the evaluation of 
expenses results from the same group of participants using two different measures, the expenses 
survey and food receipts.  At six months from baseline, there were no significant changes in food 
expenses in either the control or intervention group based on submitted receipts, both from the 
purchase location categories, and in total (Table 6.12).  As well, there were no significant 
changes in expenses between the two study groups. 
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Table 6.12 Food Purchase Receipts Among Receipts and Survey Completers 
 
 
 
 
 
 Delayed Group 
baseline I   
Mean (sd) 
Median 
(IQR) 
n=20 
Delayed Group 
baseline II  
Mean (sd) 
Median 
(IQR) 
n=20 
Delayed Group 
Baseline I  to II 
Change  
Mean (sd) 
Median 
(IQR) 
n=20 
p Immediate 
Group 
baseline  
Mean  (sd) 
Median (IQR) 
n=29 
Immediate 
Group  
6 MO  
Mean  (sd) 
Median (IQR) 
n=29 
Baseline to 6 
MO Change  
Mean (sd) 
Median (IQR) 
n=29 
 
p p 
diff 
btween 
groups 
Store food  
(grocery and other 
store) 
($/household) 
260.03  
(200.83) 
246.25  
(99.56-326.23) 
202.56  
(152.67) 
194.81  
(63.58-301.20) 
-57.46  
(225.51) 
-46.82  
(-146.03-71.26) 
.33 511.81  
(720.28) 
245.32 
(170.74-465.96) 
390.15  
(324.82) 
246.64  
(189.98-557.30) 
-121.66 
(509.57) 
-11.08  
(-106.84-94.94) 
.45 .78 
Take-out food per 
month 
($/household) 
23.08  
(67.90) 
0  
(0-10.25) 
11.91  
(20.93) 
0  
(0-12.83) 
-11.17  
(73.54) 
0 
(-10.25-10.70) 
.99 9.28  
(17.38) 
0  
(0-12.16) 
11.80  
(30.57) 
0  
(0-0) 
2.51  
(29.24 ) 
0  
(0-0) 
.95 .94 
Eating out food 
per month 
($/household) 
101.90  
(106.45) 
62.33  
(10.61-176.27) 
88.32 
(87.49) 
68.18  
(34.25-106.82) 
-13.58  
(134.68) 
5.94  
(-84.95-42.63) 
.76 123.37  
(182.78) 
34.18  
(0-147) 
70.99 
(93.18) 
25.00  
(0-139.18) 
-52.38  
(168.06) 
0  
(-82.36-15.14) 
.13 .36 
Total food 
spending per 
month ($) 
385.01  
(274.43) 
361.12  
(163.84-467.97) 
302.79  
(192.76) 
286.21 
(140.25-462.11) 
-82.22  
(296.83) 
-3.11 
(-107.95-88.52) 
.59 644.47 
(741.73) 
350.90 
(252.82-639.12) 
472.94 
(301.67) 
404.74  
(246.64-573.08) 
-171.53  
(543.97) 
-66.04 
(-167.74-89.42) 
.28 .58 
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 Food expenses reported on the expenses survey by the 49 receipts and expenses survey 
completers (same participants as in Table 6.12), also show no changes in food expenses, either 
from the various purchase locations, or in total. 
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 Table 6.13 Food Purchase Survey Estimates Among Receipts and Survey Completers 
 
 
 
 
 Delayed Group 
baseline I  
Mean  
(sd) 
Median  
(IQR) 
n=20 
Delayed Group 
baseline II  
Mean  
(sd) 
Median  
(IQR) 
n=20 
Delayed Group 
Baseline I  to II 
Change  
Mean  
(sd) 
Median  
(IQR) 
n=20 
p Immediate 
Group 
baseline  
Mean   
(sd) 
Median  
(IQR) 
 n=29 
Immediate 
Group  
6 MO   
Mean   
(sd) 
Median  
(IQR) 
n=29 
Baseline to 6 
MO Change  
Mean  
(sd) 
Median  
(IQR) 
n=29 
 
p p 
diff 
btween 
groups 
Store food  
(grocery and other 
store) 
($/household) 
354.55  
(185.96) 
328.00 
(220.00-440.00) 
413.65  
(271.63) 
400.00  
(240-500) 
59.10  
(226.18) 
0  
(-83-139) 
.57 440.97 (265.46) 
400 (230-640) 
502.38  
(353.05) 
440  
(300-600) 
61.41  
(214.27) 
40 
(-70-100) 
.26 .62 
Take-out food per 
month 
($/household) 
25.15  
(31.27) 
5.00  
(0-54) 
19.75  
(32.95) 
0  
(0-30) 
-5.40  
(35.62) 
0  
(-22.50-11) 
.51 32.07 (35.94) 
20 (0-60) 
25.69  
(40.37) 
5  
(0-24) 
-6.38  
(35.51) 
0  
(-20-0) 
.13 .54 
Eating out food 
per month 
($/household) 
169.10  
(113.42) 
160 
(80-225) 
211.00 
(157.64) 
160  
(110-300) 
41.90  
(135.00) 
14  
(-35-125) 
.27 96.03 (104.88) 
60 (25-140) 
93.83  
(102.10) 
40  
(0-160) 
-2.20  
(87.26) 
0  
(-30-30) 
.95 .30 
Total food 
spending per 
month ($) 
548.80  
(228.42) 
525  
(424-705) 
644.40  
(360.81) 
617.50  
(375-735) 
95.60  
(314.41) 
-15  
(-77.50-219) 
.51 569.07 (322.71) 
508 (265-790) 
621.90  
(379.70) 
536  
(350-720) 
52.83  
(235.28) 
35  
(-65-160) 
.27 .78 
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Scatterplots of the receipts and survey food expense data (Figure 6.2) suggest possible 
linear relationships between the two measures, permitting the use of correlation coefficients to 
test the significance of the relationship between the food expense measures.  The y-axis on the 
baseline plot (Figure 6.2) was set at $1500, resulting in the truncation of two outlying data 
points.    At baseline, Spearman’s rank correlation coefficient for food receipts and reported food 
expenses was 0.73 (p<0.0001) and at six months the coefficient was 0.69 (p<0.0001).   
While correlations between the two measures of food expenses are positive and 
significant, the directions of change at six months are mostly in opposite directions, with average 
food purchase receipts decreasing in all categories except for take-out food in the immediate 
intervention group which increased $2.51, while most categories appear to increase in the survey 
estimates, although not significantly.  Explanations for this discrepancy may include a decreased 
thoroughness and completeness of receipt collection and submission by those who submitted 
receipts at six months.  A participant was considered a “receipts completer” regardless of the 
number of receipts submitted.  Some submissions only contained a single receipt, almost 
certainly underreporting household food expenses for that two-week period.  Alternatively, 
granting that receipts collection was largely complete and accurate, it is possible that program 
participants became more aware of their food purchases by collecting receipts and through 
involvement in the intervention.  As they became more aware of their food purchase habits and 
the amounts they were spending, they may have overestimated the actual amounts they spent in 
the various food purchase categories on the survey.  It thus appears that while receipts collection 
and expense survey reports of food purchases are positively correlated, there may be some 
methodological or adherence issues that limit the accuracy of one or both as measures of change 
in food expenses over time. 
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Figure 6.2 Scatterplot of Baseline and Six Month Food Purchase Receipts and Survey 
Estimates Among Completers (n=49) 
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6.8 DEMOGRAPHIC SUBGROUP ANALYSIS 
In order to evaluate whether participant experience in terms of expenses differed by subgroup, a 
series of stratified analyses follow, including tests of significance of the change between the 
stratified groups in the immediate intervention group from baseline to six months.  Stratification 
of physical activity expenses (total of items and services) by gender and age showed that the 
decrease in expenses was significantly greater in males than in females (Figure 6.3).   
 
 
Figure 6.3 Total Six Month Expenses for PA by Gender and Age in Immediate Intervention 
Group 
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 Although there were significant increases in time spent self-monitoring in all gender and 
age groups, there were no differences by gender or age in the degree of change in self-
monitoring time (Figure 6.4).   
 
 
 
Figure 6.4 Weekly Self-Monitoring Time by Gender and Age in Intervention Group 
(minutes) 
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Change in total food expenses was not significantly different when stratified by achievement of 
any and 5% weight loss from baseline (Figure 6.5). 
 
  
 
Figure 6.5 Total Estimated Monthly Food Expenses by Weight Loss in Intervention Group 
 
 These results suggest that, in general, participants in various demographic groups had 
similar experiences in terms of the time they spent in intervention-related self-monitoring and for 
expenses for food and physical activity.  As well, weight loss was not related to change in food 
purchases.  It appears that the general behavior and experience of various participant groups may 
be quite similar. 
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6.9 CROSS-SECTIONAL WORKPLACE FOOD EXPENSE RESULTS 
Baseline food expenses data were not collected at the workplace due to a delay in preparation of 
the expenses survey form.  It was thus not possible to evaluate change in food expenses over 
time for this population as was done in Paper 3 for community center participants.  However, 
data were available to do cross-sectional comparisons of workplace food expenses reported by 
the control and immediate intervention groups at the six- and 12-month assessment visits.   
The six-month assessment (Table 6.14),  compares food expenses for the delayed control 
group which had yet to start the lifestyle program with the intervention group which had 
completed the core intervention sessions and was meeting monthly for the post-core material.  
For the 12-month assessment, food expenses of the delayed control group, having completed six 
months of intervention, are compared with the immediate intervention group which had 
completed the entire lifestyle intervention.    
At both clinical visits, there were no significant differences between the immediate 
intervention and delayed control groups for total household food purchase expenses, as well as 
for the individual purchase location categories (Table 6.14).  These results are consistent with an 
emerging trend in which there are no significant increases in expenses for participants in this 
behavioral lifestyle intervention, in either the community or workplace setting. 
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Table 6.14 Six- and Twelve-Month Cross-Sectional Analysis of Monthly Food Expenses in 
Workplace Participants 
 
 
 
 
 
 
 
 Six-Month Assessment  Twelve-Month Assessment  
Monthly Food 
Expenses by 
Site 
($/household) 
Control 
Baseline 
Mean 
(sd) 
Median 
(IQR)  
n=21 
Intervention 
Six Months 
Mean 
(sd) 
Median 
(IQR)  
n=29 
p Control 
6 Months 
Mean 
(sd) 
Median 
(IQR)  
n=14 
Intervention 
12 Months 
Mean 
(sd) 
Median 
(IQR)  
n=26 
p 
Store food  
(grocery and 
non-grocery,  
538.33 
(267.51) 
520 
(350-680) 
554.48 
(250.25) 
455 
(385-720) 
.95 406.00 
(195.33) 
345 
(300-500) 
415.15 
(190.06) 
397.50 
(304-520) 
.66 
Take-out food 
per month  
67.38 
(52.91) 
80 
(350-680) 
74.14 
(85.38) 
50 
(20-100) 
.83 78.21 
(74.10) 
42.50 
(30-100) 
69.62 
(83.15) 
50 
(20-80) 
.54 
Eating out food 
per month  
191.19 
(129.05)) 
200 
(100-300) 
207.93 
(152.54) 
160 
(100-250) 
.98 178.93 
(126.00) 
200 
(100-240) 
166.73 
(143.59) 
120 
(75-200) 
.56 
Total of 
estimated food 
spending per 
month  
796.90 
(339.79) 
770 
(620-980) 
836.55 
(338.29) 
760 
(585-1020) 
.85 663.14 
(289.47) 
665 
(480-800) 
651.50 
(273.62) 
582.50 
(470-870) 
.77 
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6.10 COMPARISON OF SELF-REPORTED FOOD EXPENSES IN COMMUNITY 
AND WORKPLACE SETTINGS  
The two intervention settings, community and the workplace, were chosen because they 
represented different demographics.  While the primary expenses results in this dissertation have 
been changes within and between the experimental and control groups, as well as pre-post results 
in the community setting, Table 6.15 extends the analyses by showing a comparison of the food 
expenses of participants in the two intervention settings.  The expenses reported for each setting 
are from the identical stage in the intervention for all participants:  the six-month clinical visit for 
the immediate intervention group and the 12-month visit for the delayed control group.  At these 
points, all participants had received six months of intervention consisting of the 12 core sessions 
and some of the post-core sessions. 
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Table 6.15 Cross-Sectional Comparison of the Self-Reported Food Expenses of Workplace 
and Community Participants after Having Completed Six Months of Intervention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With the exception of significantly greater expenses for take-out food at the workplace 
($78 to $35, p<.0001) (Table 6.15), other food expenses, including total food expenses, were not 
different between the community and workplace settings.  This result is somewhat surprising, 
given the generally higher socioeconomic level of the workplace participants.  However, among 
the community participants there were a number of highly educated and apparently affluent 
individuals, who, along with a several very large families, likely contributed substantially to food 
expenses in the community, resulting in similar results as the workplace. 
Monthly Food 
Expenses by 
Site 
($/household) 
Community 
Mean 
(sd) 
Median 
(IQR)  
n=66 
Workplace 
Mean 
(sd) 
Median 
(IQR)  
n=44 
p 
Store food  
(grocery and 
non-grocery,  
475.44 
(314.00) 
420 
(250-600) 
400.59 
(239.65) 
372.50 
(176-500) 
.19 
Take-out food 
per month  
34.76 
(48.17) 
11 
(0-52) 
78.55 
(77.77) 
74 
(30-88) 
<.0001 
Eating out food 
per month  
141.36 
(139.56) 
116 
(40-200) 
156.05 
(115.98) 
100 
(88-200) 
.42 
Total of 
estimated food 
spending per 
month  
651.56 
(380.65) 
560 
(360-850) 
635.18 
(324.05) 
585 
(352-780) 
.91 
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7.0 FINAL CONSIDERATIONS 
7.1   SUMMARY CONCLUSIONS 
Taken in totality, the findings of this dissertation illuminate an aspect of behavioral lifestyle 
interventions for preventing type 2 diabetes in the community setting that has not been 
extensively investigated, that of participant experience in such translation programs. This 
dissertation provides support for the assertion that there are direct benefits to participants beyond 
the reduction of clinical risk factors for type 2 diabetes and/or metabolic syndrome components.  
These include improvements in health-related quality of life (HRQoL), and that successful risk 
factor reduction can occur in the absence of significant increases in direct nonmedical expenses 
to the participant. 
Paper 1 reported on HRQoL in a Group Lifestyle Balance (GLB) intervention delivered 
by trained diabetes educators at three outpatient diabetes education sites.  Over the course of the 
intervention, several improvements in HRQoL emerged, measured by the CDC HRQoL–14 
Healthy Days Measure survey.  These included reductions in the number of days the participants 
felt they did not get enough rest or sleep and an increase in the number of days they felt healthy 
and full of energy.  Additionally, it was shown than participants who attended half or more of the 
GLB sessions were more likely to have reported fewer than 14 unhealthy days in the past month.  
These improvements provide evidence that participants at risk for type 2 diabetes and/or had the 
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metabolic syndrome benefitted in measurable ways from the GLB program beyond the 
previously established changes in physiologic outcome measures.  While improvements in 
HRQoL were previously shown in participants in the DPP clinical trial [52], the findings 
presented here strengthen and broaden the translational literature in the field of community 
diabetes prevention. 
Paper 2 builds on the findings of Paper 1 by evaluating HRQoL in a different setting and 
using an alternate HRQoL assessment tool.  The HRQoL data for that series of analyses came 
from a GLB intervention that pilot-tested delivery of the intervention via DVD as an alternative 
to the usual group setting.  While not powered to distinguish between the two delivery modes, 
both were shown to successfully reduce the risk factors for type 2 diabetes.  The Euro-Qol Visual 
Analog score, which represents the participants rating of their overall health on a scale of 1-100, 
improved significantly among both the group and DVD delivery participants.  These findings 
provide additional evidence that among those at elevate risk of type 2 diabetes, a prescription of 
a healthier lifestyle helps in ways beyond reduction of clinical risk factors. 
In addition to the findings related to HRQoL, this dissertation examined direct 
nonmedical expenses for individuals participating in a community lifestyle intervention 
translation effort.  Examples of such expenses include food, activity items and services, as well 
as time related to the intervention.  These expenses were reported in the DPP [59] and in 
translation from the HELP-PD intervention [60].  In both cases the intervention participants 
reported little difference in retrospectively-reported direct nonmedical expenses.  This 
dissertation adds to the translational literature by strengthening the case that there is little change 
in direct nonmedical expenses among the intervention participants when compared to the control 
group.  This finding was based upon both the lack of change in reported expenses from baseline 
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to 6 months (post intervention) in the intervention group compared to the control group, as well 
as any substantial pre-post change within either group.  The story that continues to emerge is that 
healthy lifestyle changes and reductions in disease risk can be achieved by participants in a 
behavioral lifestyle intervention for diabetes prevention without significant additional expenses, 
beyond the time invested in attending the intervention and involvement in intervention-related 
activities.   
These findings regarding expenses have important economic implications given the 
financial burden of type 2 diabetes.  Currently, 1 of every 10 healthcare dollars in the US  
attributed to the cost of diabetes [7], mostly type 2 diabetes.  By scaling up translational 
approaches based on the Diabetes Prevention Program, it should be possible to reduce financial 
burden of diabetes by preventing the disease or delaying its onset.  While such interventions have 
previously been shown to be cost-effective [156], the findings presented here have shown that 
risk factors for type 2 diabetes can be reduced within the existing budgetary and financial 
situation of participants.   Taken together, the three findings: diabetes can be prevented, as 
demonstrated in efficacy trials; diabetes prevention is cost-effective, as shown in cost-
effectiveness analysis; and the findings presented in this dissertation that out-of-pocket expenses 
to participants need not increase in order while participants reduce risk factors for type 2 
diabetes, indicate that the economic impact of diabetes might be attenuated through public health 
programming. 
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7.2   PUBLIC HEALTH SIGNIFICANCE 
This dissertation has rendered a comprehensive assessment and analysis of the experience of 
individuals participating in several deliveries of the Group Lifestyle Balance (GLB) program 
[18], a community-delivered diabetes prevention program, translated from the Diabetes 
Prevention Program (DPP) [13].  It includes quantifiable aspects of program participation as 
directly experienced by the participant, with a particular focus on health-related quality of life 
and direct nonmedical, out-of-pocket expenses paid by the participant.    
Given estimates of future increase in diabetes in America (from 23.7 million in 2009 to 
44.1 million in 2034 [12]), it is imperative that urgent public health action be taken to reduce the 
risk of diabetes.  The DPP behavioral lifestyle intervention on which the GLB is based is 
noteworthy in that it is one of only a few public health interventions that successfully 
demonstrated that it is possible to reduce the risk of a disease through behavioral change.  It is 
necessary to continue to build on the DPP legacy and expand delivery of lifestyle intervention 
programs in diverse community settings in order to help prevent or delay type 2 diabetes and 
other chronic diseases, including obesity.  The impact of the recent classification of obesity as a 
disease by the American Medical Association[185] remains to be seen, but it is probable that it 
will continue to increase the demand for programs that teach a healthy lifestyle.  
The findings presented in this dissertation should help to reduce some promotional and 
participatory barriers that community diabetes prevention interventions may experience, 
particularly surrounding the question of whether it is possible to reduce diabetes risk factors 
without incurring substantial additional expenses.  This dissertation suggests an answer in the 
affirmative, which will increase the likelihood of making diabetes prevention programming an 
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attractive option for all individuals, especially those at the lower end of the socioeconomic 
spectrum who may believe that meaningful lifestyle change is out of reach due to cost.   
Independent of a reduction of the clinical risk factors for type 2 diabetes, the fact that 
individuals may also help maintain or improve their health-related quality of life should also be 
promoted as a public health benefit of a behavioral lifestyle translation intervention such as the 
GLB.  These findings will help enable prospective participants to make informed decisions about 
the time and expenses that they should be prepared to commit in order to reduce their diabetes 
risk, as well as how their quality of life might be affected. 
Through much of its natural history [186], type 2 diabetes is asymptomatic. Although 
some pathologies related to elevated glucose may appear in the prediabetes phase [94], 
individuals with prediabetes often feel well and thus may not be motivated to take steps to reduce 
their risk of diabetes.  While this is certainly a short sighted perspective, it is nevertheless 
common, potentially making diabetes less feared than some other diseases and thus reducing the 
incentive to prevent it.  The fact that participants experience improvements in HRQoL, while 
accruing few additional expenses, should aid in dispelling the myth that diabetes prevention is 
expensive and that its benefits are intangible or only experienced at some future time.   
7.3   FUTURE DIRECTIONS 
Type 2 diabetes remains a significant health threat to many in America and around the world.  
The impact of diabetes is substantial, both to the individual and in terms of the expense to society 
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at large.  It is for these reasons that research must continue into identifying effective and efficient 
avenues so that diabetes prevention intervention can reach as many individuals as possible.    
Paper 1 showed that quality of life improved among participants in a diabetes prevention 
program.  However, it is true that the reported improvements were modest, possibly owing to the 
fact that at baseline, many of the participants considered themselves to be almost perfectly 
healthy as measured by widely-used health-related quality of life (HRQoL) assessment tools, 
including the Euro-Qol (EQ-5D-3L).  Recognizing this so-called “ceiling effect,” where a large 
number of respondents rate themselves at the highest level, a five level version of the instrument 
(the EQ-5D-5L) has been developed [132] which may allow a greater discrimination in the data 
collected, and reveal smaller changes in HRQoL that were not detectable with the instruments 
used in this investigation.  Future Group Lifestyle Balance (GLB) investigations should consider 
using the EQ-5D-3L for evaluating HRQoL. 
Although the relationship between weight loss and HRQoL has not been consistent in the 
published literature, it is generally accepted that weight loss may contribute to improvements in 
HRQoL.  This is a significant consideration for this dissertation because the relationship between 
weight loss and HRQoL is not yet established in community diabetes prevention settings.  While 
it could be argued that from the participant’s perspective it doesn’t matter whether improved 
HRQoL resulted from weight loss alone or in combination with other factors, from a research 
perspective it would be useful to determine whether diabetes prevention interventions are 
improving HRQoL due to weight loss or whether some other program outcomes are also 
contributing.  
In terms of direct nonmedical expenses research, there are additional questions that 
remain unanswered.  Paper 3 of this dissertation showed that participants can reduce their risk 
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factors for type 2 diabetes and/or components of the metabolic syndrome while experiencing 
little change in direct nonmedical expenses.  However, whether or not there were significant 
changes in the actual food items purchased (less junk food, more fruits, vegetables, or whole 
grains) remains unanswered.  Future analyses of itemized food purchase receipts collected as part 
of this investigation would help answer questions about what food items participants actually 
purchased and whether purchasing patterns changed during the intervention. 
More globally, of the findings in this dissertation, those about participant expenses will 
likely be of greatest benefit in advancing diabetes prevention activity.  It is clear from these 
results that successful reduction of risk factors for type 2 diabetes can be achieved within the 
budgetary constraints of a population of primarily white individuals from a socioeconomic range 
extending from blue collar and higher, including among retirees (see Paper 3).  However, 
whether this finding would hold in a low socioeconomic setting or among a racial or ethnic 
minority population has yet to be investigated.  Future HRQoL analyses, including from 
participants in a delivery of the Spanish version of the GLB, should be conducted to answer 
these questions.  
While the scientific evidence regarding the expenses of healthy food may be conflicting, 
there is abundant anecdotal evidence of a perception that a healthy lifestyle, consisting of healthy 
food and increased physical activity, is more expensive than the less-healthy and sedentary 
alternatives.  It is possible that recruiting efforts may be affected by this perception, even for 
diabetes prevention programs that do not charge a fee or require insurance billing.  However, the 
extent to which this perception would influence an eligible participant is unknown.  Further 
research should be conducted on how perceptions of expenses affect recruitment success, 
particularly among lower socioeconomic classes and minority groups. 
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Lastly, marketing research could help identify the most effective means to promote 
diabetes prevention efforts as an expense-neutral intervention that can result in important health 
benefits.  The challenge is that there is little profit in disease prevention and thus commercial 
organizations have little motivation for such research.  With the increasing involvement of the 
Federal government in the health of America through the Affordable Care Act, it is possible that 
the Centers for Disease Control, National Institutes of Health, or Department of Agriculture may 
be best suited to promote such a message.  The Agricultural Department already is involved in 
research on food expenses as part of the Thrifty Food Plan [180] and may be well-positioned to 
take a leadership role in this effort. 
The DPP demonstrated that type 2 diabetes can be delayed or prevented in a cost-
effective manner [13,154], a finding confirmed in translational studies [156,187].  It is known 
that diabetes prevention works, however, given the numbers at risk, the magnitude of the 
challenge can seem daunting.  It is likely that additional diabetes prevention efforts in new 
settings or using novel technology will be shown effective in reducing diabetes risk as long as 
weight loss, dietary improvement, and increased physical activity are achieved, and such 
findings are useful additions to the translational literature.  However, what is now needed is a 
concerted effort to prepare and train health professionals how deliver diabetes prevention 
programs such as the GLB in whatever setting they find themselves.  The impact of healthcare 
reform in America remains uncertain, but what is certain is that, regardless of politics, prevention 
will have to play a more important role in America’s healthcare priorities.  Those invested in 
diabetes prevention must be ready to meet the needs that emerge. 
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2University of Pittsburgh, School of Medicine and Nursing 
 
Abstract 
This study tested the hypothesis that participation in a behavioral lifestyle intervention based on 
the Diabetes Prevention Program resulted in improved health-related quality of life among 81 
participants with prediabetes and/or the metabolic syndrome.  Post-intervention, participants 
reported a significant increase in the number of “healthy days” and days when they “felt very 
healthy and full of energy,” compared with baseline, as well a decrease in the number of days 
when they didn’t get enough rest or sleep.  These findings show that, beyond improvement in 
physiological parameters, behavioral lifestyle interventions for diabetes prevention are associated 
with improvements in quality of life.   
 
Introduction 
Behavioral lifestyle intervention is an effective approach for confronting the public health 
challenge of diabetes, and has been shown to reduce the risk of type 2 diabetes in several clinical 
trials (Pan et al., 1997; Ramachandran et al., 2006; Tuomilehto et al., 2001).  In particular, the 
Diabetes Prevention Program demonstrated a 58% reduction in risk for the development of type 
2 diabetes (Knowler et al., 2002).  Participants in the Diabetes Prevention Program also showed 
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improvements in health-related quality of life (HRQoL) scores related to physical functioning 
and vitality (Florez et al., 2012). 
 Translational research studies based on the Diabetes Prevention Program lifestyle 
intervention have been successful in reducing risk factors associated with the development of 
type 2 diabetes in a variety of community settings (Ackermann, Finch, Brizendine, Zhou, & 
Marrero, 2008; Amundson et al., 2009; Davis-Smith et al., 2007; Katula et al., 2011; Kramer et 
al., 2009; Kramer et al., 2010; Kramer, McWilliams, Chen, & Siminerio, 2011; McTigue, 
Conroy, Bigi, Murphy, & McNeil, 2009; Whittemore et al., 2009).  It stands to reason that these 
community diabetes prevention programs would also improve quality of life, but this has not 
been documented. 
It is clear that elevated glucose levels are associated with reduced HRQoL in those with 
type 2 diabetes (Brown et al., 2004; Schunk et al., 2011).  Additionally, non-diabetic individuals 
with elevated blood glucose concentrations have been found to have reduced HRQoL when 
compared to those with normal glucose (Chittleborough, Baldock, Taylor, Phillips, & North 
West Adelaide Health Study, 2006).  Reduced HRQoL is also present in individuals at elevated 
risk for diabetes based on a risk questionnaire, relative to age and gender weighted population 
norms (Hakkinen et al., 2009).  Likewise, individuals with the metabolic syndrome, a condition 
that includes elevated blood glucose as a diagnostic criterion, have been shown to have lower 
HRQoL than those without the metabolic syndrome (Ford & Li, 2008; Miettola, Niskanen, 
Viinamaki, Sintonen, & Kumpusalo, 2008).   
In contrast, very little has been published with regard to change in HRQoL among 
participants in community prevention programs targeting type 2 diabetes and/or the metabolic 
syndrome.  A Korean study demonstrated that a lifestyle modification program resulted in 
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significant improvements in the HRQoL of female participants with the metabolic syndrome (Oh 
et al., 2010).  In Brazil, a program to improve quality of life and reduce depression and binge 
eating disorder among individuals with prediabetes or the metabolic syndrome also reported 
improved HRQoL (Cezaretto, Siqueira-Catania, de Barros, Salvador, & Ferreira, 2012).  These 
findings suggest that HRQoL may be influenced by community programs targeting the 
prevention of diabetes and the metabolic syndrome.   
Even though the effectiveness of behavioral lifestyle interventions for reducing risk of 
type 2 diabetes is well established, the impact of these programs on HRQoL is still emerging.  
Thus, the purpose of the current effort was to test the hypotheses that a community lifestyle 
intervention based on the Diabetes Prevention Program and administered by diabetes educators 
resulted in improved HRQoL among the participants, and that baseline HRQoL predicted 
success in attaining specific program goals. 
Methods 
The Group Lifestyle Balance program (Kramer et al., 2009) is a behavioral lifestyle 
intervention adapted from the Diabetes Prevention Program.  The Group Lifestyle Balance 
curriculum includes a weight loss goal of 7% and a target of 150 minutes per week of moderately 
intense physical activity.  These goals were successfully used in the Diabetes Prevention 
Program to decrease the risk of developing type 2 diabetes (Knowler et al., 2002) and reduce 
cardiovascular disease risk factors (Orchard et al., 2005).  The Group Lifestyle Balance program 
has been successfully implemented in a variety of settings, including medically underserved 
communities, clinical practices, a fitness center, and churches (Dodani & Fields, 2010; Kramer et 
al., 2009; McTigue et al., 2009; Seidel, Powell, Zgibor, Siminerio, & Piatt, 2008).  
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The current study is a non-randomized, single-group, evaluation of implementation of the 
Group Lifestyle Balance program, with outcome variables assessed at baseline, post-intervention 
(about four months), and at six and 12 months.  Diabetes educators trained to deliver the Group 
Lifestyle Balance program presented the intervention over 12-14 weeks, in groups of 7-16 
participants at three outpatient diabetes education program sites in Western Pennsylvania, 
operated by the University of Pittsburgh Medical Center.  The study protocol was approved by 
the University of Pittsburgh Institutional Review Board and all study participants provided 
informed consent.  A detailed description of the study design, setting, and interventionist 
training, as well as participant recruitment, has been published elsewhere (Kramer et al., 2011) 
and is summarized below. 
Eligibility and recruitment 
Individuals at least 25 years old, with a body mass index (BMI) >25 kg/m2, and no 
previous diabetes diagnosis were eligible to participate when meeting the criteria for prediabetes 
(fasting plasma glucose 100-125 mg/dl) (American Diabetes, 2004) and/or the metabolic 
syndrome.  The metabolic syndrome was defined following the National Cholesterol Education 
Program Adult Treatment Panel 3 criteria as a clustering of abdominal obesity, atherogenic 
dyslipidemia, hypertension, and insulin resistance.  Diagnostically, the metabolic syndrome is 
determined by the presence of three or more of these five conditions: 1. elevated triglycerides 
(≥150 mg/dl), 2. low HDL cholesterol (<40 mg/dl for men, <50 mg/dl for women), 3. increased 
waist circumference (>102cm for men, >88cm for women), 4. blood pressure ≥130/85 mm Hg 
(or on treatment for hypertension), 5. elevated fasting plasma glucose (≥100 mg/dL) (Expert 
Panel on Detection & Treatment of High Blood Cholesterol in, 2001).  For the current study, 
individuals previously diagnosed with diabetes, pregnant or lactating women (within past six 
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weeks), individuals unable to obtain physician referral to engage in moderate physical activity, 
or persons planning to leave the area before the end of the study, were ineligible.  
Recruitment involved the utilization of existing referral networks of primary and 
specialist physicians, direct mail and e-mail to physician practices, community posters, and local 
print media. A total of 121 physician referrals were received, with 95 individuals meeting 
eligibility criteria and 81 (85.3%) enrolling in the program.   
Outcomes 
Primary outcomes published elsewhere include change in weight and physical activity 
levels, with secondary outcomes of glucose, HDL cholesterol, LDL cholesterol and triglyceride 
levels, abdominal obesity and hypertension status (Kramer et al., 2011).  HRQoL, measured 
using the CDC Health-Related Quality of Life-14 Healthy Days Measure was also a secondary 
outcome of this study.   
CDC Health-Related Quality of Life-14 Healthy Days Measure 
The CDC HRQoL–14 Healthy Days Measure (CDC HRQoL) assesses self-reported 
health (Moriarty, Zack, & Kobau, 2003).  It consists of four core questions about general health 
and the number of unhealthy days during the past 30 days, followed by ten questions about 
recent pain, depression, anxiety, sleeplessness, or vitality; and the cause, duration, and severity 
of any current activity limitation.  The CDC HRQoL was completed at each assessment visit.   
Data analysis 
Data from those participants who attend the assessment visits were included in the 
analyses.  Within this group, analysis for each question used available data.   This may result in 
unequal sample sizes for HRQoL question due to missing data.  Fisher’s Exact Test was used for 
comparing sets of categorical variables and McNemar’s Test for the change of categorical 
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variables pre- to post-intervention.  To compare continuous variables, the paired t-test was used 
if the variable was normally distributed, and the signed rank test when the distribution was not 
normal. 
For the CDC HRQoL, self-reported health, unhealthy days, and a post-intervention report 
of a new major impairment or health problem that limited activities were investigated as 
predictors of Group Lifestyle Balance program outcomes.  Three distinct outcomes were 
investigated:   First, whether the participant attended 50% or more of the 12 weekly intervention 
sessions; second, whether 5% or greater weight loss was attained at the end of the 12-week 
intervention; and third, whether the participants reported 150 minutes or more physical activity at 
the post-intervention visit.  The 5% criterion for weight loss is based on a recent report that 
adaptations of the DPP achieved clinically significant weight loss of approximately 5% (Ali et 
al., 2012).  Health was considered “good” when the participants reported that in general, their 
health was excellent, very good, or good; and “not good” when they reported that in general, 
their health was fair or poor.    
An “unhealthy days” measure was created, consisting of the sum of days when reported 
physical or mental health was not good during the past 30 days.  Combining the days on which 
physical and mental health were not good is an approach recommended by the CDC for HRQoL 
analysis (Centers for Disease & Prevention, 2000), and has been validated (Newschaffer, 1998).  
Dichotomous variables for “unhealthy days” (which includes physical and mental health) and 
“frequent mental distress” (mental health only) were based on whether the individual reported 14 
or more unhealthy days in the preceding categories during the past month.  Analyses were 
carried out using the SAS statistical package (version 9.3, SAS Institute, Cary North Carolina, 
USA).  
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Results 
Study participants were predominantly female (88%) and white (96%), with 52% having 
a family history of diabetes and 63% having a family history of heart disease (Table A.1).  
Almost half (49%) of the participants had prediabetes at baseline. 
 
Table A.1 Baseline Participant Characteristics 
 Male 
12% (n=10) 
% (n) 
Female 
88% (n=71) 
% (n) 
Total  
(n=81) 
(n, %) 
Average age (range) 52.3 (39-66) 53.0 (26-80) 52.9 (26-80) 
White  90 (9) 97 (69) 96 (78) 
Employed full/part time 60 (6) 76 (54) 74 (60)  
Education    
High School/GED 10 (1) 24 (17) 22 (18) 
Some college/tech school 50 (5) 45 (32) 46 (37) 
College graduate 10 (1) 17 (24) 22 (18) 
Graduate degree 30 (3) 7 (5) 10 (8) 
Smoking 10 (1) 8 (6) 9 (7) 
Family History    
Diabetes 40 (4) 54 (28) 52 (42) 
Heart Disease 2 (20) 69 (49) 63 (51) 
Prediabetes  60 (6) 
 
48 (34) 49 (40) 
Source  (Kramer et al., 2011)   
 
 
Self-reported health (“good” versus “not good”) was examined over the course of the 
year among those who attended all assessment visits (n=43).  At the 4-month post-intervention 
assessment, there appeared to be an increase (from 81% to 95% p=0.07) in those reporting 
“good” health (Table A.2), compared to baseline.   
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Table A.2  Comparison of Baseline Scores for Self-Assessed Health in General With 
Follow-Up at Post-Intervention, Six Months, and 12 Months Among Completers (n=43) 
 
 Health in General 
“good”1 
n (%) 
Health in General “not 
good”2 
n (%) 
p (compared with 
baseline) 
Baseline 81 (35) 19 (8)  
Post-Intervention (4 
months) 
95 (41) 5 (2) 0.07 
Six Months 91 (39) 9 (4) 0.29 
12 Months 91 (39) 9 (4) 0.22 
1 participants who reported health in general as excellent, very good, or good 
2 participants who reported health in general as fair or poor 
 
Over the course of intervention, there was a decrease in the number of participants who 
reported that they did not get enough rest or sleep (10.7% to 6.3%, p=0.002) (Table A.3).  
Significant improvements in rest and sleep remained at six and 12 months from baseline.  In 
addition, at four months there was an increase in the number of days when the participants 
reported that they “felt very healthy and full of energy” (11.0% to 14.9%, p=0.02), with this 
change remaining significant at six months.  The other HRQoL components were not 
significantly changed from baseline to post-intervention.  Stratifying by gender did not change 
the results among females, although likely due to the small sample size (n=10), there were no 
significant changes from pre to post intervention among males.   
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Table A.3   HRQoL Measures Pre- and Post-Intervention (approx. 4 months) Among 
Completers (n=68) 
 
Parameter n 
 
Pre Post  Change p 
Mean Unhealthy 
Days  
53 7.4 7.7 0.3 0.96 
% with Unhealthy 
Days >=14  
53 24.5% (13) 20.8% (11) -3.7 0.79 
Mean Physically 
Unhealthy Days 
61 2.9 3.0 0.1 0.82 
Mean Mentally 
Unhealthy Days 
57 4.4 5.0 0.6 0.42 
% With Frequent 
Mental Distress 
57 17.5% (10) 10.5% (6) -7.0 0.29 
Mean Days When 
Poor Mental or 
Physical Health 
Limited Activities 
64 2.0 2.1 0.1 0.39 
% Limited in 
Activities because 
of  Impairment or 
Health Problem 
67 64.2% (43) 56.7% (38) -7.5 0.23 
Mean Days Pain 
Inhibited Usual 
Activities 
60 2.8 3.4 0.6 0.24 
Mean Days Sad or 
Depressed 
60 2.9 3.4 0.5 0.56 
Mean Days 
Worried or 
Anxious 
54 5.0 4.3 -0.7 0.52 
Mean Days Felt 
Did Not Get 
Enough Rest or 
Sleep 
55 10.7 6.3 -4.4 0.0002a,b 
Mean Days Felt 
Very Healthy and 
Full of Energy 
50 11.0 14.9 3.9 0.02a 
a Remained significant (p ≤ 0.05) at six months 
b Remained significant (p ≤ 0.05) at 12 months  
Participants for whom the number of unhealthy days in the past month was less than 14 
were significantly more likely to have attended 50% or more of the sessions than those who 
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reported 14 or more unhealthy days (p=0.001).  Self-reported health approached significance 
(p=0.068) in predicting Group Lifestyle Balance program success, as measured by session 
attendance of 50% or greater (Table A.4).  The use of the HRQoL measure for “baseline 
unhealthy days” appeared to predict self-reported achievement of the 150 minute per week 
activity goal at four months for those having less than 14 unhealthy days, although this finding 
was of borderline significance (p=0.077). 
At the four-month post-intervention assessment, 18 participants reported a new major 
impairment or health problem that limited their activities:  nine participants reported impairments 
related to walking, fractures, or bone/joint injury; three reported arthritis/rheumatism; two 
reported back or neck problems; two reported depression, anxiety, or emotional problems; while 
one each reported heart problems and “don’t know or unsure.”  Reports of these health problems 
did not predict attainment of Group Lifestyle Balance outcome goals 
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Table A.4   Baseline HRQoL measures and Group Lifestyle Balance attendance, weight loss, and self-reported activity at 4 
months. 
 
 Baseline Self-Reported Health in 
General 
Baseline Unhealthy Days3 Major Impairment at 12 Weeks, 
Among Participants Who Had 
None at Baseline4 
 “good”1 
(n=57) 
% (n) 
“not good”2 
(n=20) 
p <14 in past 
month 
(n=46) 
>=14 in 
past month 
(n=24) 
p No 
(n=58) 
 
Yes 
(n=10) 
p 
attend>= 50% of 
sessions 
90 (51) 70 (14) 0.068 94 (43) 67 (16) 0.001 98 (57) 100 (10) 1.000 
attained >=5% 
weight loss 
40 (23) 55 (11) 0.302 50 (23) 38 (9) 0.124 52 (30) 30 (3) 0.307 
achieved 
>=150 minutes self-
reported physical 
activity per week at 
4 months 
(n=50) 
 
48 (24)  
(n=12) 
 
4 (33) 
 
 
0.521 
(n=42) 
 
55 (23) 
(n=15) 
 
27 (4) 
 
 
0.077 
(n=55) 
 
46 (25) 
(n=10) 
 
50 (5) 
 
 
1.000 
 
1participants who reported health in general as excellent, very good, or good 
2participants who reported health in general as fair or poor 
3cumulative measure of physically and mentally unhealthy days in the past month  
4reported post-intervention: “what is the major impairment or health problem that limits your activities?” 
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Table A.5 HRQoL Measures Pre-and Post-Intervention (approx. 4 months) Among Completers Stratified by Gender (n=68). 
 
Male          Female 
Parameter n 
 
Pre Post  Change p n 
 
Pre Post  Change p p 
between  
Mean Unhealthy Days  8 6.8 8.8 2 0.56 45 7.5 7.5 0 0.99 0.75 
% with Unhealthy Days 
>=14  
8 25.0% 
(2) 
25.0% 
(2) 
0 1.0 45 24.4% 
(11) 
20.0% 
(9) 
-4.4 0.77  
Mean Physically Unhealthy 
Days 
9 2.2 1.3 -0.9 0.81 52 3.1 3.3 0.2 0.88 0.84 
Mean Mentally Unhealthy 
Days 
9 6.0 10.6 4.6 0.37 48 4.1 4.0 -0.1 0.71 0.71 
% With Frequent Mental 
Distress 
9 33.3% 
(3) 
33.3% 
(3) 
0 1.0 48 14.6% (7) 6.3% 
(3) 
-8.3 0.22  
Mean Days When Poor 
Mental or Physical Health 
Limited Activities 
10 3.3 1.0 -2.3 1.0 54 1.7 2.3 0.6 0.20 0.14 
% Limited in Activities 
because of  Impairment or 
Health Problem 
10 80.0% 
(8) 
70.0% 
(7) 
-10.0 1.00 57 61.4% 
(35) 
54.4% 
(31) 
-7.0 0.34  
Mean Days Pain Inhibited 
Usual Activities 
10 0.3 0.9 0.6 1.0 50 3.3 3.9 0.6 0.33 0.59 
Mean Days Sad or 
Depressed 
10 4.9 6.8 1.9 1.0 50 2.4 2.7 0.3 0.50 0.97 
Mean Days Worried or 
Anxious 
10 4.7 7.2 2.5 1.0 44 5.1 3.6 -1.5 0.41 0.58 
Mean Days Felt Did Not 
Get Enough Rest or Sleep 
9 7.1 3.1 -4.0 0.16 46 11.4 6.9 -4.5 0.01 0.95 
Mean Days Felt Very 
Healthy and Full of Energy 
8 14.3 14.3 0 0.81 42 10.4 15.0 4.6 0.02 0.47 
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Discussion   
Individuals with prediabetes and/or the metabolic syndrome who participated in a 
community diabetes prevention intervention experienced positive changes in several Quality of 
Life domains over the course of the intervention.  In addition, HRQoL was associated with 
participant success in achieving some of the program goals.  These results demonstrate that there 
are benefits to community diabetes prevention programs that extend beyond improvement in the 
physiological parameters typically measured.  It also suggests that the quality of life of 
participants at baseline may impact the likelihood that they will achieve some of the program 
goals. 
There was a suggestion of an increase in the number of participants who described the 
state of their health as “good” rather than “not good” at the end of the intervention relative to 
baseline.  Oh and colleagues (Oh et al., 2010) showed similar results, finding an increase in the 
general health domain of the SF-36 following a six month lifestyle modification program among 
Korean women with the metabolic syndrome.  Likewise, Levinger and colleagues (Levinger, 
Goodman, Hare, Jerums, & Selig, 2007) reported a significant increase in self-reported general 
health on the SF-36 survey among those with a high number of metabolic risk factors taking part 
in a 10-week resistance training program.  Although these earlier studies used the SF-36 HRQoL 
survey, the CDC HRQoL has acceptable criterion validity when compared to the SF-36 
(Newschaffer, 1998), suggesting that the results from both instruments are likely comparable.  
This finding of improved self-reported general health demonstrates a benefit of these behavioral 
lifestyle programs to the participant that is not usually assessed in a standard clinical visit.   
At the post-intervention visit, participants reported a significant decrease in the number 
of days that they did not get enough rest or sleep, and an increase in the number of days they felt 
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very healthy and full of energy.  There was also a significant decrease in those reporting fair or 
poor health, similar to unpublished findings from an earlier Group Lifestyle Balance intervention 
(Kramer, 2009). These results again strengthen the case that HRQoL improves among 
participants in a diabetes prevention program.  
Baseline HRQoL measures successfully predicted participant success in meeting some 
Group Lifestyle Balance goals.  Those who had less than 14 unhealthy days in the past month 
were more likely to have attended at least six of the 12 sessions, when compared to those with 14 
or more unhealthy days.  Those with fewer unhealthy days were also more likely to achieve the 
weekly physical activity goals of 150 or more minutes, with borderline significance.  This 
finding is not surprising.  Participants who feel healthier would likely be more inclined to attend 
the weekly sessions as well as be more active.  This use of HRQoL scores as a predictor of 
participant success in meeting program outcomes has not been widely reported.  Recently, Beck 
and Shah examined changes in HRQoL in a variety of settings to predict cardiac outcomes, with 
improved HRQoL found to be a significant predictor of event-free survival (Beck & Shah, 2012).  
In the future, baseline HRQoL could be used to identify participants who are at elevated risk of 
not meeting the program goals, and extra measures could be taken to help ensure their success.  
It is not obvious why the number of unhealthy days predicts attendance while “self-
reported health in general” is only a marginally significant predictor.  It is possible that 
participants found it easier to numerically quantify days when physical and mental health are not 
good, than to make the more absolute statement that their health is “fair” or “poor.”  It is also 
possible that those who are feeling well may stop attending the classes because they believe that 
they have benefitted enough from the program at that point, reducing the difference in attendance 
between the two groups.   
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It was anticipated that the emergence of new major impairments or health problems over 
the course of the intervention would impact session attendance and the attainment of weight loss 
and activity goals.  However, attendance was clearly not affected by new impairments, with 
close to 100% of both those with and without impairments attending 50% or more of the 
sessions.  The fact that neither attendance nor physical activity were affected by new physical 
impairments suggests that many of the impairments may not have been serious enough to limit 
mobility.  Additionally, as there were only 10 participants with new impairments, the finding of 
no difference between the impaired and not-impaired groups may be related to sample size.   
The Group Lifestyle Balance program is not specifically a weight loss or physical activity 
program, however, diabetes risk reduction is achieved through the prescription of calorie and 
activity goals that result in weight loss.  While lifestyle intervention programs have been shown 
to improve quality of life among those with the metabolic syndrome, other research suggests that 
the metabolic syndrome may not be independently associated with impaired HRQoL, and that 
obesity and depression may have a more important impact on HRQoL (Vetter et al., 2011).  The 
Diabetes Prevention Program also found that weight loss accounted for HRQoL benefits (Florez 
et al., 2012).  Additionally, it has been shown that among individuals with prediabetes, quality of 
life is higher among those who are physically active compared to those who are not (Taylor et 
al., 2010) and that HRQoL declines linearly with decreasing physical activity (Hakkinen et al., 
2009).  It is thus possible that improvements in quality of life in this study resulted from weight 
loss, increased physical activity, or a combination of those factors, and are not a consequence of 
decreases in other diabetes risk factors.  
There are several limitations with this study.  This was a non-randomized, single-group 
prospective design with a modest sample size.  Generalizability is limited in that the population 
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was primarily Caucasian.  Participant physical activity was self-reported and not objectively 
measured.  Additionally, it is possible that having the lifestyle intervention implemented by 
diabetes educators with advanced training in self-management strategies could bias the results. 
Conclusions 
The findings of this study show that beyond improvement in physiological parameters, 
behavioral lifestyle interventions for diabetes prevention can improve quality of life.  These 
benefits serve to bolster the case for diabetes prevention as a vital public health endeavor, 
because those who participate not only reduce their risk for diabetes, but their quality of life also 
improves, and they feel better.  This study also points the way to an approach which uses 
baseline HRQoL to identify participants at increased risk of not meeting intervention goals, 
allowing them to receive targeted or individual attention.  The continuing use of HRQoL 
assessment will expand the view of what health is, as well as identify novel benefits of diabetes 
prevention programs.  
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APPENDIX B:  PAPER 2 
 
Health-Related Quality of Life in a Diabetes Prevention Intervention Presented in Groups and Via 
DVD 
 
 
 
 
 
Introduction 
Elevated blood glucose is associated with decreased health-related quality of life (HRQoL) 
relative to individuals with normal glucose.  This finding holds whether diabetes is present [1,2] or not 
[3,4].  The presence of the metabolic syndrome is also associated with reduced HRQoL [5,6].   As 
elevated blood glucose and the metabolic syndrome are both associated with lower HRQoL, it follows 
that reducing risk factors for these conditions could improve HRQoL.     
In addition to lowering risk for diabetes, the Diabetes Prevention Program (DPP) [7], showed that 
participants in a behavioral lifestyle intervention also had improved HRQoL in general health, physical 
function, body pain, and vitality [8].  Whether participants in community DPP-based translational 
research projects experience similar improvements in HRQoL has not yet been documented.   
This effort evaluated HRQoL among participants in the Group Lifestyle Balance (GLB) program, 
a community translation of the DPP lifestyle intervention.  Specifically, it tested the hypothesis that 
participants in a translational behavioral lifestyle intervention that resulted in significantly improved 
lifestyle behavior and clinical measures, also experienced improvements in HRQoL. 
 
128 
 
Methods 
 The GLB program [9] was adapted from the DPP lifestyle intervention by the Diabetes 
Prevention Support Center (DPSC) of the University of Pittsburgh.  Typically delivered in a group 
format, this investigation pilot tested a DVD version of the program.  The group version has been 
successfully implemented in a variety of settings [10-12].  The design and methods for this investigation 
are reported elsewhere [13] and summarized here. 
Setting, Recruitment, and Eligibility 
 Health care providers at a primary care practice referred non-diabetic patients aged 18 or older, 
with a body mass index (BMI) ≥ 25, along with prediabetes [14] and/or the metabolic syndrome [15], to 
the intervention. 
Program Delivery  
Participants selected either a group setting or DVD for program delivery.  Group participants 
attended 12 sessions, delivered over 12-15 weeks by a nurse practitioner trained by the DPSC to deliver 
the program.  DVD participants attended one session with the nurse practitioner for an overview of the 
program and materials, and viewed the first DVD.  DVD participants viewed one session weekly, with 
weekly telephone contact from a lifestyle coach at the DPSC to review weight, physical activity minutes, 
and any questions.   Participants in both group and DVD delivery modes were thus offered 12 
professional contacts.  Participants received a GLB workbook, fat and calorie counter, pedometer, and 
self-monitoring books for tracking weight, food intake and physical activity.  Clinical assessment visits 
occurred at baseline, and post-intervention (approximately 3 months), six, and 12 months from baseline.     
The Institutional Review Board at the University of Pittsburgh and the Western Institutional 
Review Board approved this investigation.  All participants provided informed consent. 
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Outcomes 
 The primary outcome was weight loss.  Secondary outcomes included waist circumference, BMI, 
cholesterol, fasting glucose, HbA1C, blood pressure, triglycerides, and self-reported physical activity.  
Participants completed the EuroQol EQ-5D-3L™ at each assessment visit. 
EuroQol EQ-5D-3L™ (EQ-5D and Visual Analogue Scale (VAS)) 
 The EQ-5D-3L™ HRQoL-assessment questionnaire consists of two parts: the EQ-5D and the 
Visual Analogue Scale (VAS).   For the EQ-5D, participants indicated their impairment in each of five 
health dimensions by choosing one of three levels, equivalent to “none,” “moderate,” and “extreme.”   A 
summary EQ-5D index score was calculated, using an algorithm available from EuroQol 
(www.euroqol.com).  Index scores range from 0 to 1.  Higher values indicate better HRQoL.   
The Visual Analogue Scale (VAS) resembles a thermometer marked 0-100, on which participants 
reported their current health state.  Zero represents the “worst imaginable health state” and 100 the “best 
imaginable health state.” 
HRQoL Data Analyses 
Analyses were conducted:  1. On an intention-to-treat basis, with the last observation carried 
forward for missing data; 2. Limited to those who attended the six-month clinical visit and whose baseline 
index score was less than the US adult average; and 3. Including only those who attended all four clinical 
visits.  The paired t-test was used to test before/after differences of  normally distributed EQ-5D index 
and VAS values, and the Wilcoxon signed-rank test for non-normal distributions.  The Spearman rank-
order correlation was used to test associations between weight loss and HRQoL.  Analyses were  
performed using SAS 9.3.  
Results 
The 48 participants enrolled in this study were predominantly female (34 female, 14 male) and 
white (83%), and had a mean age of 59.7 years (Table B.1); 22 chose DVD and 26 selected group 
delivery. 
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Table B.1  Participant Baseline Characteristics 
 Total  
n=48 
n (%) 
Age   mean (range) 59.7 (22-87) 
Female 34 (71) 
White  40 (83) 
Employed full/part time 25 (52) 
Highest Education  
Some High School or Lower 3 (6) 
High School/GED 10 (21) 
Some college/tech school 16 (33) 
College graduate 11 (23) 
Graduate degree 8 (17) 
Smoker 1 (2) 
Family History  
Diabetes 25 (52) 
Heart Disease 24 (50) 
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At three months, there were significant improvements in weight, waist circumference, BMI, HbA1C, and 
systolic blood pressure among participants in both delivery groups, as well as significant increases in self-
reported physical activity [13].  At baseline, the median EQ-5D index score was 0.83 (Table B.2).  No 
significant changes occurred in the EQ-5D index scores at three, six, and 12 months, compared to 
baseline.  This finding remained constant when participants in the two delivery methods were combined, 
and when they were analyzed separately.    Among those participants who attended all four assessments 
(n=31), there were no significant changes in the EQ-5D index scores at three, six, and 12 months, 
compared to baseline (results not shown).  However, when limiting the analyses to only those participants 
whose baseline EQ-5D index scores were below the US average value of 0.87 [16] and who attended the 
three month assessment (Table B.2, bottom) (n=27), there was an increasing trend in median index score 
at three months (p=0.07).   
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Table B.2  EQ-5D Index Scores1 
All Participants 
 Baseline 3 Months p (with 
baseline) 
6 Months p (with 
baseline) 
12 Months p (with 
baseline) 
Group and 
DVD 
Combined: 
median 
25th 
75th 
 
 
(n=45 ) 
0.83 
0.78 
0.84 
 
 
 
0.83 
0.80 
1.00 
 
 
 
0.43 
 
 
 
0.83 
0.80 
0.84 
 
 
 
0.78 
 
 
 
0.83 
0.80 
0.84 
 
 
 
0.70 
DVD only: 
median 
25th 
75th 
(n=21) 
0.84 
0.82 
1.00 
 
0.83 
0.81 
1.00 
 
0.56 
 
0.83 
0.81 
1.00 
 
0.41 
 
0.83 
0.81 
1.00 
 
0.39 
Group only: 
median 
25th 
75th 
(n=24) 
0.80 
0.77 
0.83 
 
 
0.83 
0.80 
0.84 
 
0.11 
 
0.81 
0.79 
0.84 
 
0.31 
 
0.83 
0.76 
0.84 
 
0.88 
Participants whose baseline score was less than or equal to US adult mean of 0.87 [16] 
 Baseline 3 Months p (with 
baseline) 
6 Months p (with 
baseline) 
12 Months p (with 
baseline) 
Group and 
DVD 
Combined: 
median 
25th 
75th 
 
 
(n=27 ) 
0.81 
0.77 
0.83 
 
 
 
0.82 
0.80 
0.83 
 
 
 
0.07 
 
 
 
0.81 
0.80 
0.84 
 
 
 
0.31 
 
 
 
0.80 
0.76 
0.84 
 
 
 
0.79 
 
1. EQ-5D Index Score is a composite of the five quality of life dimensions.  0=poorest health, 
1=best health 
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The median baseline VAS score for all participants was 70.  During the intervention, significant 
increases occurred in the median participant VAS scores at each clinical visit, relative to baseline (Table 
B.3), with the VAS score increasing to 80 at the three and six month assessments, and 85 at 12 months.  
These increases remained significant when analyzing group or DVD delivery individually.  The median 
baseline VAS score of 65 increased to 80 (p<0.0001), 79 (p<0.0001), and 80 (p=0.0011) at 3, 6, and 12 
months post-intervention, respectively, when analyses were limited to participants with baseline VAS 
scores below 79.2, which is the average value reported in the nationally representative Medical 
Expenditure Panel Survey [17].  Spearman rank order correlations between weight change and VAS 
change were significant at 3 months (rho=0.43, p=0.004), marginally significant at 6 months (rho=0.29, 
p=0.061) and not significant at 12 months (rho=0.18, p=0.24). 
Table B.3  EQ-VAS Scores1 
 Baseline 3 Months p (with 
baseline) 
6 Months p (with 
baseline) 
12 Months p (with 
baseline) 
Group and 
DVD 
Combined: 
median 
25th 
75th 
 
 
(n=43) 
70 
59 
80 
 
 
 
80 
70 
85 
 
 
 
<0.01 
 
 
 
80 
70 
90 
 
 
 
<0.01 
 
 
 
85 
70 
90 
 
 
 
<0.01 
DVD only: 
median 
25th 
75th 
(n=21) 
75 
65 
85 
 
80 
75 
90 
 
0.01 
 
80 
75 
90 
 
<0.01 
 
85 
80 
90 
 
0.01 
Group only: 
median 
25th 
75th 
(n=22) 
67.5 
50 
77 
 
80 
70 
80 
 
<0.01 
 
77 
60 
85 
 
0.03 
 
 
82.5 
70 
90 
 
0.02 
 
1 EQ-VAS Score summarizes self-reported health on day administered.  0=worst imaginable 
health, 100=best imaginable health 
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Discussion 
In this study, despite successfully making lifestyle improvements, there was no significant change 
in EQ-5D index scores among study participants as a whole.  However, the median EQ-5D index score 
for all participants in this study was 0.83 at baseline, versus an average of 0.87 for US adults [16], 
suggesting that quality of life within the study group was not significantly impaired.  When analyses were 
limited to the subset of participants with below-average HRQoL at baseline, EQ-5D scores appeared to 
improve during the intervention.   
Measured by the EQ-VAS, participants in this effort showed improvement in HRQoL at three, 
six, and 12 months.  There is no standard Minimally Important Difference (clinically significant value) 
for those with prediabetes, however values for other conditions range from 7-12 [18,19].  It is thus likely 
that the EQ-VAS increases found here, ranging from 5-13, signify a meaningful improvement in HRQoL.  
As with the EQ-5D findings, greater improvement in VAS occurred among those whose baseline VAS 
scores were below average at baseline.  Weight loss alone cannot account for these improvements, as the 
correlation between HRQoL change and weight loss, while significant at three months, decreased 
thereafter, was not significant at 12 months.    
While not a diabetes prevention intervention, Oh et al reported improved HRQoL assessed by the 
Medical Outcome Study Short Form-36 (SF-36) in a  lifestyle intervention for middle aged women with 
the metabolic syndrome, relative to the control group [20].  Similar results were obtained by Cezaretto et 
al in a lifestyle intervention program for individuals with prediabetes or the metabolic syndrome.  They 
reported significant improvements in most of the SF-36 domains for the intensive lifestyle intervention 
group, compared to baseline, with greater improvement in the intervention group than the control [21].  
These findings are consistent with those reported in the current study, although measured by a different 
assessment instrument.  Participants in both of the above-mentioned studies and the current effort were 
mostly female and similar age as participants in this effort.  The inconsistent change in EQ-5D and EQ-
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VAS reported here, was also noted in the Swedish Björknäs study among an intervention population of 
similar age, although with greater gender balance [22]. 
A lack of demographic diversity is a limitation of the current study, as is the small sample size, 
which weakens the ability to detect differences between study subgroups. However the findings suggest 
HRQoL-improvement among those that were low at baseline.  Building on these results, future studies 
should further explore relationships between HRQoL and specific clinical and behavioral outcomes in 
translational diabetes prevention programs.    
With the physiologic benefits of type 2 diabetes risk reduction through lifestyle change well 
established in clinical [7,23 ] and translational settings [9,11,13,24,25], these findings help strengthen the 
case for increasing the use of HRQoL assessment tools in community lifestyle interventions.  
Recognizing Quality of Life as a tangible and experiential outcome of diabetes prevention programs 
should assist clinicians and researchers in moving beyond a consideration of isolated physiologic 
measures, toward an increasingly holistic view of health. 
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APPENDIX C:  PAPER 3 
Participant Expenses in a Translational Diabetes Prevention Program 
Introduction 
The Diabetes Prevention Program (DPP) [1] and translational programs based on the 
lifestyle intervention used in the DPP [2-6] have been shown effective in reducing risk factors 
for type 2 diabetes.  These programs have also demonstrated long term cost-effectiveness [7-10].  
However, from the perspective of a potential participant, the cost or expense of most direct 
interest may not be long-term program cost-effectiveness.  Instead, it may be the more immediate 
expenses that are paid out-of-pocket in order to participate in the program, or the time that is 
necessary to devote to such a program.  These nonmedical expenses are detailed in a review of 
the societal costs related to type 2 diabetes prevention [11], and include time spent on 
intervention-related activities such as involvement in physical activity, or self-monitoring of food 
and beverage intake that would otherwise be spent on a different activity, known as opportunity 
cost;  food costs related to achieving dietary goals; physical activity costs for equipment and 
services related to physical activity goals; and travel costs for intervention-related visits. 
 The DPP reported on these nonmedical expenses for both lifestyle participants and a 
placebo group for three years following the baseline visit [12].  Over three years, per capita food 
expenses were $71 less in the lifestyle group compared to the placebo, due to lower expenses for 
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food purchased away from home.  This and higher expenses for physical activity equipment and 
services like gym memberships or personal trainers, contributed to total expenses that were 
$1445 (9.2%) higher per capita in the lifestyle group than placebo over three years.  
Additionally, the lifestyle group spent a modestly greater amount of time and had higher 
transportation expenses related to attending intervention sessions than did the placebo group.  
These results suggest somewhat greater expenses overall in the lifestyle intervention group than 
in the placebo group.   
While numerous translational diabetes prevention interventions based on the DPP have 
reported clinical results, there has been only one report of direct nonmedical expenses from such 
translational programs.  The Healthy Living Partnerships to Prevent Diabetes (HELP PD) [13] 
trial reported expenses results consistent with the DPP findings:  higher intervention group 
expenses due to the expense of time spent in self-monitoring, physical activity, and travel costs 
related to the intervention, compared to the usual care group, and slightly lower food costs.    
The report of per capita expenses in the DPP and HELP-PD trials showed trends of 
expenditures for the lifestyle and placebo groups, although the statistical significance of these 
results is unknown.  In order to build on the findings of these trials, this current effort will 
examine participant expenses from baseline to six months and between intervention and control 
groups after six months of intervention, in a clinical trial within a typical community setting to 
see if these trends are significant.    
 
Methods 
The Group Lifestyle Balance (GLB) program [2] is a behavioral lifestyle intervention 
adapted from the Diabetes Prevention Program, and typically delivered by trained healthcare 
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professionals.  The curriculum includes the same weight loss goal of 7% and target of 150 
minutes per week of moderately intense physical activity that were successfully used in the DPP 
lifestyle intervention.  The GLB program has been successfully implemented in a variety of 
settings, including medically underserved communities, clinical practices, a fitness center, and 
churches [2,14-16]  
Potential participants were recruited from three community centers using membership 
communications, direct mail, and posters.  Preliminary telephone or in-person screening 
preceded on-site clinical assessment of eligibility.   
Individuals at least 25 years old, with a body mass index (BMI) >24 kg/m2 for whites and 
≥ 22 kg/m2 for Asians, and no previous diabetes diagnosis were eligible to participate when 
meeting the criteria for prediabetes (fasting plasma glucose 100-125 mg/dl) [17] and/or the 
metabolic syndrome.  The metabolic syndrome was defined following the National Cholesterol 
Education Program Adult Treatment Panel 3 criteria as a clustering of abdominal obesity, 
atherogenic dyslipidemia, hypertension, and insulin resistance.  Diagnostically, the metabolic 
syndrome is determined by the presence of three or more of the following five conditions: 
elevated triglycerides (≥150 mg/dl); low HDL cholesterol (<40 mg/dl for men, <50 mg/dl for 
women); increased waist circumference (>102 cm for men, >88 cm for women); blood pressure 
≥130/85 mm Hg (or on treatment for hypertension); elevated fasting plasma glucose ( ≥100 
mg/dL) [18]. Individuals previously diagnosed with diabetes, pregnant or lactating women 
(within past six weeks), individuals unable to obtain physician referral to engage in moderate 
physical activity, or persons planning to leave the area within 18 months, were ineligible.  
A delayed control study design was used, with two thirds of participants randomized to 
an immediate intervention group, and one third randomized to a delayed control group, which 
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received general health information during the first six months.  After six months, the delayed 
control group received the identical intervention as the immediate group did, offset by six 
months.  This design is ideal in that it provides a randomized comparison group during the first 
six months of the study when the immediate intervention group receives the majority of the 
intervention sessions or doses, while at the same time meeting the ethical imperative to 
eventually offer an effective risk reduction intervention to all participants, all of whom are at 
elevated risk for type 2 diabetes and/or have the metabolic syndrome. 
Participants attended clinical assessment visits at their community enrollment site at 
baseline and approximately every six months.  Clinical variables collected included blood lipids, 
insulin, fasting plasma glucose, and HbA1c as well as anthropometric measures.  A brief medical 
history was taken and as a series of surveys given.    
In order to assess direct nonmedical expenses of participants in this intervention, the 
participants completed an expenses survey on which they were asked about their estimated time 
and out-of-pocket expenses related to participating in the GLB intervention, including activity 
and household food expenses, over the previous six months.  These expenses survey was derived 
in part from the NHANES Flexible Consumer Behavior Questionnaire [19].  The study protocol 
was approved by the University of Pittsburgh Institutional Review Board and all study 
participants provided informed consent. 
Analyses were conducted on completers, that is, those who attended both the baseline and 
six month clinical visits.  Restricting analyses to completers, as opposed to using last observation 
carried forward (LOCF) when data is missing, is justified given the objectives of this 
investigation.  What is of interest in this investigation is change in expenses among active 
participants in the intervention, not whether the intervention can elicit change across an 
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experimental group.  To investigate change in study sub groups, results were stratified by 
demographic (age and gender) and goal attainment (weight loss, activity) variables.  Grocery and 
non-grocery store food expenses were combined into a Store Food category, reflecting changes 
in the grocery business since the Flexible Consumer Behavior Questionnaire was developed as 
stores like WalMart and Costco are now major food retailers, yet not considered grocery stores 
by earlier definitions.  The six-month food expenses were adjusted for inflation using Consumer 
Price Index data (http://www.bls.gov/cpi/cpid1301.pdf) and are presented as adjusted and 
unadjusted values. 
The Wilcoxon Signed-Rank Sum test was used to test the change of expenses within the 
two study groups from baseline to clinical visits, and the Wilcoxon Rank Sum test evaluated 
change between the immediate and control groups.  The Spearman Rank-Order Correlation test 
was used to test correlations between variables.  Analyses were carried out using the SAS 
statistical package (version 9.3, SAS Institute, Cary North Carolina, USA).  
 
Results 
 The three community centers from which participants were recruited were located 
diverse socioeconomic communities.  While all three centers had large retiree populations, 
economically and educationally they ranged from being composed of primarily blue collar to 
having a significant proportion of participants with graduate degrees.    
Interested individuals received telephone or in-person preliminary screening, identifying 
204 potentially eligible individuals, of whom 154 were confirmed eligible by clinical screening.  
Of these, 134 participants provided informed consent.  88 participants were randomized to the 
immediate intervention group and 46 to the delayed intervention control.  At baseline, there were 
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no significant differences in clinical or demographic values between the immediate intervention 
and delayed control groups (Table C.1). 
 
Table C.1  Participant Baseline Characteristics  
 
During the first six months of the intervention, weight decreased significantly (-5.1%, 
p<0.001) from baseline in the immediate intervention group, and was significantly decreased 
relative to the control group (p<0.001).  Additionally, glucose, HbA1c, and waist circumference 
were significantly reduced at six months from baseline in the intervention group and when 
compared with the control, similar to what was reported in previous GLB interventions 
[2,20,21]. The median weekly minutes of self-reported physical activity in the intervention group 
significantly increased from baseline at six months (180 to 210, p=0.02) and this change was 
significantly greater than the control group (p=0.05).  This resulted in the intervention group 
Variable  Intervention 
Mean (sd) 
Median (IQR) 
 (n=88) 
Control 
Mean (sd) 
Median (IQR) (n=46) 
p-between groups 
Weight (lbs) 212.4 (46.3) 
202.3 (181.3-241.5) 
 201.5 (37.1) 
195.1 (176.8-220.4) 
.17 
Glucose (mg/dl) 96.0 (10.3) 
94.0 (89-101) 
95.9 (13.1) 
93.0 (87-102) 
.94 
HbA1C (%) 5.80 (0.32) 
5.7 (5.6-5.9) 
5.76 (0.33) 
5.7 (5.6-5.9) 
.53 
Gender (% female, n) 65.9% (58) 69.6% (32) .67 
Age (average years, range) 62.8 (12.1) 61.9 (11.9) .66  
Usual number of people in 
household 
2.02 (0.98) 
2.0 (1-2) 
1.78 (0.66) 
2.0 (1-2) 
.32 
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reporting nearly double the weekly physical activity time of the control group (210 minutes to 
112.5). 
At the six-month clinical assessment there were no significant changes in reported food 
expenses in all food categories for participants in the immediate intervention group (store food, 
take-out food, eating-out food, total food) when compared to baseline.  Interestingly, in the 
delayed control group there was a significant increase in estimated total monthly food spending 
from $594 to $674 (p=0.04) over this same time period (Table C.2).  There was a significant 
difference in the change between the control and intervention groups in the amount of money 
spent eating at restaurants, cafeterias, and buffets, due to the fact that expenses in the control 
group increased while the intervention group expenses decreased (Table C.2).  No other changes 
comparisons between food purchase groups were significant.  Adjusting food expenses data for 
food price inflation weakened the significance of the finding regarding eating out expenses 
between the control and intervention groups.  Other food expenses results were unchanged after 
inflation adjustment (Appendix C1). 
There were no significant differences in the change of total food expenses in the 
intervention group when stratified by achievement of weight loss goals (any, ≥5% and ≥7% of 
baseline body weight) or education as a proxy for socioeconomic status (data not shown).  These 
reported expenses are household-level, and thus only indicate the expenses of an individual GLB 
participant when household size=1.  Stratifying by a household size of one compared to more 
than one also resulted in no significant changes from baseline or between groups for total food 
expenses or any of the component categories (data not shown).    
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Table C.2  Food Expenses by Purchase Site, Comparing Delayed and Immediate Groups Over Six Months of Intervention.
Estimates of 
average 
monthly food 
purchase 
amounts per 
month over last 
6 months 
Delayed 
Group 
baseline I  
Mean (sd) 
Median 
(IQR) 
n=31 
Delayed 
Group 
baseline II  
Mean (sd) 
Median 
(IQR) 
n=31 
Delayed 
Group 
Baseline I  to 
II Change  
Mean (sd) 
Median 
(IQR) 
n=31 
p Immediate 
Group 
baseline   
Mean  (sd) 
Median (IQR) 
n=60 
Immediate 
Group  
6 MO  
Mean  (sd) 
Median (IQR) 
n=60 
Baseline to 6 
MO Change  
Mean (sd) 
Median (IQR) 
n=60 
 
p  
Store food  
(grocery and 
non-grocery, 
($/household) 
364.68 
(182.57) 
360 (240-430) 
455.10 
(255.10) 
400 (260-625) 
90.42 (226.86) 
25 (-40-150) 
0.08 423.88 
(300.14) 
385 (200-575) 
469.65 
(351.00) 400 
(222.5-580) 
45.77 (323.82) 
40 (-75-100) 
0.21 .45 
Purchased take-
out food % 
(n) 
51.6% (16) 41.9% (13) -9.7% (-3) 0.61 70.0% (42) 55.0% (33) -15.0% (-9) 0.13  
Take-out food 
per month 
($/household) 
54.94 (143.58) 
10 (0-60) 
25.65 (39.00) 
0 (0-50) 
-29.29 
(147.84) 
0 (-30-12) 
0.35 36.15 (43.08) 
24.50 (0-55) 
30.62 (45.53) 
6.50 (0-50) 
-5.53 (43.44 ) 
0 (-19-0) 
0.13 .82 
Purchased eat-
out % (n) 
31 31 0% (0) 1.0 91.6% (55) 85.0% (51) -6.0% 0.39  
Eating out food 
per month 
($/household) 
174.74 
(184.28) 
132 (75-210) 
193.55 
(138.94) 
150 (100-240) 
18.81 (160.11) 
20 (-30-80) 
0.13 115.08 
(115.35) 
80 (25-175) 
101.87 (97.37) 
100 (25-155) 
-13.22 (78.98) 
0 (-40-20) 
0.25 .045 
Total of 
estimated food 
spending per 
month ($) 
594.35 
(434.84) 
525 (420-665) 
674.29 
(319.91) 
635 (430-785) 
79.94 (418.19) 
90 (-65-270) 
0.04 575.12 
(377.21) 
497.5 (275-
780) 
602.13 
(400.77) 
528 (330-
793.5) 
27.02 (371.14) 
17 (-91.5-
107.5) 
0.62 .14 
p
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For total expenses related to participating in physical activity, the change in the 
intervention group was of borderline significance ($245 to $180, p=0.06) (Table C.3), resulting 
from a significant decrease in expenses for physical activity services ($189 to $134, p=0.03).  
When stratifying by gender, there was a significant decline in expenses for physical activity from 
baseline to six months in men ($196 to $103, p=0.05) but not women.  Although participants 
aged less than 60 had higher expenses related to physical activity than those aged 60 or over, 
change in activity expenses was not different when stratified by age (data not shown).  There 
were no significant correlations between physical activity expenses or change in physical activity 
expenses and the monthly frequency or change of frequency of activities reported on the MAQ 
(data not shown). 
In terms of time, not surprisingly, participants in the immediate intervention group 
significantly increased the time they put into self-monitoring over six months, relative to baseline 
and when compared to the control group.  This result was unchanged when stratified by gender 
or age (data not shown).   
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Table C3.  Expenses Related to Physical Activity. 
 
   
Household 
Activity 
Expense 
Categories 
($/6 months) 
Control 
Baseline  
Mean 
(sd) 
Median 
(IQR) 
n=42 
Control 
6 Months 
Mean 
(sd) 
Median 
(IQR) 
n=42 
Control 
Change  
Mean 
(sd) 
Median 
(IQR) 
n=42 
p Intervention  
Baseline 
Mean 
(sd) 
Median 
(IQR)  
n=81 
Intervention 
6 Months 
Mean 
(sd) 
Median 
(IQR) 
n=81 
Intervention 
Change  
Mean 
(sd) 
Median 
(IQR) 
n=81 
  
p  
Items (ex. 
shoes, clothing, 
bike) 
38.88 
(55.14) 
0 
(0-65) 
87.81 
(174.92) 
39.50 
(0-100) 
48.93 
(165.98) 
0 
(-25-100) 
.06 56.67  
(127.55) 
0 
(0-75) 
46.12 
(65.41) 
0 
(0-83) 
-10.54 
(112.31) 
0 
(-34-10) 
.40 .10 
Services (ex. 
classes, gym 
membership) 
161.21 
(295.06) 
0 
(0-210) 
92.82 
(158.00) 
0 
(0-192) 
-68.39 
(239.88) 
0 
(-50-0) 
.09 188.93 
(512.91) 
0 
(0-192) 
134.07 
(382.29) 
0 
(0-100) 
-54.85 
(409.76 ) 
0 
(-25-0) 
.03 .86 
Total  200.10 
(300.01) 
96 
(0-285) 
180.63 
(222.21) 
95 
(0-300) 
-19.47 
(279.75) 
0 
(-55-100) 
1.0 245.59 
(535.48) 
75 
(0-270) 
180.20 
(387.33) 
60 
(0-199) 
-65.40 
(421.76) 
0 
(-76-20) 
.06 .51 
p
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Discussion 
 The results from this investigation suggest that at-risk participants in a translational type 
2 diabetes prevention intervention delivered in the community can successfully reduce their 
diabetes risk factors without substantial increases in direct out-of-pocket nonmedical expenses 
for food or to facilitate physical activity.  The only significant increase in expenses in the 
intervention group relative to the control group was related to the time involved in self-
monitoring. 
 These findings build on earlier reports from the DPP clinical trial [12] which suggested 
little change in direct nonmedical expenses in the intervention group, relative to the control.  
They are also consistent with the HELP-PD results [13], but take their results one step further 
and demonstrate that these findings are statistically significant. 
Among some unanticipated results:  Total estimated food expenses increased in the 
control group during the six months between baseline and start of the intervention.  It is possible 
that, in anticipation of future deprivation these participants purchased (and ate) more than they 
otherwise would have [22].  Alternatively, these participants might have attempted to improve 
their diet by increasing purchases of more expensive food items that they considered healthy, in 
an attempt to jump-start healthier lifestyle changes.  Seasonal factors probably contribute to two 
further unanticipated findings in both the intervention and control groups.  The decrease in 
expenses for activity services was significant in the intervention group and borderline in the 
controls.  As the baseline assessment visit was in February and March, expenses reported for the 
previous six months included late fall and early winter months when opportunities for outdoor 
physical activity are more limited and gym memberships increase.  It is likely that decreased 
indoor physical activity during the spring and summer months at gyms and fitness centers 
149 
 
accounts for the decrease in physical activity service expenses from the baseline to the August 
and September six month assessment.  The decrease in time spent cooking in both groups over 
may also be due to seasonal factors that favor meals with less preparation time during the 
warmer months of the year. 
 For time spent in self-monitoring, the increases in the intervention group from baseline 
and relative to the control reflect the impact of the GLB lifestyle intervention, which encourages 
self-monitoring as a tool to assist in meeting physical activity, calorie, and weight loss goals.  It 
should be noted that while average physical activity time significantly increased in both the 
intervention and control groups, the median decreased and the IQR increased in the control 
group and the median increased and IQR decreased in the intervention group.  This suggests that 
the GLB lifestyle intervention may have been successful in increasing physical activity among 
the intervention group as a whole, while in the delayed group, the mean activity time increase 
was due to substantial activity increases in a smaller number of highly motivated individuals. 
 These findings are limited by data that are self-reported and may not reflect actual 
purchases and individual consumption.  They are additionally subject to seasonal influences 
during the six-month period that may confound both the control and intervention groups.  
Starting a future intervention in the late summer or fall would control for possible seasonal 
factors observed here.    
 In summary, these findings indicate that, as part of a behavior lifestyle intervention, 
statistically significant and clinically meaningful reductions in type 2 diabetes risk factors can be 
achieved in the absence of significant increases in expenses, beyond the time involved in self-
monitoring.  It is likely that in a given household, economic decisions are made within the 
financial constraints of the household, and that minimally increased or cost-neutral food and 
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activity choices can be identified by committed participants, working with their lifestyle coaches.   
Such findings should help make participation in a diabetes prevention intervention program more 
attractive for those at elevated risk who might view increased costs an obstacle to successful 
program participation.   
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Appendix C.1 
Table C.4  Inflation adjusted food expenses by purchase site, comparing delayed and immediate groups over six months of 
intervention. Constant 1st half 2012 dollars. (Source: http://www.bls.gov/cpi/#tables) Jan 2013 data for Pittsburgh, PA.  Inflation 
factors: food at home 0.9% applied to store and take-out food; food away from home 0.7% applied to eating-out food. 
Estimates of 
average 
monthly food 
purchase 
amounts per 
month over last 
6 months 
Delayed 
Group 
baseline I  
Mean (sd) 
Median 
(IQR) 
n=31 
Inflation 
Adjusted 
Delayed 
Group 
baseline II  
Mean (sd) 
Median 
(IQR) 
n=31 
Delayed 
Group 
Baseline I  to 
II Change  
Mean (sd) 
Median 
(IQR) 
n=31 
p Immediate 
Group 
baseline   
Mean  (sd) 
Median (IQR) 
n=60 
Inflation 
Adjusted 
Immediate 
Group  
6 MO  
Mean  (sd) 
Median (IQR) 
n=60 
Baseline to 6 
MO Change  
Mean (sd) 
Median (IQR) 
n=60 
 
p  
Store food  
(grocery and 
non-grocery, 
($/household) 
364.68 
(182.57) 
360 
(240-430) 
451.04 
(252.83) 
396.43 
(258-619) 
86.36  
(225.23) 
19.43 
(-44-147) 
0.11 423.88 
(300.14) 
385 
(200-575) 
465.46 
(347.87)  
396.43 
(221-575) 
41.58 
(321.93) 
37.23  
(-78-98) 
0.24 .47 
Take-out food 
per month 
($/household) 
54.94  
(143.58) 
10  
(0-60) 
25.42  
(38.66) 
0  
(0-50) 
-29.52 
(147.76) 
0  
(-30-11) 
0.27 36.15  
(43.08) 
24.50  
(0-55) 
30.34  
(45.12) 
6.44  
(0-50) 
-5.81  
(43.23 ) 
-0.29  
(-19-0) 
0.07 .72 
Eating out food 
per month 
($/household) 
174.74 
(184.28) 
132  
(75-210) 
192.20 
(137.97) 
148.96  
(99-238) 
17.46 
(159.87) 
19.30  
(-30-78) 
0.19 115.08 
(115.35) 
80  
(25-175) 
101.16  
(96.69) 
99.30  
(25-154) 
-13.92  
(78.88) 
-0.70  
(-41-19) 
0.21 .058 
Total of 
estimated food 
spending per 
month ($) 
594.35 
(434.84) 
525  
(420-665) 
668.66 
(317.20) 
629.57  
(426-778) 
74.30  
(417.23) 
84.11  
(-70-260) 
0.05 575.12 
(377.21) 
497.5  
(275-780) 
596.96 
(397.28) 
523.41  
(327-787) 
21.84  
(369.28) 
14.08  
(-97-103) 
0.65 .14 
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APPENDIX D:  PARTICIPANT EXPENSE SURVEY-6 MONTH ASSESSMENT 
 
We are asking you to complete this survey so that we can learn more about the time and 
expenses related to taking part in a healthy lifestyle change program.  This survey asks 
questions about your time and expenses for attending group sessions and/or following the DVD 
sessions (depending on your choice of program delivery), the time that you spent in physical 
activity related activities, and the time your spent in tracking your progress.  This survey also 
asks about specific food and exercise items purchased, health care use, and employment. 
 
Most questions in the survey refer to a specific time period.  The most common time period for 
the responses is the last 6 months. 
 
Please complete as much of this survey as possible before your upcoming visit.  The DPSC 
staff will review the survey with you when you come for your visit.  If you have questions 
regarding the survey, you may ask them at your visit during the survey review, or please feel 
free to call the DPSC at 412-383-1286. 
 
Intervention-Related Time and Expenses: 
 
Considering what you did in the last 6 months, and thinking about your involvement with the 
study… 
 
1. What method of travel do you primarily use to get to the GLB group sessions? (Check one) 
  Your own family car (please also answer questions 2 and 3) 
  A friend’s car (please also answer questions 2 and 3) 
  Bus   (skip to question 4) 
  Train   (skip to question 4) 
  Taxi   (skip to question 4) 
  Walk   (skip to question 4) 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
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 Other (specify: ______________________________________________________) 
 Have not attended group sessions in the last 6 months (skip to question 8) 
 
2. If you drove or were driven to the group session site, about how many miles did you travel 
round trip?  [for one session]     
                                                           _________ miles         
 
3. Did you have any parking expenses?     Yes        No   Doesn’t apply 
a. If yes, what were your expenses?  [consider the total for all visits in the last 4 or 6 
months] 
                                                        $  _______________ 
 
6. What would you be doing if you were not traveling to and attending the GLB group session?   
2.  (Check all that apply) 
a.    Work at a job outside the home 
b.    Household activities (including cleaning, mowing the lawn, making home repairs, and  
other activities needed to keep the household running) 
c.    Going to school 
d.    Leisure activities (including exercise, hobbies, resting, reading, watching television, 
eating a meal) 
e.    Other (specify): ___________________________________) 
 
1 
 
2 
 
3 
 
1 
 
1 
 
1 
 
1 
 
1 
4. If you used a travel method other than your own or a friend’s car, what was the estimated 
travel cost for you for a typical round trip visit to the group session site?    
                                                               $_________                     Walked, doesn’t apply 
5. What is the estimated average round trip travel time to the group session site?  ________ 
 
 
1 
  
8  
  
  7 
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7. If you missed work in order to attend the sessions, did you lose any earnings in your 
wage or salary because of your attendance?  
                          Yes        No   Doesn’t apply 
a. If yes, about how much earnings/wage did you lose?  [consider the total for all visits in 
the last 6 months]       
                                                        $  ________________ 
8. What was the estimated average amount of time that you spent in viewing the GLB DVDs in 
a typical week?         
 :                             Did not watch any GLB-DVD’s  (skip to question 11) 
   hours           minutes    
9. What would you be doing if you were not viewing the GLB DVDs?   
3.  (Check all that apply) 
a.    Work at a job outside the home 
b.    Household activities (including cleaning, mowing the lawn, making home repairs, and 
other activities needed to keep the household running) 
c.    Going to school 
d.    Leisure activities (including exercise, hobbies, resting, reading, watching television, 
eating a meal) 
e.    Other (specify): ___________________________________) 
10. If you missed work in order to view the DVDs, did you lose any earnings in your wage or 
salary because of this action?  
                          Yes        No   Doesn’t apply 
a. If yes, about how much earnings/wage did you lose?  [consider the total for the last 6 
months]       
                                                        $  ________________ 
 
 
 
 
 
 
1 
 
2 
 
3 
     
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
2 
 
3 
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a. Time Recording Self-Monitoring Activities 
The following questions ask about your usual patterns in tracking your physical activity and 
eating.  We are interested in the time that you spent recording your eating and physical activity.   
The next two questions ask you to think about this involvement in a typical week over the first 3 
months of the GLB program. 
11. In the first 3 months of the GLB program, on average in a typical week, about how much 
time did you spend recording your physical activity levels in a diary or log? 
  :   
              hours           minutes 
12. In the first 3 months of the GLB program, on average in a typical week, about how much 
time did you spend recording your eating and beverage intake in a diary or log? 
  :   
                    hours          minutes 
The next two questions ask you to think about this involvement in a typical week over the most 
recent 3 months of the GLB program. 
 
13. In months 3-6 of the GLB program, on average in a typical week, about how much time did 
you spend recording your physical activity levels in a diary or log? 
  :   
                    hours          minutes 
 
14. In months 3-6 of the GLB program, on average in a typical week, about how much time did 
you spend recording your eating and beverage intake in a diary or log? 
  :   
                    hours          minutes 
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b. Time in Exercise  
The next questions ask about your usual involvement in physical activity.  Please think about this 
involvement in a typical week over the last 6 months. 
15. On average in a typical week, about how much time did you spend in physical activity? 
  :    If none, skip to question 17. 
                    hours          minutes 
16. What would you otherwise have been doing if you were not in physical activity?  (Check all 
that apply) 
a.    Work at a job outside the home  
b.    Other forms of leisure that do not involve physical activity  
c.    Household work  
d.    Other (specify: _________________________________________)  
 
 
 
 
 
 
    
 
1 
 
1 
 
1 
 
1 
Time in Food Preparation 
Next, please consider the time related to food preparation for the household where you live. 
Please think about this involvement in a typical week over the last 6 months. 
17. Regarding your eating habits:  
 
a. During a typical week, how many times did you or someone else in your family 
prepare or cook food for dinner or supper at home? 
    times                   or  Don’t know 
 
b. About how much time did the person(s) doing most of the cooking for the household 
spend per week on cooking dinner or supper and cleaning up after the cooking?  
(Please do not include time spent eating) 
   :                           or  Don’t know 
                         hours          minutes 
c. Physical Activity Expenses 
   
1 
     
1 
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Next, please consider any expenses that you incurred related to physical activity over the last 6 
months. 
18. Over the last 6 months, did you purchase any exercise shoes (walking, running, or sport-
specific shoes)? 
  Yes        No   Don’t know  
If YES, 
a. How many pairs of shoes were purchased?       
 
     pairs   
b. What was the total cost of the shoes 
purchased?  (round to nearest $) $  or  Don’t know 
 
1 
 
2 
 
3 
 
    
1 
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19. Over the last 6 months, have any of the following items been 
purchased to help in your physical activity?    (This may include 
equipment and clothing.)   1  Yes 
  
2  No  
If Yes, what did it cost? (round to nearest $).  
a. Exercise videos   Yes  No      Don’t know $  
b. Free weights 
(dumbbells)   Yes  No      Don’t know $  
c. Clothing for 
exercise   Yes  No      Don’t know $  
d. Stationary bicycle   Yes  No      Don’t know $  
e. Regular bicycle  Yes  No      Don’t know $  
f. Treadmill   Yes  No      Don’t know $  
g. Elliptical machine  Yes  No      Don’t know $  
h. Swimming trunks 
or swimsuit   Yes  No      Don’t know $  
i. Other (specify): 
_______________  Yes  No      Don’t know $  
 
 
 
 
 
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
    
20. Over the last 6 months, were any of the following services 
purchased to help you in your physical activities?    1  Yes 
  
2  No  
If YES, what was the total cost paid in this 6 month period for this service (include items 
like initiation fees, monthly dues, locker fees, towel fees, etc.)?  (round to nearest $) 
a. Exercise or aerobics 
classes   Yes  No   Don’t know $  
b. Health club or gym 
membership   Yes  No   Don’t know $  
c. Other exercise related 
services   Yes  No   Don’t know $  
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
    
 
1 
 
2 
 
3 
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d. Food Expenses 
e. The next questions are about how much money your family spends on food.  Food expenses 
may come from several places.  First, we will ask you about money spent on food at 
supermarkets or grocery stores.  Then, we will ask about money spent at other types of stores 
where you buy food.  Lastly, we will ask about prepared food that you carry home or have 
delivered to your home and money that you spend on eating out in restaurants.  
f. Consider your typical experience in the last 6 month period when answering the questions.  
 
21. During the last 6 months, how much money did your family spend per week or per month at 
supermarkets or grocery stores?  Include purchases made with food stamps.  (round to 
nearest $)  (you may answer either as weekly or monthly costs, whichever is easier for you 
to recall) 
g.  $  per week or $  per month or  Don’t know 
h.  
a. Was any of this money spent on nonfood items such as cleaning or paper products, 
pet food, cigarettes, or alcoholic beverages? 
i.   Yes        No   Don’t know 
j.  
b. About how much of this amount, if any, was for non-food items, such as cleaning or 
paper products, food bought for feeding a pet, or cigarettes?  (IF NONE, ENTER “0”) 
(you may answer either as weekly or monthly costs, whichever is easier for you to 
recall) 
k.  $  per week or $  per month or  Don’t know 
Think now of shopping done in different types of places (not grocery stores) that sell food. 
22. During the last 6 months, did your family spend money on food at stores other than grocery stores 
(such as bakeries, delicatessens, meat markets, wholesale stores (Costco, Sam’s), vegetable stands, 
farmer’s markets, health food stores, convenience stores, Target, Wal-Mart, Kmart, and other similar 
places)?  Please do not include stores that you have already told us about) 
  Yes        No   Don’t know 
23. During the last 6 months, about how much did your family spend on food at these types of stores per 
week or per month ?  (IF NONE, ENTER “0”.)   (round to nearest $)  (you may answer either as weekly or 
monthly costs, whichever is easier for you to recall) 
 $  per week or $  per month or  Don’t know 
 
a. Does the household regularly get food or food 
commodities from a food bank or other source?   Yes   No   Don’t Know 
         
1 
 
1 
 
2 
 
3 
         
1 
 
1 
 
2 
 
3 
         
1 
 
1 
 
2 
 
3 
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Think now of prepared food that was purchased outside of the home, but carried home to eat.  This also 
includes prepared food delivered to your home. 
24. During the last 6 months, how much did your family spend per week or per month on food carried out 
or delivered to your home?  (please do not include money that you have told us about already)  (IF 
NONE, ENTER "0") (round to nearest $)  (you may answer either as weekly or monthly costs, whichever is 
easier for you to recall) 
 $  per week or $  per month or  Don’t know 
Think now of food purchased and eaten away from your home. 
25. During the last 6 months, how much money did your family spend per week or per month on eating 
out?  Please include money spent in restaurants, fast food places, cafeterias at work or at school, or 
purchased from vending machines, for all family members. (IF NONE, ENTER "0".) (round to nearest 
$)  (you may answer either as weekly or monthly costs, whichever is easier for you to recall) 
$  per week or $  per month or  Don’t know 
Now, think of your total food purchases from all sources, regardless of where eaten, including 
restaurants. 
26. During the last 6 months, compared to your experience before the intervention, would you say that 
you spend more, spend less, or spend about the same amount of money on food? 
  Spend more on food        Spend less on food   Spend the same on food 
 
Finally, think of the usual size (number of persons) in your family or household, for which you reported 
the food expenses above. 
 
27. During the last 6 months, what was the usual number of persons in your family or household who 
were consumers of the food purchases reported here?    
 
______________ (# of persons)              
         
1 
         
1 
 
1 
 
2 
 
3 
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Medical Issues  
Next, please consider any health events that have occurred over the last 6 months and your 
use of health services for those events. 
28. In the last 6 months, were you injured as a result of your participation in physical activity?   
  Yes        No   Don’t know       (If no, skip to question 29) 
                If yes, briefly describe the type of injury and when/how/where it occurred 
            ______________________________________________________________________ 
a. If yes, did you receive any care from the following: 
               - Hospital requiring an overnight stay?   Yes        No   Don’t know 
                                  If yes, how many nights were you hospitalized?  _________________ 
               - Hospital emergency room?    Yes        No   Don’t know 
               - A doctor seen in his/her office?    Yes        No   Don’t know 
                                 If yes, how many visits to this doctor did you have?  _______________ 
b. If yes, did you receive any prescription medicines for the treatment of the injury?   
 Yes        No   Don’t know 
 
                     If yes, what were you treated with?  ______________________________ 
 
c. If yes, did you use any non-prescription medicines or devices (bandages) for the treatment of 
the injury?   Yes        No   Don’t know 
 
                     If yes, what did you use?  ____________________________________ 
 
 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
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29. In the last 6 months, were you diagnosed with diabetes or told by a doctor that you have 
diabetes?    Yes        No   Don’t know     (If no, skip to question 30) 
 
a. If yes, did you receive any care from the following: 
               - Hospital requiring an overnight stay?   Yes        No   Don’t know 
                                  If yes, how many nights were you hospitalized?  _________________ 
               - Hospital emergency room?    Yes        No   Don’t know 
               - A doctor seen in his/her office?    Yes        No   Don’t know 
                                 If yes, how many visits to this doctor did you have?  _______________ 
b. If yes, did you receive any prescription medicines for treatment of diabetes?                     
  Yes        No   Don’t know 
                     If yes, what were you treated with?  ______________________________ 
 
30. In the last 6 months, has your health changed in any notable way?  For example, you may 
feel that your health has improved or worsened.  
    Yes, my health has improved          No, my health has not changed 
    Yes, my health has worsened         Don’t Know 
31. In the last 6 months, did you receive any care from the following: (do not include the visits  
that you told us about already) 
               - Hospital requiring an overnight stay?   Yes        No   Don’t know 
                                  If yes, how many nights were you hospitalized?  _________________ 
               - Hospital emergency room?    Yes        No   Don’t know 
               - A doctor seen in his/her office?    Yes        No   Don’t know 
                                 If yes, how many visits to this doctor did you have?  _______________ 
                - Any prescription medicines?            Yes        No   Don’t know 
                     If yes, what were you treated with?  ______________________________ 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
1 
 
1 
 
1 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
 
1 
 
2 
 
3 
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Absenteeism 
Finally, please consider your work patterns over the last 6 months. 
 
 
32. In the last 6 months, were you working either full or part time?   Yes        No 
                       If no, your survey is complete and no further responses are necessary  
 
33. About how many hours altogether did you work in the last 7 days?        
                                                                                                                                                                      hours 
34. On average, how many hours does your employer expect you to work in a typical 7 day 
week?                    
                                      hours 
35. Now please think of your work experiences over the last 4 weeks (28 days).  In the questions 
below, write the number of days that you spent in each of the following work situations….. 
In the last 4 weeks, how many days did you…. 
a. miss an entire work day because of problems with your physical or 
mental health?  (please include only days missed for your own 
health, not someone else’s health)  
    days 
b. miss an entire work day for any other reason (including vacation)? 
    days 
c. miss part of a work day because of problems with your physical or 
mental health?  (please include only days missed for your own 
health, not someone else’s health) 
    days 
d. miss part of a work day for any other reason (including vacation)? 
   days 
e. Come in early, go home late, or work on your day off? 
   days 
 
  
 
1 
 
2 
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36. About how many hours altogether did you work in the last 4 weeks (28 days)? (See 
examples below.) 
     
        hours 
 
Number of hours in the last 4 weeks (28 days) 
 
 
 
 
37. On a scale from 0 to 10 where 0 is the worst job performance anyone could have at your job 
and 10 is the performance of a top worker, how would you rate the usual performance of 
most workers in a job similar to yours?  (circle the number) 
 
Worst            Top 
Performance           Performance 
 
 0  1  2  3  4  5  6  7  8  9  10 
 
 
38. Using the same 0 to 10 scale, how would you rate your usual job performance over the last 
year or two? 
 
Worst            Top 
Performance           Performance 
 
 0  1  2  3  4  5  6  7  8  9  10 
 
 
39. Using the same 0 to 10 scale, how would you rate your overall job performance on the days 
you worked during the last 4 weeks (28 days)? 
 
Worst            Top 
Performance           Performance 
 
 0  1  2  3  4  5  6  7  8  9  10 
 
 
   
Examples for Calculating Hours Worked in the Last 4 Weeks 
40 hours per week for 4 weeks = 160 hours 
35 hours per week for 4 weeks = 140 hours 
40 hours per week for 4 weeks with 2 8-hour days missed = 144 hours 
40 hours per week for 4 weeks with 3 4-hour partial days missed = 148 hours 
35 hours per week for 4 weeks with 2 8-hour days missed 
and 3 4-hour partial days missed = 112 hours 
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